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Abstract 
Helicobacter pylori (H. pylori) resides in the human stomach and is the primary cause for 
severe gastric diseases such as gastritis, peptic ulcers and even gastric cancer. It is generally 
accepted that H. pylori is acquired by oral ingestion and several studies provided evidence 
that H. pylori may be present in the human oral cavity. Therefore an interaction of this 
bacterium with components of saliva seems likely. The subject of this thesis was the 
“Interaction of H. pylori with glycosylated salivary proteins”. It ought to be investigated 
whether the mechanisms of adhesin-receptor interactions known from the stomach are also 
found for interactions with salivary glycoproteins. Thus, this Introduction chapter describes 
the pathogenesis of H. pylori and, in particular, the interaction of H. pylori adhesins with 
corresponding receptor structures. Moreover, glycoproteins from saliva that could serve as 
putative receptors for these adhesins as well as the current knowledge about H. pylori in the 
oral cavity are summarized.  
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General Introduction to Helicobacter pylori  
History 
The story began at the end of the 1980s with a fortuitous observation by J. Robin Warren, an 
australian pathologist at the Royal Perth Hospital. While examining routine biopsies from 
dyspeptic patients he observed a large number of curved and spiral-shaped bacteria.  Why had 
stomach acid not destroyed these organisms? One explanation became obvious. They were 
closely associated with the thick gastric mucus layer. J. R. Warren had observed these 
organisms only in inflamed tissues. This observation led him to study this question in more 
detail. With his colleague Barry J. Marshall he tried to culture the bacteria. Their attempts 
were not successful until they forgot some culture plates over Easter holidays. In these five 
days bacterial colonies had emerged  (reviewed in [1]). They named these bacteria 
Campylobacter pyloridis because of their morphologic similarity to other bacteria of the 
Campylobacter genus and published their observations [2]. Because Warren and Marshall had 
found C. pyloridis in the majority of patients with gastric ulcers, they reasoned that peptic 
ulcer disease is associated with the occurrence of these bacteria in the stomach. As an 
experimental test Marshall himself drank culture material with C. pyloridis and, as expected, 
developed dyspeptic illness. In addition, the spiral-shaped bacteria could be detected in his 
gastric biopsies. The infection vanished without treatment. Some years later a successful 
antiobiotic therapy was possible, and, thus, eradication of C. pyloridis. Because C. pyloridis 
did not really fit into the Campylobacter genus, they renamed these microbes into 
Helicobacter pylori (H. pylori) in 1989 [3]. Approximately 20 years after their discovery of 
H. pylori and of its role in peptic ulcer diseases Warren and Marshall were awarded with the 
Nobel prize in Physiology or Medicine [4]. 
Microbiology 
Three morphologic shapes have been described for H. pylori. Normally, this bacterium 
appears spiral-shaped or curved, but it assumes a rod-like shape on solid medium and coccoid 
forms after prolonged culture [5]. It is gram-negative and requires a microaerophilc 
atmosphere with about 5% O2 and 5-10% CO2. H. pylori cells are 2.5 to 5.0 µm long and 0.5 
to 1.0 µm wide. They have four to six unipolar flagella (Fig. 1), which are essential for 
bacterial motility and thus for infection [5]. H. pylori survives in the acidic environment of the 
stomach because it produces high levels of urease, in order to buffer the pH in its immediate 
vicinity. Urease hydrolyses urea into NH3 and CO2, in this way creating a neutral layer around 
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the bacterial surface. Because urease-defective bacteria can not colonize the stomach, it is 
obvious that urease is indispensable as a colonization factor. Despite of its capability to 
survive in strong acid, H. pylori has to leave the stomach lumen, in order to prevent its 
transport into the intestine. Using its flagella H. pylori swims towards the viscous mucus layer 
that covers the epithelial lining of the gastric mucosa, guided by chemotactic factors including 
urea and bicarbonate. Like a corkscrew the bacterium bores into the mucus layer, finally 
reaching the surface of the gastric epithelium. This behavior is a second colonization factor, 
because non-motile mutants are not able to colonize the stomach  (reviewed in [6]). 
 
 
Fig. 1: Curved Helicobacter pylori with unipolar 
flagella. Source: [7] 
 
 
H. pylori-associated diseases 
Because of its very good adaptation to the hostile environment of the human stomach H. 
pylori establishes a lifelong chronic infection after a first infection early in life. The initial 
colonization with H. pylori causes an acute inflammatory response (acute gastritis) that is 
accompanied by an infiltration of the gastric mucosa by neutrophils. The degree of mucosal 
damage correlates with the neutrophil infiltration. Today it is accepted that a H. pylori 
infection is the primary cause of active chronic (type B) gastritis in humans [8].  
 Most infected people are asymptomatic initially but they may develop peptic ulcer 
diseases including gastric or duodenal ulcers with a risk of 10%. Almost all duodenal ulcers 
and 70% of gastric ulcers are attributable to H. pylori infection. This is supported by the fact 
that the recurrence rate of peptic ulcer diseases is noticeably reduced after the successful 
treatment of a H. pylori infection [9, 10].  
  A long-term consequence of gastric ulcer could be the development of 
adenocarcinoma [11] and mucosa-associated lymphoid tissue (MALT) lymphoma [12]. 
Therefore, H. pylori was designated as a class I carcinogen by the World Health Organization 
in 1994 [13]. Although the interrelation of H. pylori and gastric cancer is known, only a small 
fraction of colonized individuals develop this malignancy. This lead to the assumption that 
not only H. pylori genotype but also host genotypes influence the risk of carcinogenesis [11]. 
Chapter 1  Introduction 
 
 
 - 11 -   
Virulence factors 
Adhesion, invasion and toxin elaboration are three important factors of virulence that can be 
used by bacteria to cause disease in the host [10]. Although urease-production and flagella 
were recognized as important colonization factors of H. pylori early on, it was tried to identify 
the virulence factors of this organism, that finally cause gastroduodenal disease. The two best-
characterized virulence factors of H. pylori are VacA and CagA. 
 The so called "vacuolating toxin", VacA inserts into the epithelial-cell membrane and 
forms hexameric, anion-selective, voltage-dependent channels. In addition, VacA forms pores 
also in the mitochondrial membrane [14]. A role of VacA in the pathogenesis of H. pylori is 
seen in the induction of apoptosis [15], in immune suppression [14] and in its 
proinflammatory activity [14]. However, the pathogenic role of this toxin is still under 
dispute, because of the extensive variability in the vacA gene in different geographic regions.  
 In contrast to VacA, the correlation between the expression of CagA (cytotoxin-
associated gene A) and H. pylori virulence is well-documented. It is associated with both, 
duodenal ulcers and gastric cancer [16, 17]. CagA is translocated into the host cell by a type 
IV secretion apparatus, that is encoded by the cag pathogenicity island (cag-PAI). CagA is 
present only in virulent type I strains of H. pylori whereas type II strains do not express CagA 
[18]. CagA enters epithelial cells where it becomes tyrosine phosphorylated  and initiates thus 
a series of events [19-21]. 
 Although VacA and CagA constitute important virulence factors of H. pylori, the 
delivery of these proteins to host cells requires intimate contact between bacteria and gastric 
epithelial cells. Therefore, bacterial adhesion is considered to contribute as well to 
pathogenicity of H. pylori. 
Adhesion Properties of Helicobacter pylori in Pathogenesis 
Bacterial adherence  
Bacteria have adapted to a great variety of ecological niches, including the human body. A 
key event in bacterial colonization of the host is adhesion mediated by bacterial adhesins or 
adhesive organelles, such as fimbria. These recognize either carbohydrates or peptide 
structures on host cell surfaces followed by adherence-associated events, such as bacterial 
uptake into cells or host signaling. By establishing a complex molecular host-pathogen 
crosstalk these events can finally lead to the disturbance of cellular function and the initiation 
of diseases [22-24]. Bacterial tools used for cell adhesion and invasion range from single 
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monomeric proteins like fibronectin-binding proteins [25] to highly sophisticated 
macromolecules like retractile type IV pili [26]. Because of fine-tuned specificities of 
bacterial adhesins and also by the tissue-specific distribution of receptors, only a restricted 
number of hosts and tissues are amenable to bacterial colonization. This is often referred to 
tissue-host tropism [27]. Tissue-host tropism is also well-known for H. pylori because it is a 
primate-host-specific pathogen that exhibits tropism for the gastric surface mucous cells in the 
lower part of the stomach [28]. The ability of H. pylori to adhere with its adhesins to specific 
receptors in the gastric mucosa is considered to be both, colonization and virulence factor. A 
lifelong infection of the stomach by H. pylori would not be able without adherence because of 
the rapid turnover of the gastric mucus and, thus, possible elution of the bacteria [29].  
H. pylori adherence 
Most H. pylori organisms are found motile in the mucus layer of the human stomach. 
Residual bacteria are found adherent to the epithelial surface (Fig. 2). The intimate attachment 
of H. pylori to gastric epithelial cells can be seen as the first step in infection, because it might 
facilitate bacterial colonization, the delivery of effector proteins such as CagA and VacA into 
host cells, or the gain of nutrients from cells that are damaged by the inflammation.  
Therefore, great efforts have been undertaken to identify adhesion mechanisms of H. pylori. 
Putative adhesins and related receptors of H. pylori have been investigated in several studies. 
Among the adhesins the H. pylori outer-membrane proteins (OMPs) BabA, SabA, AlpA and 
AlpB are very well-characterized now. Nevertheless, there are some more adhesins described 
in the literature, that have to be regarded also (reviewed in [28-30]). 
 
 
Fig. 2: Adhesion of Helicobacter pylori to gastric 
epithelium. Source: [31] 
 
 
Blood group antigen-binding adhesin (BabA) 
First indications for the interaction of H. pylori with the histo-blood group antigens was given 
by Falk et al. in 1993. He and its colleagues developed an in situ adherence assay to examine 
the nature of H. pylori binding to gastric epithelium. On the basis of three observations they 
suggested a role for fucosylated epitopes in the binding of H. pylori to surface mucous cells: 
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(i) fucosylated blood group antigens H and Lewis b blocked binding of H. pylori to epithelial 
cells, (ii) the lectin Ulex europaeus type I, that is specific for α-L-fucose, bound to the same 
cells that bound H. pylori and (iii) human colostrum secretory IgA inhibited adhesion in an α-
L-fucosidase-sensitive fashion [32]. In the same year, Borén et al. supplied evidence, that the 
Lewis b antigen mediates the H. pylori attachment to human gastric mucosa. In addition, they 
showed that the Lewis b antigen substituted with a terminal GalNAcα1,3 residue (blood 
group A determinant), was not bound by H. pylori. They concluded, that the availability of H. 
pylori receptors might be reduced in individuals of blood group A and B phenotype, as 
compared with blood group 0 individuals [33]. In 1998, the respective blood group antigen-
binding adhesin, BabA, could be purified by a novel technique called receptor-activity-
directed affinity tagging (ReTagging). The molecular weigth of BabA is 78 kDa [34]. 
Analysis of the babA gene revealed, that there are H. pylori strains that carry two babA alleles 
(babA1 and babA2) such as strain 17875 and strains that possess only one babA2 allele, such 
as J99 [35, 36]. Deletion of the babA2 allele resulted in loss of Lewis b binding activity, 
whereas deletion of babA1 had no affect on binding. The babA2 allele encodes consequently 
the Lewis b binding adhesin [34]. A recent study showed that the Lewis b-binding H. pylori 
strains subdivide into generalists and specialists. Generalists (more than 95% of all fucose-
binding strains) recognize Lewis b irrespective of any terminal modification, i.e. they bind to 
A, B, and O antigens (see also next chapter “H. pylori Receptors: Histo-Blood Group 
Antigens“). Specialists (60% of adherent South American Amerindian strains) recognize only 
naked Lewis b, i.e. they bind blood group O antigens best. The authors concluded that cycles 
of selection have contributed to the babA diversity and that these cycles have led to a 
replacement of generalists by specialists in blood group O-dominant human populations [37]. 
The importance of BabA as virulence factor became obvious, when it could be 
correlated to the group of triple positive H. pylori strains. These disease-promoting strains 
(German clinical isolates) are characterized by the presence of vacA and cagA beside babA2. 
They were found significantly more frequent in patients with ulcer disease or gastric 
adenocarcinoma, than in patients with gastritis only [38]. However, these genetic markers 
have to be treated with caution, when estimating the risk of an infection outcome. Ilver et al. 
observed that a deletion of the cag-PAI resulted in no reduction of the Lewis b antigen-
binding activity [34]. In addition, in a study with Japanese clinical H. pylori isolates, no 
significant correlation between the babA2 genotype and an infection outcome could be 
observed [39]. 
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Adherence-associated lipoproteins A and B (AlpAB)  
Mutagenesis of H. pylori genes encoding surface-exposed proteins led to the identification of 
a genetic locus, that is involved in adherence to the gastric cells [40]. This operon was 
designated as alpAB (adherence-associated lipoproteins A and B). It encodes to homologous 
OMPs (AlpAB) that were observed to be essential for H. pylori binding to human gastric 
biopsy sections [41, 42]. Unpublished observations indicate that AlpAB proteins are involved 
in the functional folding and/or presentation of SabA and other putative adhesin of H. pylori 
and are no real adhesins [43].  
Sialyl-Lewis a/x binding adhesin (SabA) 
A persistent colonization of the human stomach by H. pylori is accompanied by a strong 
inflammation of the gastric tissue. This leads to the replacement of naturally produced Lewis 
antigens by sialylated Lewis antigens as part of complex gangliosides [44]. In this regard, it 
was searched for novel H. pylori receptors. It could be observed, that H. pylori preferentially 
bound sialylated gangliosides with multiple Lewis x motifs in the core chain. The 
corresponding sialyl-Lewis a/x binding adhesin SabA could be identified [45]. It was also 
isolated by the “ReTagging”-method and the underlying sabA gene was sequenced. The 
molecular weigth of SabA is 66 kDa. [45]. The role of SabA as virulence factor was 
supported by two observations. On the one, hand sialylated antigens are known to be elevated 
in gastric carcinoma [29]. On the other hand, SabA was shown to be important for the 
nonopsonic activation of human neutrophils [46].  
N-Acetylneuraminyllactose-binding fimbrial hemagglutinin (HpaA) 
The H. pylori interaction with sialylated binding sites was known for a long time. Evans et al. 
found that H. pylori possesses a cell-bound hemagglutinin detectable with human 
erythrocytes. Hemagglutination could be inhibited with rather 3’-sialyllactose, than 6’-
sialyllactose [47]. The sialic acid-dependent hemagglutinin activity was attributed to fibrillar 
structures on the bacterial surface. The hpaA gene encoding the HpaA N-
acetylneuraminyllactose-binding fimbrial hemagglutinin could then be cloned and sequenced 
[48]. Some years later,  however, it could be shown, that HpaA is also located in the inner 
membrane and cytoplasm of H. pylori. Moreover it was demonstrated, that HpaA is not 
involved in hemagglutination, because a hpaA deletion mutant showed no reduced sialic acid-
dependent hemagglutinin activity [49]. 
Chapter 1  Introduction 
 
 
 - 15 -   
H. pylori neutrophil-activating protein (HP-NAP) 
The H. pylori neutrophil-activating protein (HP-NAP) has been shown to induce adhesion of 
neutrophils to endothelial cells in culture. Therefore, it was suggested to play an important 
role in the activation of human neutrophils [50]. In addition, HP-NAP was shown to be 
responsible for binding of H. pylori to sulfated salivary mucin [51] and to sialylated 
neutrophil glycolipids [52]. In recent studies it could be shown that HP-NAP neither leads to 
the adherence of H. pylori to neutrophils nor induce nonposponic activation of neutrophils 
[46, 53]. 
Other adhesins 
HopZ, also an H. pylori OMP, has been suggested to be involved in adherence of H. pylori. It 
was shown that H. pylori bound HopZ-mediated to gastric carcinoma cell lines AGS [54]. 
However, its role as adhesin is not yet proven. Besides the above mentioned adhesion 
properties further bacterial adhesin candidates have been described, suggesting an enrollment 
of additional interactions that are not fully explored yet. Specific binding of H. pylori to a 
phopholipid (phosphatidylethanolamine) in the antrum of the human stomach was reported 
[55]. The isolated adhesin candidate, however, was later shown to be a catalase [56]. Thus it 
seems unlikely that this was a true adhesin. Furthermore, adhesion of H. pylori to various 
extracellular matrix components such as lactoferrin and laminin was reported by many 
investigators [57-61]. Binding of H. pylori to lactoferrin was attributed to either a 60 kDa heat 
shock protein [58] or a 70 kDa lactoferrin-binding OMP of H. pylori [57]. For the binding of 
H. pylori to laminin also two explanations were proposed. A lectin-like interaction of the 
bacterium with terminal sialic acids on laminin [61] and an interaction of H. pylori 
lipopolysaccharides with laminin [62].  
H. pylori Receptors: Histo-Blood Group Antigens  
ABO blood group antigens are carbohydrates and represent terminal structures of glycan 
chains. They are found typically on erythrocytes, but they are also expressed on epithelial cell 
surfaces, such as pyloric and duodenal mucosa. Blood group A and B phenotypes are 
characterized by the presence of A and B antigens, respectively (Fig. 3). The product of the O 
gene was thought to be the O-Antigen, that was detectable with several lectins. However, it 
turned out that the “O-antigen” was present in not only O phenotypes, but also to a lesser 
extent in A, B and AB phenotypes. The “O-antigen” was in fact a precursor of the A and B 
antigens; it was then termed H-antigen. The O gene was thus a silent allele at the ABO-locus.  
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Fig. 3: Structural relationships between H. pylori-relevant blood-group determinants 
 The biosynthesis of ABH antigens proceeds from precursors by stepwise addition of 
monosaccharide units by glycosyltransferases. Two types of precursors are part of the lacto 
series (lactotetraosyl- and lactoneotetraosyl-precursor, Fig. 3) and are found amongst others in 
the gastrointestinal tract. Other types of precursors are found on O- and N-glycans or on 
various glycolipids. Starting from the lactotetraosyl- and lactoneotetraosyl-precursors the H 
type antigens (type I and type II, respectively) are formed by adding fucose to the terminal 
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galactose residue. The A and B antigens are formed by adding to the H antigens terminal N-
acetylgalactosamine and galactose, respectively. The Lewis a and x antigens are formed 
directly from the precursors by adding a branched fucose. Lewis b and Lewis y are formed by 
adding branched fucose residues to the H antigens. The sialyl-Lewis antigens are obtained by 
addition of a sialic acid first, followed by addition of a fucose. (reviewed in [63-65]) 
In the ABO blood-group system the O phenotypes dominate with ~45% carriers among 
Caucasians, reaching 100% in some populations. Lewis b is the major blood group antigen in 
the Lewis system with more than 70% of individuals being positive. Some individuals were 
found to secrete “blood group substances” in secretions such as saliva or gastric mucosa. The 
expression of H antigens in secretions and the genes involved were named Se (secretor) and se 
(non-secretor). It turned out that individuals whose red cells typed as Le(a-b+) were always 
secretors, individuals who typed as Le(a+b-) were always non-secretors. Individuals who 
typed as Le(a-b-) could be either secretors or non-secretors [64]. 
 The relevance of histo-bood group antigens as H. pylori receptors was supported by 
different observations: When the distribution patterns of blood group antigens in human 
gastric mucosa was mapped, it turned out that distribution of the A, B, H, Lewis a and Lewis 
b antigens matched the distribution of receptors for H. pylori completely. In addition, it was 
observed, that in secretor individuals, sialylated antigens are low in healthy gastric mucosa 
but are expressed strongly during gastritis [44, 45, 63]. 
The Oral Cavity as an Entry Pathway for H. pylori 
Epidemiology and transmission 
Up to one half of the world’s population harbors H. pylori [1]. The prevalence varies greatly 
among countries and population groups even within the same country and is correlated with 
socioeconomic conditions. The prevalence among middle-aged adults is over 80% in 
developing countries, compared to about 20% in industrialized countries [66].  
 The origin of infections and the way of transmission are not entirely understood [67, 
68]. The infection seems to be acquired almost always during early childhood by oral 
ingestion of the bacterium. Barry J. Marshall, who ingested H. pylori orally and, as a 
consequence, developed gastritis demonstrated that H. pylori must reach the stomach via the 
oral cavity [69]. It seems likely that in industrialized countries the direct transmission from 
person to person by vomitus, saliva, or feces predominates, whereas additional transmission 
routes, such as water, may be important in less developed countries [66, 68]. The intestinal 
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tract of humans and some non-human primates seems to be the sole reservoir for H. pylori 
[68].  
 It has been speculated whether the fecal-oral route or the oral-oral route is more likely 
or if both routes coexist. An argument for the fecal-oral transmission could be, that H. pylori 
is eliminated because of the constant turnover of the gastric mucosa after which the bacterium 
is transported into the intestine and  eliminated into the environment. The survival of H. pylori 
in the external environment may be facilitated by the formation of the non-culturable but 
viable coccoid forms [70]. In fact, H. pylori could be isolated from human feces [71]. Feces 
contaminated drinking-water was regarded as potential infection source [72], although H. 
pylori could not be isolated from water. An argument for the oral-oral route was that H. pylori 
might be able to access the oral cavity from gastric juice by reflux from the stomach, and 
saliva might thus act as a vehicle for transmission. This latter hypothesis is supported by a 
previous study, that showed an oral-oral transmission in the case of an African women who 
premasticated food given to their infants [70]. 
 Serological and DNA fingerprint analysis in several studies suggested that 
transmission of H. pylori occurs mainly within families, i.e. vertical instead of horizontal 
transmission takes place. In this regard transmission from mother to children seems more 
likely than transmission between siblings [68, 73-75].  
Detection of  H. pylori in the oral cavity 
The oral cavity has a number of ecological niches, some of which may support the 
microaerophilic environment necessary for H. pylori survival. By bacterially induced loss of 
attachment between teeth and supporting bone a soft tissue-lined pocket is formed around the 
teeth. This provides an unique environment for bacterial colonization by a great number of 
bacterial species and probably also by H. pylori [76]. Therefore, the oral cavity was regarded 
as a transient or even permanent extra-gastroduodenal reservoir for H. pylori infection and 
transmission [77]. In many studies H. pylori DNA was detected in the mouth utilizing the 
polymerase-chain-reaction (PCR) technique (reviewed in [67]). However, this technique 
produced no consistent results about the number and frequency of occurrence of H. pylori in 
the oral cavity. Detection rates ranged from 0% to 100%, perhaps caused by the fact that 
studies differed in the primer sets used for PCR as well as in the choice of their study subjects 
that originated from different countries [67, 78-80]. In addition, contamination artifacts might 
have been a problem [81]. Therefore it was tried to culture H. pylori from oral samples. This 
failed in most cases [82-84]. However, there are a few reports that show the successful culture 
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of H. pylori from the oral cavity and a confirmation of these strains as H. pylori by 
hybdridization [70, 85, 86]. The low number of H. pylori organisms compared to a great 
number of other, faster-growing bacterial species in the oral cavity and the possible presence 
of non-culturable, but viable coccoid H. pylori organisms might complicate the culture of this  
bacterium further [87]. 
Interaction of Oral Bacteria With Salivary Proteins 
Bacteria in the oral cavity 
The Dutch glassmaker Antony van Leeuwenhoek can be regarded as the father of oral 
biology. By using very simple one-lens microscopes he discovered the first microbes in the 
mouth already 400 years ago, and recorded the diversity of these organisms [88]. The human 
body harbors a 10-fold greater number of microbial cells than human cells [89]. More than 
700 bacterial taxa, of which over 50% have not been cultivated, have been detected in the oral 
cavity [90]. Van Leeuwenhoek stated:”...there’s always been a sense that the community is 
what matters; the community is capable of doing things that individual [species] cannot” [88]. 
A guideline that is to keep at the back of one’s mind when a certain bacterial species of the 
oral cavity ought to be investigated.  
 Numerous examples of specific interactions between oral bacteria and salivary 
components have been reported. The study of bacterial adhesion as the first step in infection 
had its origin in the examination of the interaction of oral bacteria with salivary proteins. The 
fact that the oral cavity is easily accessible, facilitated adhesion studies that would have been 
more difficult for other organ systems (e.g. respiratory or gastrointestinal). The fact that many 
human systemic pathogens probably first colonize the oral cavity before initiating diseases of 
target organs as it was suggested for the development of pneumonia or gastritis was another 
favourable condition [67, 91]. 
Salivary pellicle  
The microbial community exists principally organized in biofilms on oral surfaces, on teeth, 
gums, tongue or prostheses when present [92]. Biofilm formation is initiated by the adhesion 
of primary microorganisms to components of the acquired enamel pellicle [93]. This term 
describes a thin (0.1 to 1.0 microns thick) organic film of proteinaceous nature that develops 
on a cleaned tooth surface within seconds to minutes [91, 94]. It was suggested that pellicle 
formation reaches an equilibrium between adsorption and de-sorption of protein within two 
hours [95]. This pellicle forms, however, not only on enamel, but also on cementum, on 
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dental restorative materials, on the mucosal epithelium and even on surfaces of oral 
microorganisms.  
 Attachment of salivary molecules to the tooth surface results from a combination of 
physical forces e.g. ionic or hydrophobic interactions, hydrogen bonding and van der Waals 
forces. Mainly negatively charged carboxyl-, phosphate-, sulfate- and sialic acid groups of 
theses salivary molecules interact with calcium ions of hydroxyapatite. Periodic acid schiff 
stain of extracted teeth led to the assumption of carbohydrates in the pellicle. A high content 
of glucose but also mannose, galactose, glucosamine and galactosamine could be identified. 
The high content of glucose was puzzling because this monosaccharide is rare in 
glycoproteins. Thus, it was suggested that the majority of glucose present in pellicle does not 
origin from salivary glycoproteins. Also the amino acid composition of the pellicle was 
investigated. One interesting aspect of these investigations was, that the composition of 
pellicle proteins is different from those of whole saliva. Pellicle proteins contain significantly 
more hydrophobic and less neutral amino acid than whole saliva. Major salivary proteins in 
the pellicle are mucin MUC5B, secretory immunglobuline A (S-IgA), lactoferrin, lysozyme, 
cystatin (type SA-I), acidic proline-rich proteins and amylase. Salivary carbonic anhydrase, 
albumin, IgM and IgG were found as well. In addition to salivary components, dental pellicles 
also contain constituents from crevicular fluid, microbial and cellular sources. The so-called 
early pellicle forms within 2 hours. It is assumed that the process of pellicle formation is 
generally similar on various surfaces. In contrast, the pellicle composition is influenced by 
surface modifications. The early pellicle undergoes by-and-by a transition to the so-called 
later pellicle, mainly caused by enzymatic degradation and/or addition of further components. 
Enzymes originate from bacteria, desquamated epithelial cells and leukocytes from crevicular 
fluid. This pellicle transition influences the pellicle composition, e.g. by a decrease of proline-
rich proteins. Simultaneously a transition in bacterial attachment can be observed because 
receptors for one group of bacteria are destroyed and  new receptors for others arise. 
(reviewed by [91, 95]) 
Oral biofilm  
Bacteria in an aquatic environment show a tendency to interact with surfaces. Bacteria 
become first reversibly associated with tissue surfaces by electrostatic or hydrophobic forces 
of low specificity. However these forces are not sufficient to resist cleansing forces and to 
permit colonization. This reversible adherence can therefore only seen as a first approach of 
bacteria  in the biofilm development. The real step of initial biofilm development is the 
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binding of proteinaceous components (adhesins) of bacteria to complementary molecules 
(receptors) on the tissue surface. The oral biofilm develops, thus, by binding of primary 
colonizers to proteins of the pellicle. This includes lectin-like recognition of oligosaccharide 
receptors or protein-protein interactions [96]. Amongst the earliest colonizers are more than 
60% streptococci [93] as well as Actinomyces [97, 98], Veillonella and Neisseria [99]. These 
pioneer organisms then provide a new surface and appropriate metabolic conditions for the 
attachment of succeeding organisms (Fig. 4). Proteins bound by primary colonizers  are, 
amongst others, proline-rich proteins and proline-rich glycoprotein, statherin, salivary mucins, 
salivary agglutinin gp-340, α-amylase, immunglobulins or lactoferrin [91]. Once bacteria 
have adhered to the oral surfaces, the development of the mixed species biofilm proceeds by 
cell growth and division as well as coaggregation of bacteria, such as Fusobacterium 
nucleatum and Porphyromonas gingivalis  with the primary colonizers [100].  
 
 
 
Fig. 4: Diagrammatic representation of the proposed sequence of events in human oral biofilm 
formation on the tooth surface.  Source: [100] 
 Not all bacteria that enter the oral cavity adhere and colonize. Only a small fraction of 
the bacteria attach and remain in the oral cavity but the majority of them are removed. 
Bacterial clearance occurs by mechanical flushing, i.e. swallowing, chewing or spitting that is 
moreover facilitated by binding of salivary components to bacterial adhesins [101]. These 
interactions can result in clumping (saliva-mediated agglutination) or steric hindrance of 
adhesion [91]. 
Chapter 1  Introduction 
 
 
 - 22 -   
Salivary Glycoproteins 
Salivary glycoproteins provide receptor structures for microbial adherence and they exert a 
number of protective functions in the oral cavity. Chemically, salivary glycoproteins can be 
broadly divided into two groups: (1) Salivary glycoproteins of serous cell origin and (2) of 
mucous cell origin. Group (1) contains N-glycosidic units characterized by the presence of 
mannose and a glycopeptide linkage of N-acetylglucosamine-Asn. Group (2) is more heavily 
glycosylated, contains O-glycosidic carbohydrate units and has a N-acetylgalactosamine-
Ser/Thr glycopeptide linkage. Some glycoproteins, however, such as S-IgA have both N- and 
O-linked carbohydrate units. Beside this classification, salivary glycoproteins can also be 
grouped into several families (e.g. salivary mucins, PRPs). Their members share common 
structural features with the exception of structural differences arising from transcriptional and 
post-translational modifications [102]. The following sections include salivary glycoproteins 
that are relevant for this thesis. 
Salivary mucins 
Salivary mucins are glycoproteins, that are characterized by a high number and diversity of 
oligosaccharide side chains, O-glycosidically linked to a polypeptide backbone of repeating 
amino acid sequences. The glycopeptide-linkage is formed between N-acetylgalactosamine 
and threonine or serine [103]. Sugar residues are galactose, N-acetylgalactosamine, N-
acetylglucosamine, fucose and sialic acid [104]. Because of their strong glycosylation the 
conformation of mucins is often compared with a bottlebrush. Unglycosylated regions of 
mucins are vulnerable to proteolysis [105]. Mucins form viscoelastic, hydrophilic gels, that 
stick to all kinds of mucous surfaces and function as physical barriers, in this way protecting  
the underlying tissue. As constituents of the pellicle they protect oral surfaces against 
chemical and mechanical damage as well as microbial invasion [106]. Among salivary 
mucins, there is a high molecular weight species, MUC5B (> 1000 kDa), and a lower 
molecular weight species, MUC7 (200-250 kDa) [107] (Fig. 5). 
 Only 15% of the total molecular mass of MUC5B stems from the protein core. The 
protein core is composed of disulfide-linked subunits. The carbohydrate content contributes 
78% and sulfate 7% to the molecular of MUC5B. The major oligosaccharides range in size 
from 4 to 16 sugar residues [107]. In saliva of secretors, ABH, Lewis a, and Lewis b blood 
group antigens are mainly expressed on MUC5B [108].  
MUC7 is composed of a single peptide chain, which account for 30% of the total 
molecular mass. The carbohydrate content is about 68% with oligosaccharides of 2 to 7 
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monosaccharide residues in length. Approximately 170 oligosaccharide side chains are 
distributed over the polypeptide backbone. It is known that MUC7 contain terminal α2,3-
linked sialic acids, α1,2-linked fucose and β1,3-linked galactose [107]. 
 
Fig. 5: Schematic model of salivary mucins. MUC5B shows several subunits. MUC7 is composed of 
one subunit. Source: modified from [109] 
Salivary agglutinin (gp-340) 
Salivary agglutinin is a 300 to 400 kDa glycoprotein that was originally identified as the 
protein responsible for its Streptococcus mutans aggregation properties [110]. Recently it has 
been shown that agglutinin is identical to the lung glycoprotein gp-340, a member of the 
scavenger receptor cysteine-rich (SRCR) superfamily [111, 112]. gp-340 is a product of an 
alternatively spliced form of the DMBT1 gene. This gene codes for 3 distinct conserved 
proteins domains. One of these domains is the SCRC domain [113]. It has been reported that 
blood group antigens and Lewis antigens are present on agglutinin, dependent on the secretor 
status. In addition, the presence of α2,3-bound sialic acid-containing epitopes has been shown 
[114]. 
Salivary α-amylase 
The calcium-requiring metalloenzyme α-amylase catalyzes the hydrolysis of internal α(1-4) 
glycosidic linkages in starch, glycogen, and glucose polymers [107]. Salivary amylases 
comprise two major families; family A amylases are glycosylated 62 kDa glycoproteins 
whereas family B amylases are nonglycosylated 55 kDa proteins [115, 116]. More than 25% 
of amylase secreted into saliva is assumed to be glycosylated [115, 117]. These contain four 
biantennary N-glycosidically linked oligosaccharide units. One of these units possesses a 
terminal sialic acid residue [107]. The role of salivary amylase in the digestion of 
carbohydrates is thought to be minimal [101]. In contrast it has been demonstrated in the past 
that amylase can play a role in the colonization and metabolism of oral bacteria. Amylases 
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have been identified  as constituent of enamel pellicle [118], and shown to act as  receptors 
for bacterial adhesion [119]. In addition, amylases have been shown to retain their enzymatic 
activity when bound to the bacterial surface [120]. 
Proline-rich glycoprotein 
The proline-rich glycoprotein (PRG) is a member of the proline-rich family of salivary 
proteins (PRPs) [121]. These highly polymorphic proteins comprise about 70% of the total 
protein in human saliva and are encoded by six different genes that map to chromosome 12. 
Acidic PRPs (encoded by PRH1, PRH2) are needed to maintain calcium homeostasis in the 
mouth by binding calcium and inhibiting hydroxyapatite crystal growth. They are also capable 
of mediating the binding of microorganisms to tooth surfaces. Basic PRPs (encoded by PRB1, 
PRB2, PRB3 and PRB4), that include also PRG, bind oral bacteria and exhibit masticatory-
lubricating properties. For the non-glycosylated basic PRPs it was suggested, that they 
precipitate tannin and thereby prevent adsorption of this potential toxin from the alimentary 
tract [122-124]. PRG (encoded by PRB3) has a molecular mass of approximately 89 kDa. 
Concerning the glycosylation of PRG, there are different statements in the literature. Gillece-
Castro et al. reported a carbohydrate content of 50% in the form of highly fucosylated N-
linked saccharides. The major structure was a biantennary asialosaccharide that contained two 
fucose residues on one antenna [121]. A prior study of Reddy and co-workers stated six N-
glyosidically linked triantennary oligosaccharide units with three neutral and three sialic acid 
containing units [125]. Analogous to the salivary mucins, PRG is responsible for lubricating 
food and interacting with oral bacteria [101]. 
Carbonic anhydrase VI 
Carbonic anhydrase VI (salivary carbonic anhydrase) is analogous to gustin, a zinc-
metalloprotein of 37 kDa, that was associated with taste sensation [126]. Carbonic anhydrases 
participate in the maintenance of pH homeostasis in various tissues and biological fluids by 
catalyzing the reversible reaction CO2 + H2O ? HCO3- + H+. Carbonic anhydrase VI is the 
only secretory isoenzyme of the carbonic anhydrase family. It is not only found in saliva but 
also in the upper alimentary tract and in the stomach [127].  
Secretory immunglobulin A (S-IgA) 
Secretory IgA is the predominant immunglobulin within all human mucosal secretions, 
including saliva. It protects the mucosal surface against invasion by pathogens. S-IgA occurs 
mainly as dimer in which the two IgA molecules are joined together via a small J chain (16 
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kDa) (Fig. 6). It is produced by plasma cells within the major and minor salivary glands. The 
epithelial cells express the polymeric immunglobulin receptor that binds one heavy chain of 
dimeric IgA. This complex is then translocated across epithelial cells. When reaching the 
mucosal surface the secretory component (50-90 kDa) is cleaved from the polymeric 
immunglobulin receptor and the IgA/J chain/secretory component-complex (S-IgA) is 
secreted. The heavy chain, the J chain and the secretory component are glycosylated. IgA 
occurs in two isotypic forms: IgA1 and IgA2. The glycosylation patterns differ between IgA1 
and IgA2. The IgA1 heavy chain carries both, N-linked oligosaccharides and O-linked 
oligosaccharides whereas the heavy chain of IgA2 carries only N-linked oligosaccharides. The 
secretory components is mainly N-glycosylated and over 70% of these glycans are sialylated. 
It was suggested, that the secretory component carries different Lewis and sialylated Lewis 
epitopes. (reviewed by [107, 128]) 
 
Fig. 6: Schematic representation of human dimeric secretory IgA1 and IgA2. Source: [128] 
Zinc-α2-glycoprotein 
Zn-α2-glycoprotein has a molecular weight of 38.5. Its name derives from its tendency to 
precipitate with zinc salts. Zn-α2-glycoprotein is normally present in most body fluids such as 
serum, saliva, sweat or urine [129]. The carbohydrate content (three N-glycans) was reported 
to be 18% including sialic acid, galactose, mannose, fucose and N-acetylglucosamine. Zn-α2-
glycoprotein shares a high degree of amino acid sequence identity with the α chains of the 
class I major histocompatibility complex. Moreover this protein was shown to be a member of 
the immunglobulin gene superfamily [130]. 
Parotid secretory protein 
The parotid secretory protein has been described for the first time in rodents, pigs and cattle. 
In a recent study it could be identified as a member of human oral and airway epithelial 
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proteins, that are similar to lipopolysaccharide-binding proteins. It is assumed, that the parotid 
secretory protein can serve as a template for the design of anti-inflammatory peptides [131]. 
So far, there is no published data on the glycosylation of the parotid secretory protein. 
However, a closely related protein, the palate-lung-nasal epithelium clone (PLUNC), is 
known to be sialylated [132]. In addition, the electrophoresis pattern of this molecule provides 
indication for glycosylation (Sven-Ulrik Gorr, personal communication). 
Lactoferrin 
Lactoferrin is an iron-binding glycoprotein and belongs to the transferrin family. It has a 
molecular mass of about 77 kDa with two N-linked biantennary oligosaccharide units per 
molecule. Lactoferrin contains approximately 7% carbohydrates including terminal sialic 
acids, fucose and galactose [133]. The two glycans are structurally heterogeneous and differ 
from those of other transferrins. Lactoferrin is synthesized by glandular epithelial cells, as 
well as neutrophils and occurs mostly in secretions which bathe human mucosal surfaces 
[107]. It is known that lactoferrin has antibacterial functions. It is effective against bacteria 
that require iron for their metabolic processes and it was shown to be antibacterial 
independent of iron deprivation [101]. The significance of glycosylation for lactoferrin is not 
completely understood, although protection against proteases such as the pancreatic enzyme 
trypsin has been suggested [134]. 
Fibronectin 
Fibronectins occur on cell surfaces, within basement membranes, in the extracellular matrix 
and within several body fluids, such as saliva. They have molecular masses of 210 to 260 kDa 
and contain 5-12% carbohydrate [107]. The carbohydrate content is dependent on the source 
of fibronectin [135]. Fibronectin usually exists as a dimer composed of two nearly identical 
250 kDa subunits. The subunits are linked by a pair of disulfide bonds. Each monomer 
consists of three types of repeating units. Glycosylation sites, that are either N-linked or O-
linked, reside predominantly within type III repeats and a collagen-binding domain. 
Fibronectins play an important role in cell adhesion [136] and interaction with various 
microorganisms, such as Staphylococcus aureus [137-140] 
Current Knowledge About the Interaction of Helicobacter pylori 
with Salivary Components 
Several hypothetical scenarios can be envisioned to describe the passage of H. pylori through 
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the oral cavity on its way to the human stomach. This organism might be simply swallowed 
without showing any interactions with saliva components or it binds to or is bound by salivary 
components. In the latter case the coaggregation with oral bacteria or attachment to salivary 
proteins might be possible.  
 A coaggregation of H. pylori with the secondary colonizing strain Fusobacterium has 
been shown [141]. It was suggested, that an adhesin was present on the fusobacteria whereas 
the corresponding receptor was present on the helicobacters. Thus, with regard to the great 
number of bacterial species in the oral cavity, further coaggregation partners are very likely.  
 Studying adhesion of H. pylori to salivary glycoproteins is obviously important, 
because known receptor structures recognized by H. pylori adhesins, as mentioned above, are 
also expressed on salivary glycoproteins. In addition, an interaction of H. pylori with salivary 
mucin MUC5B (MG1) has been reported in several studies, whereby disagreement exists 
concerning the responsible receptor epitope. Namavar et al. attribute this adhesion to an 
interaction between the neutrophil-activating protein of H. pylori and sulfated oligosaccharide 
motifs on salivary mucin MUC5B [51, 142]. Prakobphol et al. suggested that H. pylori binds 
to carbohydrate structures, mainly Lewis blood group epitopes, of MUC5B [143]. In the same 
study, also attachment to oligosaccharide motifs of MUC7 and gp-340 could be revealed. 
Concerning the interaction of H. pylori with gp-340, Prakobphol et al. showed initially the 
reverse case, namely that gp-340 binds to H. pylori [112]. This observation was considered 
relevant. Either H. pylori shows the phenomenon of becoming part of the oral biofilm by 
coadhesion to oral bacteria or by adhesion to pellicle proteins as mentioned above. Or it is 
bound by salivary proteins or binds them in solution and is thus cleared from the oral cavity 
by mechanical flushing. In addition, H. pylori could somehow change its pathological 
properties by interacting with salivary proteins. 
Beside these known interactions of H. pylori with salivary glycoproteins further binding 
properties have been described. These were noted for proteins that occur in saliva too, such as 
lactoferrin [57, 58], fibronectin, and S-IgA [33]. 
 These first studies on the interactions between H. pylori and salivary components as 
well as the fact that the oral cavity is the first part of the intestinal tract and the entry point for 
the gastric pathogen H. pylori, led to the underlying question of this thesis, namely whether 
saliva might be bound by the adhesins of this bacterium. 
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Because the oral cavity is the only possible entry point for gastric Helicobacter pylori (H. 
pylori) (chapter 1) it is important to know, whether H. pylori passes simply through the oral 
cavity, or whether this bacterium interacts with components of saliva analogous to bacteria of 
the indigenous oral microbial flora. Salivary proteins, primarily glycosylated salivary 
proteins, are known to promote microbial adhesion. Therefore, the immediate aim of this 
thesis was to search for possible interactions of H. pylori with glycosylated salivary proteins 
and to evaluate a method to determine the molecular basis of such interactions. 
This work has three parts: 
 
1. Proteome analysis of human saliva 
2. Establishment of an eligible glycoconjugate array to generally characterize binding 
properties of H. pylori and to give a first indication for minimal receptor structures  
3. Comprehensive adhesion studies with H. pylori on salivary proteins.  
1.  Proteome analysis of human saliva 
The main part of this section displays a proteome map of human saliva (whole saliva (WS), 
parotid and submandibular/sublingual (SMSL) secretions) by means of two-dimensional gel 
electrophoresis (2-DE) and matrix-assisted laser desorption/ionization mass spectrometry 
(MALDI-MS) in order to obtain an overview about protein composition of WS in comparison 
to glandular secretions, and to have a tool for adhesion studies with H. pylori on human 
saliva. Some 2-DE studies of human saliva were already published, but these studies 
considered only WS and some important protein families (proline-rich proteins, salivary 
mucins) were missing in the previously published saliva proteome maps. Therefore, the first 
step was to optimize the method of sample preparation for 2-DE of human saliva (chapter 3), 
in order to obtain more complete proteome maps for above mentioned objects. The second 
step was the comparative proteome analysis of WS, parotid and SMSL secretions by MALDI 
time-of-flight (TOF) MS and MALDI TOF/TOF MS (chapter 4). In this part of the thesis 
intra- and inter-individual variations in human saliva proteome maps were considered 
particularly with regard to further adhesion studies. 
2. Glycoconjugate array 
Because many oral microbes colonize the mouth by interaction with glycosylated salivary 
proteins, first adhesion studies were carried out by bacterial overlay with fluorescence-labeled 
bacteria on purified glycoproteins and synthetic neoglycoproteins, that were immobilized on 
nitrocellulose membranes as dots. The aim of this part of the thesis was to develop an array 
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suitable to characterize the H. pylori wild-type strain and its adhesin-deficient mutants (babA 
and sabA mutants) and to narrow down minimal receptor structures necessary for binding. 
The glycoconjugate array included natural occurring glycoproteins and structural related 
neoglycoproteins, mainly with focus on molecules that are known to be bacterial receptor 
structures of H. pylori. Binding patterns of H. pylori wild-type strain and its adhesin-deficient 
mutants to (neo)glycoproteins were compared with the binding patterns of lectins with similar 
specificities (Lotus tetragonulobus and Ulex europeaus lectin) and oral bacteria as control 
(chapter 5). In order to demonstrate that the bacterial overlay assay with fluoresecence-
labeled bacteria on glycoconjugate arrays is an appropriate method for the display of binding 
specificities also of other bacterial strains it was additionally carried out with two species of 
oral bacteria (actinomyces and streptococci) as probes, that have well-defined binding 
properties (chapter 7).  
3. Adhesion studies on human saliva 
The analysis of the human saliva proteome and the investigation of binding specificities of H. 
pylori and its adhesin-deficient mutants were the basis for this section of the thesis. 
Interaction of H. pylori with the whole range of salivary proteins was studied 
comprehensively by bacterial overlay (chapter 6). Bacterial overlay was first carried out on 
blots with salivary proteins separated by 1-DE, and it was tried to identify putative receptors 
of H. pylori by MALDI-MS. In a next step bacterial overlay was adapted for transfer blots of 
2-D gels and identification of H. pylori receptors was achieved by comparison of signal spots 
of H. pylori with protein spots of 2-D proteome maps of the preceding study. These 
experiments were also carried out with another bacterial strain (Streptococcus gordonii) in 
order to show the applicability of this method also for other species of bacteria (chapter 7). 
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Abstract 
A major aim of this thesis was to utilize two-dimensional gel electrophoresis (2-DE) and 
subsequent transfer of separated proteins onto nitrocellulose membrane (blotting) for a high 
resolution bacterial overlay. Identification of salivary proteins as possible substrates for 
bacterial binding should be facilitated by proteome analysis. Therefore, a protein map as 
complete as possible should be obtained by 2-DE to display the whole range of salivary 
proteins. The immediate aim of this study was to establish 2-DE of human whole saliva (WS) 
as a prerequisite for the aforementioned application. Different conditions for the first 
dimension were compared, convenient pH gradients were figured out, as well as appropriate 
sample preparation procedures. Additionally, a first proteome analysis of a resulting 2-D gel 
by mass spectrometry was performed. It turned out that in-gel rehydration in the first 
dimension with rehydration under voltage over a pH range of 3-10 was most suitable for 
obtaining a complete protein map of WS. Proteome analysis of WS, that was directly dialyzed 
and lyophilized showed a high keratin contamination and many other cellular components. By 
contrast, filtration of WS reduced the number of spots and showed a new, noticeable spot 
group in the anodic region of the gel. These spots were stained pink with coomassie blue and 
were supposed to be proline-rich proteins.  Thus, filtration of whole saliva is an important 
methodological step of saliva preparation for 2-DE. 
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Introduction 
Proteome analysis is used to separate, visualize and analyze complex protein mixtures in 
fluids, such as saliva [1, 2]. Up to now a rapidly growing number of proteins has been 
identified in human saliva by the use of various methods, e.g. two-dimensional gel 
electrophoresis-mass spectrometry (2-DE-MS) [3-9], 2-D liquid chromatography-MS [8, 10] 
or Fourier transform ion cyclotron resonance-MS [11]. However, 2-D polyacrylamide gel 
electrophoresis (PAGE) [12] is the overall accepted technology to separate complex protein 
mixtures because of its ability to separate thousands of proteins simultaneously, and to 
display, in a visual way, proteins with posttranslational modifications [1] or isoform variances 
[13].  
 Trends in salivary proteomics are not only approaching the cataloging of proteins but 
also functional and diagnostic studies [14]. In this regard 2-D PAGE of saliva might be 
suitable also for clinical investigations because of its diversity in potential applications. Sick 
and healthy status of subjects or other individual differences can be compared by 2-D gels of 
saliva because there are a number of diseases associated with a defined protein profile in 
human saliva including connective tissue disorders, cystic fibrosis and diabetes mellitus [15]. 
This task could be performed either by image analysis [7] or by using different staining 
methods in combination with glycosidases [16]. A further important and already performed 
application of 2-DE of humans saliva is, after electrophoresis, the protein transfer onto 
nitrocellulose membranes and immunoblotting [7, 16, 17]. Modifying the latter technique by 
probing 2-D transfers with labeled bacteria instead of antibodies, as already successfully 
employed with 1-D gels [18, 19], a powerful tool would be available to screen for bacterial 
receptors in saliva. Establishing a 2-D map of human saliva in which every spot is identified 
could moreover facilitate the identification of bacterial receptors. A prerequisite for all these 
applications is a 2-D map that reflects the complete range of salivary proteins by choosing 
convenient pH gradients and appropriate sample preparation procedures in order to produce a 
reproducible 2-D spot pattern. 
  The immediate aim of the present study was to investigate different sample 
preparation procedures and to compare comprehensively different pH ranges as well as 
different isoelectric focusing (IEF) methods in order to establish a 2-D map of human whole 
saliva (WS) suitable for a subsequent proteome analysis as well as for bacterial overlay 
applications. 
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Materials and Methods 
Reagents 
Glycerol (approximate 87%), sodium dodecyl sulfate (SDS), trichloroacetic acid (TCA), 
acetic acid, and glycine were purchased from Merck (Darmstadt, Germany). 3-[(2-amino-2-
oxoethyl)amino]ethanesulfonic acid (CHAPS), dithiothreitol (DTT), urea, Pharmalyte 3-10 
for isoelectric focusing (IEF), dry strip cover fluid as well as agarose were obtained from GE 
Healthcare Bio-Sciences (München, Germany). Iodacetamide was from Sigma, thiourea was 
from Fluka (Buchs, Switzerland), tris(hydroxymethyl)aminomethane (Tris) was from USB 
Corporation (Cleveland, OH, USA) and ethanol was from J.B. Baker (Deventer, Netherlands). 
Coomassie brilliant blue R-250 was from Bio-Rad (Bio-Rad Laboratories GmbH, München, 
Germany).  
Sample preparation 
WS was obtained from a healthy female subject by expectoration after rinsing the mouth with 
water, according to general accepted guidelines [20]. Samples were kept on ice during the 
collection procedure and were then processed in four different ways. 
Table 1: Saliva preparation procedures performed in this study 
Preparation step 1 Preparation step 2 
x dialyzed and lyophilized 
filtrated dialyzed and lyophilized 
x concentrated with Amicon Ultra® 
filtrated concentrated with Amicon Ultra® 
 
WS was filtered twice with a disposable membrane filter unit (Minisart, Sartorius, Hannover, 
Germany). In a first filtration step a pore size of 5 µm was used in order to remove larger 
insoluble material. In the second filtration step a pore size of 0.2 µm was used in order to 
remove bacteria. Subsequent dialyzation (sample volume approximately 2 ml) against 2 l of 
double distilled water for 16-20 h at 4°C was performed using a Slide-A-Lyzer® Kit (Pierce, 
Rockford, IL, USA). Protein concentrations were determined by the bicinchoninic acid (BCA) 
protein assay (Pierce) with bovine serum albumin as a standard, yielding a protein 
concentration of 2-3 mg/ml. For lyophilizing saliva, samples were aliquoted (300 µg of 
protein), frozen in liquid nitrogen and transferred into the to lyophilizing apparatus (Christ 
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Alpha 1-4, Martin Christ Gefriertrocknungsanlagen GmbH, Osterode am Harz, Germany). 
Alternatively, samples were desalted and concentrated with Amicon® Ultra (Millipore, 
Bedford, MA, USA) centrifugal filter devices (molecular weight cut-off, 5,000) up to protein 
concentrations of 10-20 mg/ml. All samples were stored at -80°C.  
Two-dimensional gel electrophoresis 
IEF was carried out with the IPGphor system from GE Healthcare Bio-Sciences using precast 
IPG strips (pH 3-10 NL, pH 4-7, pH 6-11; 18 cm; Immobiline Dry Strip, GE Healthcare Bio-
Sciences) as described by Görg et al. [21]. Samples were applied by cup-loading or by in-gel 
rehydration. For cup loading the IPG strips were rehydrated overnight in a reswelling solution 
containing 7 M urea, 2 M thiourea, 2% CHAPS, 1% DTT and 1% Pharmalyte 3-10. 
Lyophilized or concentrated saliva samples (300 µg of protein) were solubilized in 100 µl of 
sample buffer (same composition as reswelling solution). Sample solutions were applied to 
the reswelled gels in the Ettan IPGphor Cup Loading Strip Holder (GE Healthcare Bio-
Sciences) according to the manufacturer’s instruction. For in-gel rehydration the IPG strip 
was rehydrated directly with saliva (300 µg of protein solubilized in 350 µl of sample buffer). 
For 2-D separation of proline-rich protein 1 (PRP-1, kindly provided from Donald I. Hay, 
Forsyth Institute, Boston, MA, USA), 10 µg of purified PRP-1 were dissolved in 350 µl of 
sample buffer and applied by in-gel rehydration. Running conditions for the first dimension of 
2-DE were used as recommended by the manufacturer (see table 2).  
 
Table 2: Running conditions for isoelectric focusing used in this study 
Cup loading (pH 3-10 NL) 
Initial IEF 200 V (1h), 500 V (1h), 1000 V (1h) 
Gradient 1000-8000 V, 30 min 
IEF 8000 V, 3 h 
Cup loading (pH 6-11 NL) 
Initial IEF 500 V (1h), 1000 V (1h) 
IEF 8000 V, 3,5 h 
In-gel rehydration loading (without voltage) (pH 3-10 NL) 
Reswelling 0 V, 12 h 
Initial IEF 200 V (1h), 500 V (1h), 1000 V (1h) 
Gradient 1000-8000 V, 30 min 
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IEF 8000 V, 3 h 
In-gel rehydration loading (with voltage) 
Reswelling 30 V, 12 h 
Initial IEF 200 V (1 h), 500 V (1 h), 1000 V  (1 h) 
Gradient 1000-8000 V, 30 min 
IEF 8000 V, 3 h  (pH 3-10 NL) or 4 h (pH 4-7) 
 
The second dimension (SDS-PAGE) was performed on a vertical system (Ettan DALT six 
electrophoresis unit, GE Healthcare Bio-Sciences) with precast Ettan DALT gels (12,5%T, 
3%C, 255 x 196 x 1mm, GE Healthcare Bio-Sciences). The IPG strip was applied on top of 
the gel, according to the manufacturer’s instruction and gels were run overnight at 1W per gel 
and 25°C. 
Staining 
Gels were stained with Coomassie brilliant blue (R-250). In brief: Gels were first incubated 
for 1 h in 20% TCA and were then incubated in 0.1% Coomassie R-250 with 40% ethanol / 
10% acetic acid for 2 h. Excess dye was removed with two changes of 40% ethanol / 10% 
acetic acid for 30 min respectively, before intensifying them with 1% acetic acid overnight. 
Gels were washed with deionized water and conserved in an aqueous solution of 30% 
glycerol. All staining and washing steps were performed under continuous gentle agitation. 
Tryptic digestion 
Sample preparation for MS and MS analysis was carried out by the company Protagen AG, 
Dortmund, Germany. 2-D gels were first analyzed using the automated line (Bruker Daltonik 
GmbH, Bremen, Germany) and then displayed with a robot control software (spControl 3.1). 
Spots were picked with the spot picking robot PROTEINEER sp and transported into pierced 
96 well PCR plates as described by the manufacturer. Digestion was carried out using the 
PROTEINEER dp digestion robot with a reagent kit and digestion protocol provided by the 
manufacturer. Gel pieces were first washed and then dried using acetonitrile. Trypsin was 
added to the dried residues and the samples were incubated for 4-8 h at 37°C. 
MALDI-analysis 
The peptides obtained after tryptic digestion were extracted and spotted onto a target plate 
that was pre-coated with α-cyano-4-hydroxy-cinnamic acid (all reagents from Bruker 
Daltonik GmbH) and washed. Peptide mass spectra were obtained using a  MALDI-time of 
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flight (TOF)-TOF mass spectrometer (Ultraflex TOF/TOF, Bruker Daltonik GmbH) equipped 
with a ScoutTM MTP MALDI target according to the manufacturer's instructions. Peptide 
mass fingerprint (PMF) spectra were obtained by measuring peptides in the mass range from 
700-4,000 Da by summing up 200 shots per spot. For identifying the monoisotopic peak of 
each peptide signal, peaks were labeled using the Similarity-Neighborhood Approach (SNAP) 
algorithm provided by the manufacturer of the mass spectrometer. Protein spots that could not 
be identified by PMF were analyzed additionally by peptide fragmentation fingerprint (PFF) 
analysis. For this analysis the most prominent peaks were selected by an acquisition method 
that was triggered by an intelligent algorithm in the data base that can choose peptides 
suitable for fragmentation. 
Database search 
Software for searching PMF spectra were ProFoundTM (Genomic Solutions Ltd., 
Cambridgeshire, UK) and MascotTM (Matrix Science Ltd, London, UK) and for PFF spectra 
MascotTM, SequestTM (Thermo, San Jose, CA, USA) or PFFSolver (Protagen AG, Dortmund, 
Germany). Searches were performed against the NCBI nonredundant protein database without 
restriction by the taxonomy. Results from PMF spectra were collated into one table with a 
unified scoring system that allowed a comparison of the different algorithms on a scale from 0 
to 100. Protein identifications with a unified score larger than 90 were considered to be 
correct. Results from individual PFF spectra were combined for each spot and protein 
identification was based on the combined score. Protein identifications with a combined score 
larger than 10 for Sequest and 100 for Mascot were considered to be correct.  
Results and Discussion 
Comparison of different running conditions and pH gradients 
In order to produce high-quality 2-D maps of saliva for medical, functional or comparative 
studies, it is important to figure out appropriate pH ranges and running conditions that provide 
for a good pattern quality and a complete display of all spots.  
 The first step was therefore the comparison of different pH ranges in the IEF step in 
order to evaluate the optimal pH range. Therefore, zoom gels (pH 4-7 and pH 6-11) were 
made as well as a wide-pH-range gel (3-10NL) (Fig. 1). Dark traces at the right side of the pH 
4-7 zoom gel and on the left side of the pH 6-11 zoom gel indicated that proteins accumulated 
at the end of the respective IPG strips. The reason for this phenomenon is evident in the 
middle gel (pH 3-10NL).  It is obvious, that the pH range of salivary proteins extend at least 
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from pH 3-10.  For our proteome analysis of WS this pH range proved to be most useful, as it 
was also used in several other proteome studies of WS [5-8]. On the other hand, proteomics 
trends towards functional studies, emphasizing finer distinctions between several 
subproteoms. Therefore zoom gels will be of greater importance in the future and could 
provide some additional information about certain proteins. When comparing zoom gels it is 
remarkable that the separation of protein spots in the pH 4-7 gel is better than in the pH 6-11 
gel. This confirms the more difficult separation of alkaline proteins in 2-DE [1] and  the 
requirement of sample cup-loading for focusing between pH 6-11. 
 
 
Fig. 1: Comparison of different pH ranges 
in the isoelectric focusing step (pH 4-7, 3-
10NL, 6-11). For all procedures saliva 
was dialyzed/lyophilized and an amount of 
300 µg of protein was loaded. IEF was 
carried out by cup-loading (pH 6-11) or 
by in-gel rehydration (pH 3-10NL, 4-7). 
Gels were stained with Coomassie blue R-
250. Zoomed regions are marked with 
arrows on the middle gel (pH 3-10NL). 
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 Next, three different sample application methods, and thus, running conditions for IEF 
were compared (Fig. 2). It turned out that the overall spatial pattern of the protein spots was 
similar in all gels, independent of the electrophoresis settings. Although it is known that IPGs 
up to pH 10 are compatible with cup-loading as well as with in-gel rehydration [22], less spots 
and poorer resolution were seen in the anodic region of the 2-D gel with cup-loading IEF 
compared to in-gel rehydration IEF. This might be due to precipitation effects at the sample 
application point [23] or because of the higher protein concentration of the sample solution in 
the cup loading procedure (cup-loading: 3 mg/ml versus in-gel rehydration: 0.8 mg/ml). 
Differences between rehydration without voltage and under voltage were only marginal 
except that spots appeared more distinct  in the former case.  
 
Fig. 2: Comparison of different running conditions for isoelectric focusing (IEF). For all procedures 
saliva was dialyzed/lyophilized and an amount of 300 µg of protein was loaded. IEF was carried out 
over a pI range of 3-10. Gels were stained with Coomassie blue R-250. Running conditions for IEF 
are described in detail in Table 2 in the Material and Methods section. 
 
Identification of protein spots by mass spectrometry 
In order to facilitate a later identification of bacterial receptors on 2-D transfers of human WS 
a first proteome analysis was carried out (Fig. 3). Because of above mentioned results the 
analysis was performed with WS rehydrated under voltage over a pI range of 3-10. Gels were 
stained with Coomassie blue and analyzed by the company Protagen AG. In this gel 351 
protein spots were detected, picked and analyzed by MALDI-TOF and MALDI-TOF/TOF. Of 
these, 253 spots could be identified. 
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Fig. 3: 2-DE pattern of human whole saliva. Saliva was lyophilized/dialyzed and an amount of 300 µg 
was loaded. Separated proteins were detected by Coomassie blue staining. Circled spots are the spots 
identified without keratin. All spots that could be identified unambiguously are listed in Table 3.  
Among the 253 spots identified, 138 spots were identified as keratin (not circled in Fig. 3). 
All other protein spots identified (circled in Fig. 3) are listed in Table 3. Protein spots, that 
could not be identified unambiguously were disregarded in Table 3. Possibly, these proteins 
were of bacterial origin. 
 
Table 3: List of proteins in unfiltrated human whole saliva identified by two-dimensional 
polyacrylamide gel electrophoresis and mass spectrometry. Spots that were identified as keratin or 
that couldn’t be identified unambiguously  were disregarded. 
Spot 
No. 
Accession Protein Name Spot 
Count 
1 
2 
14250401 
728792 
Actin, beta  
Actin 3  
2 
2 
3 5031573 Actin-related protein  1 
4 229674 Aldolase A  2 
5 2804273 Alpha-actinin  1 
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Spot 
No. 
Accession Protein Name Spot 
Count 
6 12025678  1 
7 
8 
9 
10 
442631 
4502101 
16306978 
1703319 
Annexin I (lipocortin I) 
 
Annexin A2 (lipocortin II)  
Annexin A4 (lipocortin IV)  
5 
7 
2 
1 
11 14539767 Carbonic anhydrase VI  3 
12 60822435 S100 calcium binding protein A9 (Calgranulin 
B)  
3 
13 539565 Cystatin D 1 
14 4503109 Cystatin S (3) 3 
15 359513 Cystatin SA  1 
16 235948 Cystatin SA-III precursor of acquired enamel 
pellicle  
1 
17 118188 Cystatin SN  2 
18 225541 Cystic fibrosis antigen 1 
19 4503571 Enolase 1  1 
20 4503471 Eukaryotic translation elongation factor 1 
alpha 1 
1 
21 5453597 F-actin capping protein alpha-1 subunit 1 
22 23200510 Glutathion-S-transferase 1 
23 
24 
25 
26 
462325 
2495339 
5729877 
4504517 
Heat shock 70 kDa protein 1 (HSP70.1)  
Heat shock 70 kDa protein 2 (HSP70.2)  
Heat shock 70 kDa protein 8, isoform 1  
Heat shock 27 kDa protein 1  
1 
1 
1 
1 
27 
28 
29 
30 
15988376 
1633119 
3212456 
40254482 
Human salivary amylase  
 
 
 
5 
7 
2 
6 
31 285975 Human rab GDI 1 
32 223335 Ig κ light chain VLJ region  1 
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Spot 
No. 
Accession Protein Name Spot 
Count 
33 27894321 Interleukin 1 receptor antagonist isoform 4 1 
34 33875446 JUP protein (junction plakoglobin) 1 
35 494252 Lactoferrin  1 
36 
37 
6729885 
307141 
Lysozyme  
 
1 
1 
38 14603253 Phosphoglucomase 2 1 
39 40068518 Phosphogluconate dehydrogenase  1 
40 129902 Phosphogylcerate kinase 1  1 
41 4507953 Phospholipase A2 1 
42 514366 Poly-Ig-receptor  2 
43 4505821 Prolactin-induced protein  2 
44 
45 
13489087 
4505789 
Protease inhibitor 2  
Protease inhibitor 5  
2 
1 
46 352334 SAP-1  1 
47 
48 
49 
15988375 
31615330 
3212456 
Serum Albumin       
 
 
1 
2 
1 
50 230777 Thioredoxin  1 
51 
52 
4557871 
4699632 
Transferrin  
 
3 
1 
53 
54 
13638501 
21465999 
Transglutaminase 3  
 
1 
1 
55 422542 Tubulin alpha chain  1 
56 4699583 Zinc-α2-glycoprotein, chain B  3 
 
 
The high abundance of keratin spots (~ 54 % of all spots identified) indicates a contamination 
of the saliva sample. Keratins are structural proteins that are expressed in epithelial cells. Two 
distinct classes of proteins are known that are always expressed as pairs: acidic type I and 
basic or neutral type II keratins [24]. Almost all keratin spots identified in WS were keratin 13 
and its basic partner keratin 4. These keratins are expressed in suprabasal layers of non-
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cornified, stratified, mucosal epithelia [24] including oral epithelium [25], providing evidence 
that this keratin contamination may originate from cellular debris within the oral cavity and 
not from external skin or hair contamination during the experimental procedure. Besides 
keratins, further spots of proteins of cellular origin were identified, e.g. actin or annexin. Both 
proteins have been detected in the oral epithelium in previous studies [26, 27]. The presence 
of cellular proteins, in particular the high abundance of keratin in human salivary 2-D map 
prevents the true display of human saliva proteome Therefore, the direct application of 
lyophilized / dialyzed saliva to 2-DE turned out to be useless, also, because it implies the risk 
to map bacterial proteins. Thus, an alternative way of saliva preparation was tested in this 
study. 
Comparison of different sample preparation procedures 
In previous 2-DE studies on human WS, saliva samples were always subjected to a 
centrifugation step, whereas no dialyzing step was performed [4-8]. Although centrifugation 
of saliva may remove cellular debris and keratin contamination, it was tried to find an 
alternative way of saliva treatment in the present study. Four different sample preparation 
procedures were compared (see also Table 1) including lyophilizing/dialyzing with or without 
a preceding filtration step as well as concentration with Amicon Ultra® with or without a 
preceding filtration step (Fig. 4). Filtration was divided into two steps: first, the removal of 
larger insoluble material by using a 5 µm pore size filter and subsequently a sterile filtration 
by using a 0.2 µm pore size filter as described previously [28]. 
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Fig. 4: Comparison of different ways of saliva sample preparation for two-dimensional gel 
electrophoresis. Human whole saliva was A. filtrated and concentrated with Amicon Ultra®, B. 
filtrated and dialyzed/lyophilized, C. only concentrated with Amicon Ultra® and D. only 
dialyzed/lyophilized. Isoelectric focusing was carried out by in-gel rehydration over a pI range of 3-
10. Gels were stained with Coomassie blue. Spot groups that appeared pink with Coomassie blue 
staining are marked by arrows. 
Filtration of saliva samples (gels A, B) resulted in a noticeable effect on the 2-D spot pattern 
compared to saliva preparations without filtration (gels C, D). The number of spots was 
reduced, suggesting the absence of keratin and, perhaps, bacterial proteins from the samples 
(total spot count detected in gel A was 193). However, a new, pink spot group appeared  in 
the anodic region of the gel (marked by arrows). It is known that PRPs, separated by gel 
electrophoresis, stain pink with Coomassie blue R-250 [29]. Thus, this spot group could be 
acidic PRPs. This notion was supported by applying purified PRP-1 to 2-DE (Fig. 5), 
resulting in two small, pink spots at the same location as the pink spots detected in 2-D gel of  
filtrated WS. The presence of PRPs in the 2-D map of the filtrated WS sample, that was 
absent in unfiltrated WS shows the advantage of the filtration steps, because PRPs are a 
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dominant group of proteins in human saliva [30]. A possible explanation for the appearance of 
PRP spots after sample filtration might be that these proteins are particularly sensitive to 
enzymatic cleavage by bacterial proteases [31]. It would be likely that this process could be 
considerably slowed down after removal of the naturally occurring oral bacteria in whole 
saliva by means of filtration. 
Fig. 5: 2-DE pattern of purified proline-rich 
protein 1 stained with Coomassie Blue R-250. 
The arrow shows the position of purified 
proline-rich protein 1 in the complete gel. 
 
 
In contrast to the advantageous effects of the filtration steps, only little differences were 
noticed between concentrating and lyophilizing saliva (A/B or C/ D respectively) 
demonstrating that each method leads to the same result. The need for desalting samples prior 
to electrophoresis had been examined earlier.  
Concluding Remarks 
When performing 2-DE studies of complex protein mixtures, the nature of the analyzed 
samples, the pI range of their proteins as well as the purpose of the study have to be 
considered. With regard to the aim of generating a proteome analysis of human saliva and of 
establishing a high-resolution bacterial overlay it turned out that focusing over a pH range of 
3-10, by in-gel rehydration, is the best way to display the whole range of salivary proteins in a 
reproducible way. In terms of sample preparation, a compromise has to be found between a 
high number of protein spots and the true display of all typical salivary proteins, thus filtrating 
of WS prior to electrophoresis experiment was chosen as the method of choice for subsequent 
studies. 
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Abstract 
The secretions of the salivary parotid and submandibular-sublingual (SMSL) glands constitute 
the main part of whole human saliva (WS) in which proline-rich proteins (PRPs) and mucins 
represent dominant groups. Although proteome analysis had been performed on WS, no 
identification of PRPs or mucins by two-dimensional gel electrophoresis (2-DE) and mass 
spectrometry (MS) was achieved in WS and no comprehensive analysis of both glandular 
secretions is available so far. The aim of this study was to compare the protein map of WS to 
parotid and SMSL secretions for the display of PRPs and mucins. WS and glandular 
secretions were subjected to 2-DE and spots were analyzed by matrix-assisted laser 
desorption/ionization-MS. New components identified in WS were cyclophilin-B and prolyl-
4-hydroxylase. Also acidic and basic PRPs as well as the proline-rich glycoprotein (PRG) 
could now be mapped in WS. Acidic PRPs were found equally in parotid and SMSL 
secretions, whereas basic PRPs and PRG were found primarily in parotid secretion. Salivary 
mucin MUC7 was identified in SMSL secretion. Thus, the more abundant proteins of WS can 
be explained mainly by mixed contributions of parotid and SMSL secretions with only few 
components remaining that may be derived from local sources in the oral cavity.  
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Introduction 
Proteins in saliva have important functions not only for mastication and digestion of food but 
also for mineralization of teeth, protection of oral mucosa and interactions with a complex 
oral microbiota [1-4]. Because saliva, in contrast to blood, is easy to collect and also contains 
many biologically active substances such as cytokines, growth factors and hormones it may 
have a great potential as a diagnostic fluid [5, 6]. Unfortunately, although the protein 
components of saliva and their functions are well known, sufficient qualitative and 
quantitative analytical methods suitable for diagnostics were not available in the past.  
In comparison to other body fluids, whole human saliva (WS) is a complex mixture 
derived from not only different major and minor salivary glands but also from crevicular fluid 
as well as from contaminating bacteria and cellular debris [1]. 2-DE is a well suited method to 
display proteins in complex mixtures [7]. Several approaches had been undertaken in the past 
to separate saliva by 2-D PAGE [8-11] and more recently comprehensive proteome analyses 
have been completed for WS [12-16] and for glandular parotid secretion [17]. In a recent 
study, multidimensional protein identification technology (MudPIT) has been used for the 
analysis of the WS proteome [18]. The results show the applicability of 2-D chromatography 
to study the saliva proteome. More than 100 proteins were identified in WS, many of those 
not previously detected by an electrophoretic approach.  
In contrast to MudPIT, the classical approach by a combination of 2-D PAGE and MS 
allows the separation of different isoforms and has the further advantage that probing with 
antibodies or other biologically reactive compounds can be performed on transfer-blots of 2-D 
gels [19]. Previous 2-DE analyses of WS do not provide complete information about two 
dominant and unique groups of salivary proteins, namely the proline-rich proteins (PRPs) and 
the salivary mucins in a comparative display with submandibular-sublingual (SMSL) and 
parotid glandular secretions. PRPs have important functions for calcium-binding, 
mineralization of dental hard tissues, and possibly for inactivating the effects of dietary 
tannins [20, 21]. Salivary mucins are important for lubrication and protection of oral epithelial 
surfaces as well as for food bolus formation and swallowing [22, 23]. Both PRPs and mucins 
adsorb to the tooth surface in form of the acquired pellicle [24] where they protect teeth from 
acid-induced demineralization [25] and provide adhesion sites for certain oral bacterial 
adhesins [4, 26].  
In the present study, it was attempted to analyze WS as well as parotid and SMSL 
glandular secretions by state-of-the art proteomics approach applying high-resolution 2-DE 
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and MALDI-MS with the intention to comprehensively map PRPs and mucins in these 
different secretions.  
Materials and Methods 
Reagents 
Urea, CHAPS, DTT, Pharmalyte 3-10 for IEF, dry strip cover fluid as well as agarose NA 
were purchased from Amersham Biosciences (Freiburg, Germany), Iodacetamide was from 
Sigma, thiourea was from Fluka (Buchs, Switzerland), Tris was from USB Corporation 
(Cleveland, OH, USA) and ethanol was from J.B. Baker (Deventer, Netherlands). Glycerol 
(approximate 87%), SDS, TCA, acetic acid, glycine, acetone and acetonitrile were obtained 
from Merck (Darmstadt, Germany). Coomassie brilliant blue R-250 was acquired from Bio-
Rad (Bio-Rad Laboratories GmbH, München, Germany).  
Sample preparation for 2-D PAGE 
The study was approved by the Ethics Committee of the Medical Faculty of the University of 
Regensburg. Salivary samples were collected from four healthy (2 female, 2 male) donors. 
For spot identification, samples from one female individual out of this group were taken. 
Unstimulated WS was collected by expectoration and kept on ice. Immediately after 
collection, WS was filtrated twice with a single use filter unit (Minisart, Sartorius, Hannover, 
Germany) using a pore size of 5 µm to remove larger insoluble material and then using a pore 
size of 0.2 µm to remove bacteria from the sample. Parotid saliva was collected with Lashley 
cups (Stone Machine Company, Colton, CA, USA) after stimulation of the tongue with 2% 
citric acid solution [27]. While the orifice of the parotid duct was blocked by Lashley cups, 
the sublingual area was isolated with cotton wool rolls, and SMSL saliva was collected with a 
50 ml sterile syringe fitted with a sterile silicon tube. As a quality control for purity of the 
separate glandular secretions, one-dimensional gels were run on aliquots of the samples and 
were stained by silver stain as well as by a carbohydrate stain and resulted in a clearly distinct 
pattern of bands. Samples were desalted and concentrated with Amicon® Ultra (Millipore, 
Bedford, MA, USA) centrifugal filter devices (molecular weight cut-off, 5,000) yielding final 
protein concentrations of 5-25 mg/ml as determined using the bicinchoninic acid (BCA) 
protein assay (Pierce, Rockford, IL, USA) with bovine serum albumin as the standard. The 
samples were stored at -80°C until analyzed.  
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2-D gel electrophoresis 
The first dimension, IEF, was performed in the IPGphor from Amersham Biosciences by in-
gel rehydration as described by Görg et al. [28]. The IPG strip, pH 3-10 NL, 18 cm 
(Immobiline Dry Strip, Amersham Biosciences) was rehydrated directly with saliva (300 µg 
of protein) solubilized in 350 µl of sample buffer containing 7 M urea, 2 M thiourea, 2% 
CHAPS, 1% DTT and 1% Pharmalyte 3-10. For analysis of PRP-1 (kindly provided from 
Donald I. Hay, Forsyth Institute, Boston, MA, USA) as standard control, 10 µg of PRP-1 
were dissolved in 350 µl of sample buffer. Low voltage (30 V, 12 h) was applied during the 
rehydration step, IEF was started with 200 V for one hour and increased to 500 V and 1,000 V 
for one hour, respectively, before continuously (gradient, 30 min) raising the voltage to 8,000 
V for a final focusing time of 3 h. IPGs were stored at -80°C until analyzed. The second 
dimension (SDS-PAGE) was performed in a vertical apparatus (Ettan DALT six 
electrophorese unit, Amersham Biosciences). The IPG strip was applied on top of the Ettan 
DALT gel (12,5%T, 3%C, 255 x 196 x 1mm, Amersham Biosciences), according to the 
manufacturer’s instruction and the gel was then run for 16 h (1 W per gel, 25°C). 
Staining 
2-D gels were stained with Coomassie brilliant blue (R-250) under gentle agitation. The 
proteins were first fixed with 20% TCA for 1 h and then stained with 0.1% Coomassie R-250 
in 40% ethanol / 10% acetic acid for 2 h. Gels were destained twice in 40% ethanol / 10% 
acetic acid for 30 min before intensifying with 1% acetic acid overnight. After washing with 
deionized water, gels were conserved in an aqueous solution containing 30% glycerol and 
were stored at 4°C. 
Sample preparation for MS  
For MS-based protein identification, both a manual [29] and a robotic procedure were 
performed. For the robotic approach, 2-D gels were analyzed using the automated 
PROTEINEER® line (Bruker Daltonik GmbH, Bremen, Germany). 2-D gels were rinsed with 
water in order to remove excess stain from the surface. Then the gels were fitted between a 
glass plate and a metal frame in order to prevent gel movement during the picking process. 
This assembly was mounted onto the surface of a high-resolution scanner that is integrated 
into the spot picking robot PROTEINEER sp with enough water to cover the gel. Using the 
robot control software spControl 3.1, an image of the 2-D gel was acquired. The spot 
detection was performed automatically, using the integrated spot detection algorithm. Spots 
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were picked into pierced 96 well PCR plates that were coded with a transponder for sample 
tracking. For spot picking, the method for backed gels was provided by the manufacturer. 
Digestion and MALDI target spotting  
The samples were digested using the PROTEINEER dp digestion robot. For the manual 
procedure, the samples were prepared as described elsewhere [29]. Following the automatic 
procedure, the sample plates were transferred from the spot picker to the appropriate positions 
on the digesting robot. The robot can identify the samples on the deck by means of an 
integrated transponder reader. The samples were digested using the reagent kit and digestion 
protocol provided by the manufacturer. Briefly, the gel plugs were washed to remove the 
Coomassie stain and dried using acetonitrile. Trypsin was applied to the gel plugs and 
samples were incubated for 4-8 h at 37°C. The resulting peptides were extracted and spotted 
onto a AnchorChip® MALDI target that was pre-coated with α-cyano-4-hydroxy-cinnamic 
acid (all reagents from Bruker Daltonik GmbH) and washed. 
MALDI-analysis 
For the analysis of tryptic peptides, MALDI-TOF MS was applied using the UltraFlexTM 
(Ultraflex TOF/TOF, Bruker Daltonik GmbH) equipped with a ScoutTM MTP MALDI target 
according to the manufacturer's instructions. In a first analysis (PMF analysis) the masses of 
the intact peptides generated in the digestion process were measured in the mass range from 
700-4,000 Da. The target spots were analyzed by summing up 200 shots per spot while the 
laser attenuation was adjusted automatically to an optimal level by utilizing a fuzzy-logic 
feedback algorithm. For the manual measurement, adopting laser attenuation and summing 
MS spectra were performed individually by the user. The peaks in the spectrum were labeled 
using the Similarity-Neighborhood Approach (SNAP) algorithm provided by the vendor of 
the mass spectrometer in order to identify the monoisotopic peak of each peptide signal. 
Thereafter, the spectra were exported to the Proteinscape database (Bruker Daltonik GmbH) 
for protein identification. Protein spots that could not be identified by PMF were analyzed in a 
second round performing PFF analysis from the most prominent peaks in the PMF spectrum. 
The acquisition of PFF spectra was triggered by an intelligent algorithm in the data base that 
can choose peptides suitable for fragmentation based on different criteria such as intensity, 
selectivity from neighboring peptide masses and / or protein identification. 
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Protein identification 
The MALDI spectra were automatically imported into the database and linked to the 
appropriate spots in the 2-DE gel image. In the database, the MALDI spectra were 
recalibrated using known contaminant peaks e.g. from keratin or trypsin in order to obtain 
precise peptide masses. The masses of contaminant peaks were removed from the spectra 
leaving only peaks with unknown masses for the database search. From PMFs, protein 
identification was achieved by searching the mass spectra against the NCBInr protein 
database without restriction by the taxonomy using several external search algorithms 
ProFoundTM (Genomic Solutions Ltd., Cambridgeshire, UK) and MascotTM (Matrix Science 
Ltd, London, UK). The results were collated into one table with a unified scoring system that 
allowed a comparison of the different algorithms on a scale from 0 to 100 [30]. The 
significance of the search result was then evaluated based on the unified score. Protein 
identifications with a unified score larger than 90 were considered to be correct.  
For PFF spectra arising from the MALDI TOF/TOF mode, protein identification was 
achieved by searching a protein database using several algorithms including MascotTM, 
SequestTM (Thermo, San Jose, CA, USA) or PFFSolver (Protagen AG, Dortmund, Germany). 
The results from individual PFF spectra were combined for each spot and protein 
identification was based on the combined score. For Mascot, this was achieved by the 
algorithm itself, for Sequest and PFFSolver, the algorithm provided by the Proteinscape 
database was used. Protein identifications with a combined score larger than 10 for Sequest 
and 100 for Mascot were considered to be correct. The significance level calculated by the 
Mascot software was a score of 50. The threshold for protein identification was set 
considerably higher in order to prevent false positive identifications. 
Results 
Separation of salivary proteins by 2-D PAGE and identification of protein spots 
In Coomassie blue-stained WS (Fig. 1A), major protein groups were represented by different 
isoforms of salivary amylase (spots 15) and a group of PRPs. Most PRPs appeared as typical 
diffuse pink spots [31] grouped within one zone of the acidic region (pI 3.2 - 4.9, spots 23). 
Additional pink spots appeared between pI 5.3 – 6.2 (spot 23) in the same Mr position and in 
the basic region (spots 24 and 25). Interestingly, the pink spots could only be seen, when 
saliva was filtrated with a membrane filter of 0.2 µm pore size prior to 2-DE.  
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Fig. 1: 2-DE pattern of human whole saliva (A), parotid saliva (B) and submandibular/sublingual 
saliva (C). Separated proteins were stained with Coomassie Blue R-250. Spot numbers refer to 
proteins listed in Table 1 and the Table in the Supplementary Materials. The number of circles does 
not represent the number of total spots excised (for spot counts and for a more detailed description of 
mapped proteins see Table in the Supplementary Material). 
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A total of 192 spots were picked from the WS-gel shown in Fig. 1A. The peptides resulting 
from tryptic digestion were analyzed and 131 spots could be identified by MALDI-MS (Table 
1).  
 
Table 1: List of proteins in whole saliva (WS) as well as in parotid and submandibular-sublingual 
(SMSL) secretions identified by two-dimension (2-D) polyacrylamide gel electrophoresis (PAGE) and 
mass spectrometry (MS) in comparison to previous proteome studies. 
Source of 
Protein Previous Proteome Studies 
Sp
ot
 N
o.
 
Protein Name W
S 
Pa
ro
tid
 S
al
iv
a 
SM
SL
 S
al
iv
a 
2-
D
 P
A
G
E 
M
ud
PI
T 
h 
LC
-M
S 
i   
 
1 Actin x   e, g x x 
2 Calgranulin A x   b, c, d, e x x 
3 Calgranulin B x   b, c, d x x 
4 Carbonic Anhydrase VI x x x d, f, g x  
5 Chain B, D Human Zn-α2-Glycoprotein x x x c, d, e, f, g x x 
6 Cyclophilin B x      
7 Cystatin B x   d, f x x 
8 Cystatin C x  x d x x 
9 Cystatin D x   c, d, f x x 
10 Cystatin SA-III precursor of acquired enamel 
pellicle 
x   b, d, e x  
11 Cystatin SA x  x b, c, d, e, f, g x x 
12 Cystatin SN precursor x x x b, c, d, e, g x x 
13 Cytokeratin 1 x      
14 Enolase 1 x   d, e, g x  
15 Human salivary amylase x x x a, b, c, d, e, g x x 
16 Ig alpha-1 chain C region x   a, c, d, f, g x x 
17 Keratin 10 x      
18  Lactoferrin x   a, d x  
19 Parotid secretory protein x  x d x  
20  Phosphoglycerate kinase x   g   
21 Poly-Ig-receptor x x x a, c, d, e, f, g x x 
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Source of 
Protein Previous Proteome Studies 
Sp
ot
 N
o.
 
Protein Name W
S 
Pa
ro
tid
 S
al
iv
a 
SM
SL
 S
al
iv
a 
2-
D
 P
A
G
E 
M
ud
PI
T 
h 
LC
-M
S 
i   
 
22 Prolactin-inducible protein x  x c, d, e, g x x 
23  Proline-rich phosphoprotein (gene PRH1 Db 
allele) 
x x x    
24 Proline-rich protein BstNIn, subfamily 1, 
isoform 3 
x x    x 
25 Proline-rich protein BstNI,   subfamily 3 
(PRG) 
x x  f  x 
26 Prolyl-4-hydroxylase x      
27 Serum albumin x x x a, b, c, d, e, f, g x x 
28 Thioredoxin x   e x x 
29 Transferrin x   e, g   
P1 HSPC059  x     
P2 Ig alpha-2 heavy chain  x  g x x 
P3 Ig κ light chain VLJ region  x  a, c, d, e, f, g x x 
P4 Lactoperoxidase, Salivary peroxidase  x   x x 
P5 Salivary acidic proline-rich phosphoprotein 
1/2 precursor 
 x  f x x 
S1 CST1   x    
S2 Cystatin S   x c, d, g x x 
S3 Histatin 1   x b, d, f x x 
S4 Mucin 7   x   x 
S5 0808206A peptide PA, proline-rich peptide   x    
a Beeley et al. (1991): 2-DE and immunoblotting (parotid saliva) 
b Yao et al. (2002): 2-DE and MS (WS, acquired enamel pellicle) 
c Ghafouri et al. (2003): 2-DE and MS (WS) 
d Vitorino et al. (2004): 2-DE and MS (WS) 
e Huang et al. (2004): 2-DE and MS (WS) 
f  Hardt et al. (2005): 2-DE and MS (parotid saliva) 
g Hu et al. (2005): 2-DE and MS (WS) 
h Wilmarth et al. (2004): MudPIT (WS) 
i Hu et al. (2005): LC-MS (WS) 
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The proteins that were identified for the first time in WS by a combination of 2-DE and MS 
include cyclophilin B (spot 6), prolyl-4-hydroxylase (spot 26), acidic PRP (spots 23), basic 
PRP (spot 24), and proline-rich glycoprotein (PRG) (spot 25). In agreement with their 
predominant appearance in the 2-D gel, salivary amylase and PRPs also amount to the 
majority of spots (Table in the Supplementary Material).  
In Coomassie-stained glandular secretions (Figs. 1B, C) a smaller number of spots as 
compared to WS were apparent. In parotid saliva, from 58 spots analyzed, 43 spots were 
identified and in SMSL secretion from 63 spots analyzed, 53 spots were identified. Most spots 
were found to be identical to the ones identified in WS. In parotid saliva (Fig. 1B), five 
proteins were found that could not be detected in WS, including HSPC059 (spot P1), Igα-2 
heavy chain (spot P2), Igκ light chain VLJ region (spots P3) lactoperoxidase (spot P4), and 
salivary acidic proline-rich phosphoprotein 1/2 precursor (spot P5). In SMSL saliva (Fig. 1C), 
CST1 (spots S1), cystatin S (spots S2), histatin 1 (spots S3), MUC7 (spot S4), and 0508206A 
peptide PA (proline-rich peptide, spot S5) could be found as additional proteins that were not 
detectable in WS. Comparing SMSL spot intensities to WS and parotid secretion, lower 
amounts of salivary α-amylase were noted and PRG as well as basic PRPs could not be 
identified in the basic pI-region.  
Identification of PRPs by comparison to purified PRP-1 
Following 2-D PAGE of purified PRP-1, two pink spots within a pI range of about 4,5 and Mr 
of about 22,000 were revealed (gel not shown). PMF- and PFF-spectra of these spots (Fig. 
2B, C) were in agreement with the database entry "salivary acidic proline-rich phosphoprotein 
1/2 precursor" and, thus, substantiated the identity of the proteins in these spots as PRP-1. As 
seen in Fig. 2A, the PMFs of the pink spots in WS and glandular secretions (all: spot 23) 
differ from those of purified PRP-1 (Fig. 2B). An additional peptide peak with a mass of 
2,136 Da was detected that was not present in purified PRP-1. The amino acid sequence of 
this peptide as revealed by PFF analysis (Fig. 2C), identified PRP type Db (gene PRH1) [32]. 
This PRP variant has an additional 21-amino acid repeat that is missing in the amino acid 
sequence of PRP-1-precursor [32, 33] (Fig. 2D). It is noteworthy that a horizontal scattering 
of Db protein spots within a pI range from 3.2 to 6.2 was observed. 
 In parotid saliva (Fig. 1B), an additional subclass of acidic PRPs was found (spots P5) 
that showed a mass spectrum comparable to that of purified PRP-1 (Fig. 2B). As evident from 
Fig. 2D, the N-terminal region of the PRPs was not detectable by MALDI mass spectrometry 
due to the paucity of tryptic cleavage sites and the limited mass range for PMF spectra. Due to 
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this limitation of analysis, it could not be distinguished which of the gene products of PRH2 
(PRP-1, PRP-2, PRP-4, PRP-4, PIF-f, PIF-s) is represented by spot P5.  In WS from another 
individual (Fig. 3B, Individual 3), different PRP species were found that did not contain the 
peptide peak with a mass of 2,136 Da, confirming the existence of inter-individual variations 
in this diverse family of proteins [34] (data not shown).  
 
 
Fig. 2: Identification of acidic proline-rich proteins by MS. A. PMF spectrum of proline-rich 
phosphoprotein identified in whole human saliva as well as in glandular secretions (gene PRH1, Db 
allele) B. PMF spectrum of purified PRP-1 (gene PRH2). C. PFF spectrum of the 2,136 Da peptide 
that is missing in PRP-1. D. Comparison of amino acid sequences of the two acidic PRPs identified. 
gi⏐131008⏐, Salivary acidic proline-rich phosphoprotein 1/2 precursor (gene PRH2); gi⏐88462⏐, 
proline-rich phoshoprotein (gene PRH1, Db allele).The peptide sequences identified by MALDI-PFF 
are highlighted in grey. 
 
Intra-individual and inter-individual comparisons of the 2-D protein patterns of WS and 
glandular secretions 
For comparison of intra-individual variations, WS as well as glandular parotid and SMSL 
secretions were collected from one individual on three different days. A visual comparison of 
the Coomassie-stained 2-D gels derived from these samples (Fig. 3A) showed a good 
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reproducibility of the major spots in WS that was even better when comparing the glandular 
secretions.  
 For comparison of inter-individual differences, WS as well as glandular secretions 
were collected from three additional individuals. Although major spots appeared similarly in 
all individuals, quantitative differences were observed when comparing the spot patterns of 
WS (Fig. 3B). An example is albumin (spots 27) that was found in greater amounts in 
individual 3. These differences were considerably less pronounced when comparing the spot 
patterns of glandular secretions. Inter-individual variations were most notable in the region of 
the acidic PRPs (spots 23) in WS and glandular secretions.  
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Fig. 3: Intra- and interindividual comparisons of Coomassie-stained 2-DE patterns of whole saliva 
(WS), parotid (PAR) and submandibular-sublingual (SMSL) saliva. (A) Intraindividual comparison of 
samples collected at different days. Gels at collection time point 1 are the ones analyzed (identical to 
Fig. 1). (B) Interindividual comparison of samples collected from four different individuals.  
Individual 1 is the donor analyzed in Fig. 1. 
 
Discussion 
A number of investigations using a combination of 2-DE and MS have been carried out for 
the study of human saliva [10-17]. Even though an impressive number of proteins could be 
identified, two major classes of proteins in human saliva, namely the PRPs and the salivary 
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mucins, had so far escaped identification in WS by a combination of 2-D PAGE and MALDI-
MS. In the present study, it was now possible to enlarge the WS protein map and combine it 
with a comprehensive analysis of separated parotid and SMSL glandular secretions for the 
display of acidic PRPs, basic PRPs, PRG as well as salivary mucin MUC7. The results show 
that, with little intra- and inter-individual variations, most components in WS can be 
explained by mixed contributions of the two major salivary glands with only few components 
remaining that may be derived from local sources in the oral cavity.  
 Some spots were readily apparent in WS that could not be detected in glandular 
salivas, e.g. calgranulin A (spot 2), calgranulin B (spot 3) or transferrin (spots 29). These 
components may not be derived from the salivary glands but rather from local sources in the 
oral cavity such as crevicular fluid [35]. Furthermore, some spots were seen in glandular 
secretions, that could not be detected in WS, e.g. histatin 1 (spots S3), cystatin S (spots S2) or 
immunglobulins (spots P2, P3). This might in part be explained by the fact that both SMSL 
and parotid saliva become diluted once they mix with each other. However, for spots as 
strong as histatin 1 and cystatin S it is unlikely that the effect of dilution would be the only 
cause for disappearance of these spots in WS. An additional explanation could be that certain 
proteins selectively form macromolecular aggregates in WS, as has been described for 
MUC5B [36], and was suggested to lead to the formation of salivary micelles [37]. Such 
macromolecular aggregates could be lost during sample preparation due to precipitation or 
filtration, as in the case of WS. Such a loss would be even more likely for proteins if they 
would bind to or would be bound by bacteria retained in the filter.  
 The overall qualitative pattern of protein spots showed comparatively little intra-
individual variation at different time points of sample collection. This holds particularly true 
for parotid and SMSL secretions. In WS greater variations were observed, that could be 
explained by changes in the relative amount of volume contributed by the major salivary 
glands to mixed saliva but might be also due to other changes in the local environment of the 
oral cavity. It has to be conceded, however, that in the present study the collection of saliva 
took place under controlled conditions. Under extreme conditions, such as strong physical 
activity, emotional stress, disease, or pharmacological influence, more pronounced changes 
are likely to be expected, as had been shown in past studies (reviewed by [38]). The inter-
individual comparison showed a consistent similarity of most major spots. Differences among 
individuals, seen in WS only, may reflect the momentary status of the local environment in an 
individual's oral cavity. This was particularly evident for proteins that enter the oral cavity by 
way of diffusion through the epithelial barrier or through the gingival crevice, such as serum 
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albumin (spots 27), that was found in high amounts in the 2-D gel of individual 3 (Fig. 3B). 
Serum albumin is known to be a marker for leakage of plasma proteins into saliva [39] and is 
related to the level of gingival inflammation [40] which in turn can be related to the degree of 
oral hygiene [41]. In contrast to WS, the inter-individual comparison of pure glandular 
secretions showed a higher degree of similarity. Differences seen in the spot pattern of 
glandular secretions among individuals were most notable for acidic PRPs (spots 23) and in 
this case might be due to the known genetically determined heterogeneity for this particular 
family of proteins [34].  
The identification of PRPs by MS is complicated by the fact that the arginine/lysine-
proline bond is not commonly cleaved by trypsin [42]. Therefore, only one tryptic peptide 
within the mass range of 700-4,000 Da can be expected for the acidic PRPs. Thus, the PRPs 
were not identified using the usual database search parameters with trypsin specificity. When 
allowing the cleavage of the R-P and K-P bond in the database search [43], PRP-1 can 
theoretically be cleaved into 19 peptides. Advanced bioinformatics for spectra calibration and 
removal of contaminating peptides were applied prior to database searching in order to 
increase the significance of the protein identifications achieved. Choosing these parameters, 
in combination with a comparison to a sample of purified PRP-1, allowed the unambiguous 
identification of PRPs by MALDI-PMF and MALDI-PFF measurements. Thus, the presence 
of several acidic and basic PRPs, recently shown in WS by Wilmarth et al. using the MudPIT 
technique [18] was confirmed in the present study by a combination of 2-D PAGE and 
MALDI-MS and extended by including the analysis of parotid and SMSL glandular 
secretions.  
In agreement with previous knowledge concerning the composition of proteins in WS, 
it should be expected that various subclasses of PRPs are to be revealed by 2-DE. Among the 
six PRP genes known, PRH1 and PRH2 code for acidic PRPs (PRH1 for Pa, Db and PIF, 
PRH2 for PRP1-4, PIF-f and PIF-s). PRB1, PRB2 and PRB4 code for basic PRPs and PRB3 
codes for PRG. PRB1 – PRB4 are of the BstNI type which means that the restriction enzyme 
BstNI cuts the repetitive region of these genes frequently [44]. As a consequence of this 
genetic heterogeneity and of posttranslational modifications, at least 20 different members of 
the PRP family should occur in human saliva that show different electrophoretic mobility 
[45]. In the present study, within the group of acidic PRPs, only the Db protein (gene PRH1) 
could be detected in WS as well as in both glandular secretions. Solely in parotid saliva, a 
gene product of PRH2 (spot P5) could be detected but due to analytical limitations it could 
not be definitively determined to which of the various types (PRP-1, PRP-2, PRP-3, PRP-4, 
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PIF-s, PIF-f) this protein belongs. Basic PRPs could not be sufficiently separated due to the 
limitations of isoelectric focusing in the basic region. Nevertheless, a type of basic PRP 
(BstNI-type, subfamily 1) and PRG (synonyms: BstNI-type, subfamily 3-GI protein) were 
identified. Notably, in contrast to WS and parotid saliva, these latter proteins could not be 
identified in SMSL saliva.  
Another group of well characterized salivary proteins, that had not been detected by 2-
DE in previous reports are the mucins MUC5B and MUC7 [3]. In this study, it was possible 
for the first time to resolve MUC7 after 2-D PAGE of SMSL saliva. Because MUC7 is 
predominantly derived from SMSL glands and becomes diluted once it is mixed with parotid 
saliva it may not anymore be readily detectable after 2-D PAGE of WS. Another possible 
explanation for the failure to detect MUC7 in WS could be that salivary micelles in WS 
containing MUC7 [37] might be lost during sample preparation. The fact that MUC5B could 
not be detected might likely be due to its high molecular weight (> 40 x 106 Da), that may 
prevent it from entering either the IPG-strip or the second dimension gel.  
Despite some limitations of 2-DE and, although, novel techniques such as MudPIT 
provide a considerably larger number of identified proteins, the possibility of a subsequent 
transfer of a 2-D gel onto a protein-binding membrane combined with immunological or 
biochemical blotting techniques may allow further insight into the biological functions of 
certain distinct proteins. 
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Abstract 
The microaerophilic bacterium Helicobacter pylori (H. pylori) is well established for its role 
in development of different gastric diseases. Bacterial adhesins and corresponding binding 
sites on the epithelial surface allow H. pylori to colonize the gastric tissue. In the present 
investigation, the adhesion of H. pylori to dot blot arrays of natural glycoproteins and 
neoglycoproteins was studied. Adhesion was detected by overlay with fluorescence-labeled 
bacteria on immobilized (neo)glycoproteins. The results confirmed the interaction between 
the adhesin BabA and the H-1-, Lewis b-, and related fucose-containing antigens. In addition, 
H. pylori bound to terminal α2-3-linked sialic acids as previously described. The use of a 
sabA mutant and sialidase treatment of glycoconjugate arrays showed that the adherence of H. 
pylori to laminin is mediated by the sialic acid-binding adhesin, SabA. The adhesion to 
salivary mucin MUC5B is mainly associated with the BabA adhesin, and to a lesser extent 
with the SabA adhesin. This agrees with reports, that MUC5B carries both fucosylated blood 
group antigens and α2-3-linked sialic acids. The adhesion of H. pylori to fibronectin and 
lactoferrin persisted in the babA/sabA double mutant. Because binding to these molecules was 
abolished by denaturation rather than by deglycosylation, it was suggested to depend on the 
recognition of unknown receptor moieties by an additional unknown bacterial surface 
component. The results demonstrate that the bacterial overlay method on glycoconjugate 
arrays is a useful tool for exploration and characterization of unknown adhesin specificities of 
H. pylori and other bacteria. 
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Introduction 
The spiral, gram-negative bacterium Helicobacter pylori (H. pylori) persistently colonizes the 
gastric mucosa of 50% of the human population and is associated with the induction of 
chronic type B gastritis, peptic ulceration, and the development of gastric carcinoma and 
MALT (mucosa-associated lymphoid tissue)-lymphoma (for a review see [1]). Close 
association of H. pylori with gastric epithelial cells [2] and the mucin layer covering the 
epithelial surface [3, 4] is believed to facilitate the permanent colonization of the stomach by 
this bacterium. An intimate association with the epithelial cells allows the bacteria to 
encroach upon signal transduction processes, in particular, by action of the so-called Cag type 
IV secretion system [5, 6], resulting in rearrangement of the cytoskeleton [7] and the 
induction of proinflammatory cytokines [8]. 
 In the past, biochemical as well as genetic approaches have been chosen to identify 
bacterial factors involved in the adherence process of H. pylori to gastric cells. By using 
affinity purification and overlay assays, a subset of putative receptors could be identified, 
including fucosylated, sialylated, or sulphated oligosaccharides, glycolipids, glycoproteins, 
mucins, and lipid-like compounds [9-16]. Recently, two major receptor structures and their 
corresponding adhesins were characterized in more detail. One is a fucosylated 
oligosaccharide structure present both in the H-1 and Lewis b blood group antigens (blood 
group O phenotype) [10, 17] that was identified as a receptor motif for the H. pylori outer 
membrane protein (OMP) BabA, the blood group antigen binding adhesin [18]. Another is the 
sialyl-Lewis x antigen, that is recognized by the OMP SabA, the sialic acid-binding adhesin 
[19]. The fucosylated blood group antigens are highly expressed in gastrointestinal epithelium 
which favors colonization of the gastric mucosa. The sialyl-Lewis x antigen is described to be 
predominantly expressed in inflamed tissues and might promote the chronicity of the infection 
process once gastritis is established [19]. 
 Beside these well-characterized interactions, other eucaryotic receptors and bacterial 
adhesin candidates have been described, suggesting the enrolment of additional interactions 
that are not fully explored yet. In this regard, extracellular matrix (ECM) proteins, such as 
laminin and collagen type IV, have been proposed as receptors for H. pylori [20, 21]. In 
addition, surface-exposed components of H. pylori such as the OMPs AlpAB [22, 23] and 
HopZ [24] as well as Lewis x structures in the O-antigen side chain of the lipopolysaccharide 
[25] have been shown to be involved in adherence to gastric cells. 
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 Recently, arrays of immobilized purified glycoproteins and neoglycoproteins have 
been successfully used to explore the adhesin specificities of oral actinomyces and viridans 
streptococci [26, 27]. These arrays are well suited to assess bacterial adhesin specificities 
because both the naturally occurring glycoproteins and related oligosaccharide structures, 
presented on neoglycoproteins, can be compared for receptor activity and for exploration of 
the minimal oligosaccharide motifs necessary for binding. This method has now been adapted 
using a set of sabA- and babA-deficient fluorescence-labeled mutants of H. pylori to 
investigate a wider range of natural and synthetic glycoproteins for receptor activity. 
Material and Methods 
Bacteria and growth conditions  
The wild-type H. pylori strain J99 [28] and its isogenic mutants in the sabA and/or babA 
genes [19] were grown for 48-72 h at 37°C in a microaerophilic atmosphere on Wilkins-
Chalgren agar (Oxoid, Wesel, Germany) containing 10% horse blood, Dent supplement 
(Oxoid, Wesel, Germany) and 0.4 g KNO3 per liter. Streptococcus gordonii strain DL1 
(Challis) and the sialic acid binding deficient mutant strain D102, kindly provided by 
Yukihiro Takahashi (The Nippon Dental University School of Dentistry at Tokyo, Japan) 
were grown in complex medium as previously described [29]. 
SDS-polyacrylamide gel electrophoresis and immunoblot 
For immunoblot analysis the bacteria were collected from agar plates and suspended in 300 µl 
sample solution [30]. Boiled aliquots were subjected to SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) in a 10% acrylamide gel using a mini-gel apparatus (Biorad, 
München, Germany) and blotted onto nitrocellulose membranes at 1 mA/cm2 using a semi-
dry blot system (Biotec Fischer, Reiskirchen, Germany). The membranes were blocked with 
3% BSA in Tris-buffered saline (TBS) (50mM Tris-HCl, pH 7.5; 150 mM NaCl) and 
incubated with antisera AK277 (anti-BabA) [31] or AK278 (anti-SabA) for at least 2 h 
(1:10,000 dilution). Alkaline phosphatase-coupled protein A was used to visualize the bound 
antibody by decomposition of nitroblue tetrazolium. 
Glycoproteins and neoglycoproteins 
Dry nitrocellulose membranes (Invitrogen, Carlsbad, CA, USA, pore size 0.4 µm) were 
spotted with 1 µl volumes containing 1 µg of glycoproteins or neoglycoproteins. 
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Table 1: Neoglycoproteins used in this study 
Sugar chains Neoglycoprotein conjugates 
Lacto-N-tetraose Galβ1-3GlcNAcβ1-3Galβ1-4(Glc)-APD-HSAa 
Lewis a Galβ1-3[Fucα1-4]GlcNAcβ1-3Galβ1-4(Glc)-APD-HSAa 
H-1 Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4(Glc)-APD-HSAa 
Lewis b Fucα1-2Galβ1-3[Fucα1-4]GlcNACβ1-3Galβ1-4(Glc)-APD-HSAa 
A-Trisaccharide GalNAcα1-3[Fucα1-2]Galβ1-O-APE-HSAa 
sialyl-Lewis a Neu5Acα2-3Galβ1-3[Fucα1-4]GlcNAcβ1-3Galβ1-4(Glc)-APD-HSAa 
Lacto-N-neotetraose Galβ1-4GlcNAcβ1-3Galβ1-4(Glc)-APD-HSAa 
Lewis x Galβ1-4[Fucα1-3]GlcNAcβ1-3Galβ1-4(Glc)-APD-HSAa 
H-2 Fucα1-2Galβ1-4GlcNAcβ-O-APE-HSAa 
Lewis y Fucα1-2Galβ1-4[Fucα1-3]GlcNAcβ1-O-APE-HSAa 
B-Trisaccharide Galα1-3[Fucα1-2]Galβ1-O-APE-HSAa 
sialyl-Lewis x Neu5Acα2-3Galβ1-4[Fucα1-3]GlcNAcβ1-3Galβ1-4(Glc)-APD-HSAa 
Lactose Galβ1-4Glcβ-O-10 Å spacer-BSAb 
6’-Sialyllactose Neu5Acα2-6Galβ1-4(Glc)-APD-HSAa 
3’-Sialyllactose Neu5Acα2-3Galβ1-4(Glc)-APD-HSAa 
2’-Fucosyllactose Fucα1-2Galβ1-4(Glc)-APD-BSAa 
3’-Sialyl-3-fucosyllactose Neu5Acα2-3Galβ1-4[Fucα1-3]Glc-3 atom spacer -BSAc 
N-Acetyllactosamine Galβ1-4GlcNAc-3 atom spacer - BSAc 
3’-Sialyl-N-
acetyllactosamine 
Neu5Acα2-3Galβ1-4GlcNAc-3 atom spacer-BSAc 
 
a IsoSep AB, Tullinge, Sweden (10-20 mol oligosaccharides/mol HSA/BSA) 
b Glycorex AB, Lund, Sweden (20 mol oligosaccharides/mol BSA) 
c Dextra-Laboratories Ltd, Reading, UK (7-11 mole oligosaccharides/mol BSA) 
 
The glycoproteins used were: fetuin (Calbiochem, Bad Soden, Germany), asialofetuin 
(Sigma), glycophorin A (Sigma), asialoglycophorin (Sigma), laminin (from human placenta, 
Sigma), MUC5B (kindly provided by M. J. Levine, Department of Oral Biology, SUNY, 
Buffalo, NY), transferrin (Sigma), fibronectin (from human plasma, Sigma), and lactoferrin 
(from human milk, Sigma). The neoglycoproteins used are listed in Table 1. Human serum 
albumin (HSA, fraction V, Sigma) and bovine serum albumin (BSA, fraction V, 
immunoglobulin-free, protease-free, Sigma) were included as negative (non-glycosylated) 
controls.  
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Pretreatment of dot blot arrays 
For sialidase treatment, membranes were incubated with 0.1 U/ml of sialidase (from 
Clostridium perfringens type X, Sigma) in TBS containing 5% BSA (fraction V, Sigma), 1 
mM CaCl2, 1 mM MgCl2 and 0.1% sodium azide at 37°C before overlay. For denaturation of 
spotted proteins, membranes were treated with 0.1% SDS (Merck, Darmstadt, Germany) in 20 
mM sodium phosphate buffer (pH 7.2) containing 50 mM β-mercaptoethanol (Merck) at 
100°C for 5 min. For N-glycosidase F digestion, 0.05 U/ml of recombinant Glyko® N-
glycanase from Chryseobacterium meningosepticum (PROzyme, San Leandro, CA, USA) and 
0.75% NP-40 (PROzyme, San Leandro, CA, USA) were added after denaturation and further 
incubation was carried out overnight at 37°C. All enzymatic pre-treatments of membranes 
were performed in sealed plastic bags. 
Bacterial overlay 
The method was performed as previously described [32] except that fluorescence labeled 
bacteria were used as probes. Bacteria at 1 x 108/ml in PBS were fluorescein labeled by 
incubation with fluorescein-5-isothiocyanate (Molecular Probes, Oregon, USA) at 100 µg/ml 
for 30 min at room temperature. Untreated and pretreated membranes were blocked in TBS 
containing 5% BSA (fraction V, Sigma), 1 mM CaCl2, 1 mM MgCl2 for 2 h at room 
temperature. Labeled bacteria were recovered by centrifugation at 900 x g for 7 min, 
resuspended in 10 ml blocking buffer and added to a final concentration of 2,5 x 107 bacteria 
in a total volume of 40 ml (about 1 ml of bacterial suspension per cm2 of nitrocellulose 
membrane). The overlays were incubated for 30 min at 4°C in the dark without mixing and 
washed three times at room temperature for 5 min on a rotary shaker in TBS containing 
0,05% Tween-20, 1 mM CaCl2 and 1 mM MgCl2. The fluorescence of adherent bacteria was 
detected by a Typhoon imaging system (Typhoon 9200, Amersham Biosciences, Freiburg, 
Germany).   
Chemical labeling of glycoconjugates 
For the oxidation of carbohydrates, nitrocellulose membranes with (neo)glycoproteins 
immobilized were incubated for 30 min in acetate buffer (0.1 M, pH 5.5) with 10 mM sodium 
periodate (ICN Biomedicals, Aurora, OH) at room temperature in the dark. After washing in 
PBS, membranes were incubated for 1 h at room temperature in acetate buffer containing 100 
µg/ml biotin-LC-hydrazide (Pierce). The membranes were washed three times with TBS and 
were then blocked in TBS containing 3% BSA (Sigma) for 1 h at room temperature. The 
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membranes were subsequently incubated for 30 min in the dark with 5 mg fluorescein avidin-
D (Vector Laboratories, Inc., Burlingame, CA) per ml in blocking buffer. Membranes were 
washed three times in TBS containing 0.1% Tween-20 and once in TBS. Fluorescent signals 
were detected by a Typhoon imaging system (Typhoon 9200, Amersham Biosciences). 
Lectin blotting 
Membranes were blocked for 1 h at room temperature with TBS containing 2% polyvinyl 
alcohol (average molecular weight 30,000 - 70,000, Sigma), 0.1% Tween 20, 1 mM CaCl2 
and 1 mM MgCl2. Membranes were subsequently incubated for 1 h at room temperature in 
the dark with fluorescein-labeled UEA I (Vector Laboratories, Inc., Burlingame, CA) and 
fluorescein-labeled LTA (Sigma) at concentrations of 5 µg per ml in blocking buffer [32] The 
blots were washed three times in TBS containing 0.1% Tween-20 and the fluorescence of 
bound lectins was detected by a Typhoon imaging system (Typhoon 9200, Amersham 
Biosciences).  
Aminogroup detection 
Untreated and pre-treated membranes were washed three times in borat buffer pH 9.7 
containing 0.05 M Na2B4O7 x 10 H2O (Merck) and 0.2% Tween 20 and then incubated for 1 h 
with 100 µg/ml of sulfo-NHS-LC-biotin (Pierce, Rodeford, IL). After washing two times in 
borat buffer and two times in TBS containing 0.1% Tween-20, the membranes were incubated 
for 30 min in the dark with 5 mg/ml fluorescein avidin-D (Vector Laboratories) in TBS 
containing 0.1% Tween-20. Membranes were washed again three times in TBS containing 
0.1% Tween-20 and fluorescent signals were detected by a Typhoon imaging system 
(Typhoon 9200, Amersham Biosciences). 
Results 
Characterization of adhesin expression in H. pylori mutants 
Using specific antisera directed against BabA and SabA, respectively, the expression of these 
OMPs was verified on H. pylori J99 wild-type (wt) (Fig. 1). The BabA and SabA proteins 
could be detected with apparent molecular weights of ~80 kDa and 70 kDa, respectively. The 
BabA protein was expressed in the J99 sabA mutant but not in the J99 babA and J99 
babA/sabA mutants. The expression of the SabA protein could be detected in the J99 babA but 
not in J99 sabA or J99 babA/sabA mutants. These data confirm the correct mutagenesis of the 
desired genes in each mutant strain. 
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Fig. 1: The characterization of adhesin expression in Helicobacter pylori J99 wild-type (wt) and 
adhesin-deficient isogenetic mutants. Protein lysates from H. pylori J99 wt, J99 sabA mutant, J99 
babA mutant, and J99 babA/sabA double mutant were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), and western transfers were incubated with anti-
BabA and anti-SabA antisera. Bound antibodies were detected with alkaline phosphatase-coupled 
protein A and nitroblue tetrazolium color reaction. 
Validation of glycoconjugate array 
To verify that proteins were properly immobilized on the nitrocellulose membrane and are 
glycosylated, the incubation of blots with 10 mM sodium periodate for oxidation of 
carbohydrates and subsequent incubation with biotin-LC-hydrazide was performed. The result 
confirmed that each protein spot on the array carries sugar chains with the exception of BSA 
and HSA, that were included as internal negative controls (Fig. 2A). 
 A further characterization of carbohydrates was performed by lectin blotting with Ulex 
europaeus agglutinin (UEA-I) and Lotus tetragonolobus agglutinin (LTA) that both bind to α-
L-fucose and recognize the H-2 trisaccharide epitope [33, 34] (Fig. 2B, C).  
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Fig. 2: Chemical labeling of carbohydrates on glycoconjugate arrays and recognition by fucose-
specific plant lectins. Carbohydrates on (neo)glycoproteins spotted on nitrocellulose (1 µg per spot) 
were (A) oxidized by sodium periodate before labeling with biotin-LC-hydrazide and the detection by 
avidin-D fluorescein-5-isothiocyanate (FITC) or incubated with (B) FITC-conjugated UEA-I and (C) 
FITC-conjugated LTA. Bound lectins were detected by a fluorescence scanner. The locations of 
spotted (neo)glycoproteins are indicated below. 
In previous studies UEA-I was used for detection of receptor motifs recognized by H. pylori 
[35]. In the present study, both lectins bound strongly to H-2-, Lewis y-, and 2'-
fucosyllactose-carrying neoglycoproteins. LTA but not UEA-I recognized also the Lewis x-
antigen (dot C2). Weaker binding was noted to fucosylated blood group type 1 chains that 
were recognized by UEA-I and LTA to different extents. Strong binding of both lectins was 
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found to MUC5B (dot A6), indicating the presence of α-L-fucose on this glycoprotein as 
expected from the presence of type 2 human blood group determinants on this molecule [36]. 
To further validate the glycoconjugate overlay method, Streptococcus gordonii DL1, 
expressing an adhesin (Hsa) specific for α2-3-linked sialic acids [29, 37], was used as a 
probe. This strain bound strongly to fetuin, glycophorin A, laminin, and 3’-sialyllactose (Fig. 
3A). Strain D102, which lacks the sialic acid binding adhesin, failed to bind any component 
on the glycoconjugate array (Fig. 3B). 
 
 
Fig. 3: The adhesion of fluorescein-5-isothiocyanate (FITC)-labeled Streptococcus gordonii DL1 (A) 
and mutant strain D102 (B) to glycoconjugate arrays. (Neo)glycoproteins spotted on nitrocellulose  
(1 µg per spot) were overlaid with FITC-labeled bacteria and adherent bacteria were detected by a 
fluorescence scanner. The locations of spotted (neo)glycoproteins are the same as outlined in legend 
to Fig. 2. 
 
Lectin-dependent H. pylori binding to natural and synthetic glycoproteins 
Binding characteristics of H. pylori adhesins were determined by comparing the binding of wt 
strain J99 with babA- and sabA-deficient mutant strains (Fig. 4). J99 wt bound to fetuin, 
glycophorin A, laminin, MUC5B, sialyl-Lewis a, sialyl-Lewis x, 3'-sialyllactose, 3'-sialyl-3-
fucosyllactose, and 3'-sialyl-N-acetyllactosamine (Fig. 4A). These glycoproteins were 
recognized also by the J99 babA mutant strain (Fig. 4B). No binding of any H. pylori strain to 
6'-sialyllactose (dot D2) could be detected. Strong binding of J99 wt was noted to H-1- and 
Lewis b-containing neoglycoproteins (Fig. 4A). These two determinants were also recognized 
by the J99 sabA mutant (Fig. 4C). Binding to MUC5B (dot A6) was still detected with both, 
the babA and the sabA mutant, the latter, however, showing a stronger signal. The J99 
babA/sabA double mutant failed to bind to any component on the glycoconjugate array (Fig. 
4D).  
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Fig. 4: The adhesion of fluorescein-5-isothiocyanate (FITC)-labeled Helicobacter pylori wild-type 
(wt) strain J99 (A), babA mutant strain (B), sabA mutant strain (C), and sabA/babA double mutant 
strain (D) to glycoconjugate arrays. (Neo)glycoproteins spotted on nitrocellulose (1 µg per spot) were 
overlaid with FITC-labeled bacteria and adherent bacteria were detected by a fluorescence scanner. 
The locations of spotted (neo)glycoproteins are the same as outlined in the legend to Fig. 2. 
 
 To further confirm the sialic acid-dependency of SabA-mediated binding, blots were 
incubated with sialidase prior to overlay with bacteria (Fig. 5). Sialidase treatment abolished 
binding of J99 wt and the babA mutant to fetuin, laminin and sialic acid-containing 
neoglycoproteins (Fig. 5A, B), resulting in a binding pattern analogous to the sabA mutant 
(Fig. 4C). Residual binding of the babA mutant to MUC5B (Fig. 5C) was completely 
abolished by pre-treatment with sialidase (Fig. 5D). 
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Fig. 5: The adhesion of fluorescein-5-isothiocyanate (FITC)-labeled Helicobacter pylori wild-type 
(wt) strain J99 (A, B) and J99 babA mutant strain (C, D) to glycoconjugate arrays. 
(Neo)glycoproteins spotted on nitrocellulose (1 µg per spot) were overlaid with FITC-labeled bacteria 
and adherent bacteria were detected by a fluorescence scanner. Blots remained untreated (A, C) or 
were sialidase treated (B, D) before the addition of bacteria. The locations of spotted 
(neo)glycoproteins are the same as outlined in the legend to Fig. 2. 
 
BabA- and SabA-independent binding of H. pylori to fibronectin and lactoferrin 
In the course of testing additional glycoproteins as putative receptor candidates for H. pylori, 
adhesion to fibronectin and lactoferrin was noticed (Fig. 6). Remarkably, this was observed 
not only with the wt strain but also with the babA/sabA double mutant, suggesting that a 
different unknown bacterial surface component on H. pylori might be involved in this 
interaction. To map the receptor motif in these glycosylated proteins, the protein structure was 
denatured by sodium dodecyl sulfate (SDS) and heat treatment or the sugar residues were 
removed by treatment with N-glycosidase F. Following only denaturation, the adhesion to 
fibronectin and lactoferrin disappeared in both J99 wt and the babA/sabA double mutant. 
However, denaturation did not influence the SabA-dependent binding of J99 wt to laminin. 
Binding of J99 wt to laminin only disappeared, when denatured membranes were treated with 
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N-glycosidase F, confirming lectin-like interaction in this recognition process. Aminogroup 
detection was used to control that denaturation did not result in loss of immobilized proteins.  
 
Fig. 6: SabA and BabA-independent binding of Helicobacter pylori to lactoferrin and fibronectin. 
Fibronectin (Fn), lactoferrin (Lf), and laminin (Lm) were spotted on nitrocellulose membranes (1 µg 
per spot) and were stained for amino groups by labeling with NHS-LC-biotin and detection by 
 avidin-D FITC as well as for bacterial binding of FITC-labeled H. pylori wild-type strain (wt) J99 or 
babA/sabA-double mutant strain. Fluorescent signals were detected by a fluorescence scanner. 
 
Discussion 
Numerous adhesive properties of H. pylori have been described, including hemagglutination, 
attachment to epithelial cells and binding to distinct receptors, such as oligosaccarides or 
proteins of the basement membrane [20, 38]. The aim of this study was to establish a 
screening system for exploration of novel receptor-adhesin interactions in H. pylori. The 
results of this study confirmed the binding specificity of H. pylori adhesin BabA to H-1-, 
Lewis b-, and Lewis b-related oligosaccharide determinants as well as the specificity of 
adhesin SabA to sialyl-Lewis x and sialyl-Lewis a containing oligosaccharides [10, 19]. 
Preferential binding of H. pylori to α2-3-linked sialic acid [13] was attributed to the SabA 
adhesin. In addition, the SabA adhesin was found sufficient to explain binding to laminin that 
had been previously observed [20]. Binding of H. pylori to salivary mucin MUC5B that also 
had been described [16] was now shown to be predominantly mediated by the BabA adhesin 
and to a lesser degree also by the SabA adhesin. Only the binding to fibronectin and 
lactoferrin could not be explained by the activities of the SabA or BabA adhesins. Because 
binding of H. pylori to these glycoproteins was abolished by denaturation rather than by 
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deglycosylation, it is proposed to depend on recognition of unknown protein moieties by an 
additional adhesive surface structure on H. pylori. 
 For the validation of the glycoconjugate array, lectins (UEA-I and LTA) were chosen 
that exhibit binding specificity for α-L-fucose [35] and in this respect are similar to the H. 
pylori BabA adhesin that is known to bind to the Lewis b antigen, an oligosaccharide 
structure containing terminal α1-2-linked-fucose [18]. The minimal structure in the 
glycoconjugate array for recognition by UEA-I was shown to be Fucα1-2Gal, present in both 
type 1 and type 2 chains of blood groups, but a preference for the H type 2 trisaccharide 
epitope (Fucα1-2Galβ1-4GlcNAc) was noticed that is in agreement with earlier reports [33, 
34]. Strong binding to 2’-fucosyllactose confirmed that the N-acetyl group of type 2 chains is 
not necessary for binding [34]. Analogous to UEA-I, the binding specificity of LTA for H-2 
antigen [34] could be confirmed. A significant difference between UEA-I and LTA was the 
additional recognition of the Lewis x antigen (Galβ1-4[Fucα1-3]GlcNAc) by LTA but not by 
UEA-I, that is also in agreement with previous reports [39]. So far, UEA-I had been used as a 
probe to identify potential receptors for H. pylori [35]. However, the results of this 
investigation demonstrate, that UEA-I recognizes a broader range of fucose-containing 
receptors than the H. pylori BabA adhesin. This becomes particularly evident from the finding 
that, in contrast to UEA-I which strongly bound 2'-fucosyllactose, H. pylori J99 wt and the 
sabA mutant showed only weak binding. Thus, although terminal Fucα1-2Gal might be 
sufficient for binding of H. pylori, significantly stronger binding occurs to the Fucα1-2Galβ1-
3GlcNAc motif found in H-1 and Lewis b antigens. 
 In the past, two possible explanations for the binding of H. pylori to laminin were 
proposed. First, a lectin-like interaction of the bacterium with terminal sialic acids on laminin 
[40] and second, an interaction of H. pylori lipopolysaccharides with laminin [41]. Our results 
clearly show that a lectin-like interaction of the SabA adhesin with terminal sialic acid is 
responsible for binding to laminin. Thus, strong binding to laminin that was detectable with 
the J99 wt strain disappeared in the sabA-deficient mutant (Fig. 4) as well as after 
preincubation of the membranes with sialidase (Fig. 5). These findings expand the binding 
activities of the SabA adhesin beyond the previously reported recognition of sialyl-Lewis 
blood group antigens [19]. A broader recognition of terminal sialic acid-containing 
oligosaccharides is supported by the finding that the sabA mutant failed to bind to fetuin, 
glycophorin, 3’-sialyllactose-HSA, 3’-sialyl-3-fucosyllactose-BSA, and 3’-sialyl-N-
acetyllactosamine-BSA. Because 6’-sialyllactose-HSA was not recognized as a receptor, it is 
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proposed that the previously found binding activity of H. pylori to terminal α2-3-linked sialic 
acid [13] can be attributed to the SabA-adhesin. In this respect, the binding specificity of the 
SabA adhesin to laminin appears similar to the sialic acid-binding adhesin of Streptococcus 
gordonii DL1 that also exhibits a preference for α2-3-linked sialic acids [29]. Interestingly, 
the elucidation of the oligosaccharides on laminin had revealed only the presence of terminal 
α2-3- but not α2-6-linked N-acetyl neuraminic acid [42]. This might explain stronger binding 
of H. pylori to laminin than to fetuin, the latter carrying both α2-3- and α2-6-linked N-acetyl 
neuraminic acids [43, 44].  
 Binding of H. pylori to salivary mucin MUC5B, that had been previously reported 
[16], could now be confirmed by binding of wt strain J99. Notably, both the sabA and the 
babA mutants still bound to MUC5B whereas the sabA/babA double mutant failed to bind. 
Strong binding of the sabA-deficient mutant to MUC5B indicates the importance of H-1-, 
Lewis b-, and Lewis b-related oligosaccharide epitopes for the recognition of this mucin by 
the BabA adhesin. Analysis of glycosylation had shown the presence of these oligosaccharide 
determinants on MUC5B [36]. Binding of the babA-deficient mutant to MUC5B was weaker 
and suggests an additional involvement of the SabA adhesin with corresponding terminal 
sialic acids on this molecule. This was further confirmed by pretreatment of the membranes 
with sialidase that removed the residual binding of the babA-deficient mutant but not of the wt 
strain J99 to MUC5B (Fig. 5). These data suggest that binding to MUC5B can solely be 
explained on the basis of both the BabA and the SabA adhesin. The requirement of an 
additional adhesin recognizing sulfated oligosaccharide structures, as previously proposed 
[16], could not be supported based on the present data. Because the recognition of various 
sialic acid-containing oligosaccharides differs between the SabA adhesin of H. pylori and the 
Hsa adhesin of S. gordonii DL1 (Figs. 3 and 4), sub-terminal sugars to α2-3-linked sialic acid 
seem to be involved in recognition. This becomes particularly apparent for MUC5B that is 
bound by H. pylori but not by S. gordonii DL1. Binding of H. pylori to MUC5B, a human 
salivary mucin, may enable H. pylori to colonize the oral cavity [16] which may in turn have 
implications for oral transmission of this pathogen [45]. 
 Binding of H. pylori to lactoferrin had been previously described and was attributed to 
either a 60 kDa heat shock protein [46] or a 70 kDa lactoferrin-binding OMP of H. pylori 
[47]. For the 60 kDa heat shock protein, it was suggested that carbohydrate moieties of 
lactoferrin were involved in binding [46]. In this investigation, however, it could be 
demonstrated that binding of H. pylori to lactoferrin is not dependent on BabA or SabA 
activities because the babA/sabA double mutant still bound to this protein. Thus, the presence 
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of an additional binding activity on H. pylori has to be hypothesized. Analogous to lactoferrin, 
binding of H. pylori to fibronectin, an ECM component, was also independent of BabA or 
SabA activities, clearly distinguishing it from the SabA-dependent binding to laminin, another 
protein of the ECM. The fact that denaturation rather than deglycosylation of both lactoferrin 
and fibronectin abolished binding of H. pylori to these components, suggested that protein 
moieties rather than carbohydrates might play a role in receptor recognition. ECM proteins 
such as fibronectin, laminin or vitronectin are involved in integrin-mediated signal 
transduction pathways that regulate cellular processes including actin rearrangements, cell 
cycle regulation or survival of cells [48]. Several pathogenic bacteria such as Staphylococcus 
aureus or Neisseria gonorrhoeae, have learned to exploit this signaling network to invade 
epithelial cells by bridging fibronectin-binding proteins to β1-integrins on the epithelial 
surface [49, 50]. Because evidence for H. pylori invasiveness has been described [51, 52] but 
the mechanism of entry is not known, it will be interesting to identify the fibronectin-binding 
component on H. pylori.  
 The high specificity and reliability of the current overlay method as well as the simple 
handling, in combination with well defined bacterial mutants, may allow future analysis of 
complex mixtures of, for example, gastric epithelial cell membranes or salivary proteins for 
identification of natural receptors for H. pylori adhesion. 
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Abstract 
Because gastric infection by Helicobacter pylori (H. pylori) takes place via the oral route, 
possible interactions of this bacterium with salivary proteins could be of pathogenic 
importance. By using a combination of bacterial overlay and proteomics techniques, the 
interactions of H. pylori adhesins BabA and SabA with the whole range of salivary proteins 
were explored. Proteins of human whole saliva and glandular secretions were separated by 
one-dimensional and two-dimensional gel electrophoresis and transferred onto nitrocellulose. 
Adhesion of H. pylori strain J99 to transferred salivary proteins was detected by bacterial 
overlay with fluorescence-labeled organisms. Receptor molecules were identified by either 
matrix-assisted laser desorption/ionization mass spectrometry or by comparison with the 
proteome maps of a preceding study. Binding of H. pylori to MUC5B, MUC7 and gp-340 was 
confirmed and by use of isogenic adhesin-deficient mutants the adhesins responsible for 
binding could be revealed. Adhesion to MUC7 and gp-340 could be associated with the SabA 
and BabA adhesins, respectively, whereas binding to MUC5B was associated with both 
adhesins. Binding of H. pylori to the proline-rich glycoprotein was newly detected and 
assigned to the activity of the BabA adhesin whereas the SabA adhesin was found responsible 
for binding to other newly detected receptor molecules, including carbonic anhydrase VI, 
secretory component, parotid secretory protein and zinc-α2-glycoprotein. Interactions between 
H. pylori surface adhesins and salivary receptors may modify the pathogenic properties of this 
organism. The establishment of the two-dimensional overlay technique represents an useful 
supplement in the adhesion studies of bacteria with complex protein mixtures.  
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Introduction 
Adhesins of pathogenic bacteria are considered to be virulence factors important for initial 
binding and subsequent colonization of host tissues as well as for triggering a host response 
[1]. There is a need for techniques that allow to identify the corresponding host receptors for 
such bacterial adhesins both on the tissue surface and in the complex biological fluids coating 
most internal surfaces. A bacterium for which the importance of adhesin-receptor interactions 
has been well documented is the gastric pathogen Helicobacter pylori (H. pylori). More than 
50% of all people worldwide are infected by this organism [2], that causes type B gastritis, 
gastric and duodenal ulcers and is involved in the development of gastric adenocarcinoma [3, 
4]. 
 Because the infection is acquired by oral ingestion of the bacterium [4], it is likely 
that, while being ingested, H. pylori may interact with human saliva, a predominant 
component in the oral cavity. Between 0.5 and 1.5 liters of saliva are produced per day [5] 
most of it being swallowed and ending up in the stomach [6, 7] and a smaller part being 
expectorated. Thus, it is not unlikely that saliva and its constituents could potentially 
influence H. pylori infectivity in the stomach or might function as a vehicle for a possible 
oral-to-oral transmission. In this regard, it is noteworthy that several studies suggest a 
transient or even permanent colonization of H. pylori in the oral cavity (reviewed by [8]). 
 A putative relevance of saliva for H. pylori pathogenesis is also supported by recent 
investigations that have shown adhesive interactions of H. pylori with salivary proteins. The 
inhibitory action of crude bovine and human salivary mucins on H. pylori haemagglutination 
has been known for a long time [9, 10]. More recently, adhesive interaction of H. pylori with 
human salivary mucin MUC5B (MG1) could be demonstrated by ELISA and by 
immunoblotting adsorbed salivary proteins eluted from the H. pylori surface [11, 12]. This 
interaction was confirmed by a study of Prakobphol et al. in which direct binding of H. pylori 
to MUC5B and also to the other major salivary mucin MUC7 (MG2) was shown by bacterial 
overlay and was suggested to be associated with the expression of Lewis blood group antigens 
on these glycoproteins [13]. In addition, the same group reported that the salivary agglutinin 
which is identical to the lung scavenger receptor cysteine-rich protein (gp-340) caused 
aggregation of H. pylori, could be eluted from the surface of this organism [14], and mediated 
binding of H. pylori to nitrocellulose transfers of salivary proteins separated by SDS-PAGE 
[13]. 
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 It is known that carbohydrate motifs are important receptors for adhesin-mediated 
colonization of gastric tissues by H. pylori organisms [15]. Best characterized among many 
reported adhesins are the blood group antigen-binding adhesin BabA [16, 17] and the sialic 
acid-binding adhesin SabA [18] that belong to the family of outer membrane proteins (OMP). 
Carbohydrate receptor motifs recognized by the BabA adhesin include H-1-, Lewis b- and 
related fucose-containing blood group antigens whereas the SabA adhesin binds preferentially 
to sialyl-Lewis x antigen and more general to α2-3-linked sialic acid termini [18-20]. The 
assumption that these adhesins could also be important for binding salivary glycoproteins, 
was proven recently in a glycoconjugate array that showed dependency of H. pylori binding 
to salivary mucin MUC5B on both expression of the BabA and the SabA adhesin, 
respectively [20]. To further explore the whole range of human salivary glycoproteins 
specifically recognized by H. pylori adhesins, H. pylori wild-type (wt) strain J99 together 
with a set of well defined isogenic sabA- and babA-deficient mutants were used as probes in a 
bacterial overlay on nitrocellulose transfers of whole and glandular salivary secretions 
separated by SDS-PAGE. Taking advantage of a previous proteome analysis of human whole 
and glandular salivas [21], the bacterial overlay technique was now newly adapted for usage 
on transfers of two-dimensional (2-D) gels with the aim of a better resolution and possible 
identification of salivary receptor proteins that may be of pathogenic relevance during the 
passage of H. pylori through the upper alimentary tract. 
Materials and Methods 
Bacteria and growth conditions 
The wt H. pylori strain J99 [22] and its isogenic mutants in the sabA and/or babA genes 
(J99babA, M917B, M61B) were grown for 48-72 h at 37°C in a microaerophilic atmosphere 
on Wilkins-Chalgren agar (Oxoid, Wesel, Germany) containing 10% horse blood, Dent 
supplement (Oxoid, Wesel, Germany) and 0.4 g KNO3 per liter. Bacteria were harvested from 
plates by wiping off the colonies with a sterile cotton swab and adjusting the bacterial 
concentration to an optical density of 0.4 in phosphate-buffered saline, pH 7.2 (PBS). 
Saliva collection 
Unstimulated whole saliva (WS) was collected by expectoration into a polypropylene vial, 
kept immediately on ice, and then filtrated sequentially with single use filter units of a pore 
size of 5 µm and 0.2 µm (Minisart, Sartorius, Hannover, Germany). Parotid salivary secretion 
was collected with Lashley cups (Stone Machine Company, Colton, CA, USA) by 
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intermittent stimulation of the tongue with 2% citric acid solution. Submandibular/sublingual 
(SMSL) secretion was collected utilizing a 50 ml sterile syringe fitted with a sterile silicon 
tube as previously described [21]. Samples (4.5 ml of saliva) were concentrated with the help 
of Amicon Ultra centrifugal filter devices (Molecular weight cut-off, 5,000, Millipore, 
Bedford, MA, USA) by centrifugation at 3,000 x g for 30 minutes at 4°C. Salt concentration 
was lowered by addition of an equal part of sterile double-distilled water, containing 5 mM 
EDTA, to the concentrate followed by a second centrifugation step. The resulting protein 
concentrations were determined utilizing the bicinchoninic acid (BCA) protein assay (Pierce, 
Rockford, IL, USA) with bovine serum albumin (BSA) as the standard. 
1-D gelelectrophoresis and staining of proteins and carbohydrates 
Salivary samples for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
were denatured under reducing conditions and applied to 4-20 % gradient gels (Novex, 
Invitrogen, Karlsruhe, Germany) as previously described [23]. The amounts of proteins 
loaded were 0.75 µg per lane for silver stain, 40 µg per lane for Pro-Q Emerald® stain, 0.2 µg 
per lane for aminogroup detection, and 20 µg per lane for hydrazide stain, lectin blotting as 
well as bacterial overlay. Proteins in gels either were stained with silver (SilverXpress®, 
silver staining kit, Invitrogen) or with Pro-Q Emerald® 488 glycoprotein stain [24] 
(Invitrogen) according to the manufacturer’s instructions. Alternatively, salivary proteins 
were transferred to nitrocellulose membranes (0.45 µm pore size, Invitrogen) in a semi-dry 
transfer unit (Invitrogen) under a constant voltage of 0.4 V/cm for 18 h at 4°C in 25 mM Tris 
(USB Corporation, Cleveland, OH, USA), 192 mM glycine (Merck, Darmstadt, Germany) in 
20% v/v methanol (Merck) as transfer buffer. Proteins transferred and bound to the 
nitrocellulose membrane were detected by labeling aminogroups with sulfosuccinimidyl-6-
(biotinamido)hexanoate (sNHS-LC-Biotin, Pierce) and transferred carbohydrates were 
oxidized with 10 mM sodium periodate (ICN Biomedicals, Aurora, OH) followed by labeling 
with biotin-LC-hydrazide (Pierce) as previously described [20]. Bound biotin was stained 
with fluorescein avidin-D (Vector Laboratories, Burlingame, CA, USA). Alpha-L-fucose-
containing carbohydrates were detected by binding of fluorescein-labeled Lotus 
tetragonolobus agglutinin (LTA, Sigma-Aldrich, Taufkirchen, Germany) (5 µg/ml in blocking 
buffer) after blocking the membranes for 1 h at room temperature with 20 mM Tris-buffered 
saline, pH 7.6 (TBS) containing 2% polyvinyl alcohol (average molecular weight 30,000–
70,000, Sigma), 0.1% Tween-20, 1 mM CaCl2, and 1 mM MgCl2 as described previously 
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[20]. Fluorescent signals were recorded using a fluorescence scanner with a green laser 
excitation wavelength of 532 nm (Typhoon 9200, GE Healthcare, Freiburg, Germany). 
2-D gel electrophoresis 
Isoelectric focusing (IEF) was performed in the IPGphor from GE Healthcare Bio-Sciences 
by in-gel rehydration as described by Görg et al. [25]. The IPG strip, pH 3-11 NL, 18 cm 
(Immobiline Dry Strip, GE Healthcare Bio-Sciences) was rehydrated directly with saliva (300 
µg of protein), solubilized in 350 µl of sample buffer containing 7 M urea (GE Healthcare 
Bio-Sciences), 2 M thiourea (Fluka, Buchs, Switzerland), 2% CHAPS (GE Healthcare Bio-
Sciences), 1% DTT (GE Healthcare Bio-Sciences) and 1% Pharmalyte 3-10 (GE Healthcare 
Bio-Sciences). Low voltage (30 V, 12 h) was applied during the rehydration step, IEF was 
started with 200 V for one hour and increased to 500 V and 1,000 V for one hour, 
respectively, before continuously (gradient, 30 min) raising the voltage to 8,000 V for a final 
focusing time of 4 h. SDS-PAGE was performed as previously described [21] in a vertical 
apparatus (Ettan DALT six electrophoresis unit, GE Healthcare Bio-Sciences) with Ettan 
DALT gels (12,5%T, 3%C, 255 x 196 x 1 mm, GE Healthcare Bio-Sciences), according to 
the manufacturer’s instruction and the gels were run for 16 h (1 W per gel, 20°C). A sample 
(100 µg of protein) of the respective salivary secretion for 1-D separation was included on all 
gels as a control. After lifting off the gel from the plastic support film by use of a Film 
Remover (GE Healthcare Bio-Sciences), salivary proteins were subsequently transferred onto 
nitrocellulose membranes (0.45 µm pore size, Schleicher & Schuell, Dassel, Germany) by 
electroblotting in a semi-dry transfer unit (Multiphor II with NovaBlot unit, GE Healthcare 
Bio-Sciences) for 2 h at a constant current of 0.8 mA/cm2 using 25 mM Tris (USB), 192 mM 
glycine (Merck) in 20% v/v methanol (Merck) as transfer buffer. Proteins transferred from 2-
D gels were detected on the nitrocellulose membranes by Sypro Ruby® blot stain (Invitrogen) 
according to the manufacturer’s instruction but at 4°C and visualized by a Typhoon Imaging 
System (green laser, 532 nm) (GE Healthcare Bio-Sciences). 
Bacterial overlay 
All steps of the bacterial overlay procedure were performed in the cold. Sypro Ruby®-stained 
membranes were washed in TBS for 10 min to remove excess stain and transfers were then 
blocked in TBS containing 5% BSA (fraction V, Biomol, Hamburg, Germany), 1 mM CaCl2, 
1 mM MgCl2 for 2 h. H. pylori organisms at a concentration of 1 x 108 bacteria/ml in PBS 
were labeled as previously described [20] by incubation with fluorescein-5-isothiocyanate 
(Molecular Probes, Oregon, USA) at 100µg/ml for 30 min. Labeled bacteria were washed 
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three times with PBS and recovered by centrifugation at 900 x g for 7 min, resuspended in 10 
ml blocking buffer and added to the membranes a final concentration of 2.5 x 107 bacteria per 
ml in a total volume of 40 ml for 1-D transfers or 250 ml for 2-D transfers (equivalent to 
about 0.6 ml of bacterial suspension per cm2 of nitrocellulose membrane). The overlaid 
membranes were incubated stationary for 30 min in the dark to allow bacterial binding and 
subsequently washed three times for 5 min on an orbital shaker (KM-2 Swip, Bühler, Johanna 
Otto GmbH, Hechingen, Germany) with TBS containing 0,05% Tween-20, 1mM CaCl2 and 
1mM MgCl2 to remove unbound bacteria. Fluorescent signals of bound bacteria were 
recorded by use of a Typhoon imaging system. 
Mass spectrometry and protein identification 
Bands in the Pro-Q Emerald®-stained 1-D gels corresponding to bands on transfers to which 
H. pylori had bound, were cut out and analyzed by matrix-assisted laser desorption/ionization 
mass spectrometry (MALDI-MS) by the company Protagen (Dortmund, Germany) using the 
UltraFlexTM mass spectrometer (Ultraflex TOF/TOF, Bruker Daltonik GmbH, Bremen, 
Germany). Gel pieces were washed three times alternately with 10 mM NH4HCO3 and 5 mM 
NH4HCO3/50% acetonitrile. After drying the gel pieces in a vacuum centrifuge (Univapo, 
UniEquip, Martinsried, Germany) trypsin (Promega, Mannheim, Germany) was added to 
digest the protein overnight at 37°C. The peptides were extracted from the gel pieces and 
purified using C18 material (ZipTipTM, Millipore) before spotting onto the MALDI target. 
Peptide mass fingerprint (PMF) spectra and peptide fragmentation fingerprint (PFF) spectra 
were acquired and database searches were performed against the NCBI database. Proteins 
corresponding to spots on 2-D transfers to which H. pylori had bound, were identified with 
the help of previously established 2-D maps [21]. 
Results 
Staining of salivary proteins and glycoproteins after separation by 1-D-PAGE 
To obtain a comprehensive overview of protein and glycoprotein components in WS and 
glandular secretions, a series of different gel and blot stains was performed. As seen in Fig. 1, 
silver staining of gels (Fig. 1A) alone is not sufficient to detect the whole range of salivary 
proteins. In particular, the highly glycosylated components become visible only after staining 
for glycoproteins with Pro-Q-Emerald® 488 (Fig. 1B). From both, silver stain and Pro-Q-
Emerald® glycoprotein stain, it becomes evident, that WS and the two different glandular 
secretions show a distinct banding pattern typical to what is known from previous studies 
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[23]. This also ensures, that the two separate glandular secretions could be successfully 
collected without contamination from each other. Both, proteins and glycoproteins, including 
the high-molecular weight components, were transferred to nitrocellulose membranes as 
revealed by labeling aminogroups (Fig. 1C) or by hydrazide stain of carbohydrates (Fig. 1D). 
Fucose-containing glycoproteins as putative receptors for the H. pylori BabA adhesin were 
detected by lectin blotting with FITC-labeled Lotus tetragonolobus agglutinin (Fig. 1E). As 
shown in a previous investigation [20] however, the specificity of Lotus tetragonolobus 
agglutinin for α-L-fucose does only partially overlap with the binding specificity of the H. 
pylori BabA adhesin. 
 
 
 
Fig. 1: Staining of proteins and glycoproteins in whole saliva and glandular secretions. Whole saliva 
(W), submandibular-sublingual (S), and parotid (P) secretions were separated by SDS-PAGE and gels 
were stained with A, silver stain, and B, Pro-Q-Emeraldâ 488 glycoprotein stain. Nitrocellulose 
transfers of these gels were stained by C, aminogroup labeling with sNHS-LC-Biotin, D, glycoprotein 
stain with biotin-LC-hydrazide after oxidation of sugars with 10 mM sodium periodate, or E, lectin 
blotting with FITC-labeled Lotus tetragonolobus agglutinin (LTA). Bound biotinylated compounds 
were detected with FITC avidin-D and fluorescent signals were recorded using a fluorescence 
scanner. Glycoprotein bands in the Pro-Q-Emerald®-stained gels that had been cut out and identified 
by MALDI-MS and MALDI-MS/MS are indicated by numbered arrows. 
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BabA and SabA-dependent recognition of salivary glycoproteins on 1-D transfers 
To search for putative receptors among the range of salivary glycoproteins, bacterial overlays 
with FITC-labeled H. pylori were performed on nitrocellulose transfers of WS as well as 
SMSL- and parotid glandular secretions separated by 1-D PAGE (Fig. 2).  
 
 
Fig. 2: Adhesion of FITC-labeled H. pylori J99A wild-type and adhesin-deficient mutants J99babA, 
M917B, and M61B to blots of whole saliva (W), submandibular-sublingual (S), and parotid (P) 
secretions separated by SDS-PAGE. The presence or absence of the adhesins BabA or SabA are 
indicated above the strain designation. Blots were overlaid with FITC-labeled bacteria. Following 
removal of non-adherent organisms, bound bacteria were detected by a fluorescence scanner. The 
locations of MUC5B, gp-340, and MUC7 that had been identified by MALDI-MS and MALDI-MS/MS 
in Pro-Q Emerald®-stained gels (see Fig. 1) are indicated. 
 
Binding of H. pylori wt strain J99A was observed to a diffuse band at the origin of the gel in 
WS and SMSL-secretions that was also strongly bound by the sabA-deficient mutant M917B 
but not by the babA-deficient mutant J99babA. The band was cut out at the corresponding 
place in the Pro-Q-Emerald®-stained gel (see arrow 1 in Fig. 1) and analysis by MALDI-TOF 
and MALDI-TOF/TOF identified this component as the high molecular weight mucin 
MUC5B (gi|51470790) (Fig. 3). H. pylori wt J99A bound also to another major band in the 
molecular range of about 200 kDa in WS and SMSL glandular secretion. This band was also 
strongly bound by the babA -deficient mutant J99babA but no binding was found with the 
sabA -deficient mutant M917B. Analysis by MALDI-TOF and MALDI-TOF/TOF identified 
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this band (see arrow 3 in Fig. 1) as the low molecular weight mucin MUC7 (MG2, 
gi|22748665) (Fig. 3).  
 
 
Fig. 3: MS analyses of MUC5B, MUC7 and gp-340 identified as salivary receptors for H. pylori-
adhesins. Peptide mass fingerprint spectra were acquired by MALDI-TOF analysis of tryptic peptides 
from bands cut out of the 1-D gel shown in Figure 1 B. Results were verified by additional MALDI-
TOF/TOF analysis. Amino acid sequences identified by MALDI-TOF as well as MALDI-TOF/TOF of 
the corresponding proteins are displayed in the Supplemental Data. 
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An additional band half-way in between the bands of MUC5B and MUC7 was bound by H. 
pylori wt J99A to different extents in WS and glandular secretions. This band was bound by 
the sabA-deficient mutant M917B but not recognized by the babA-deficient mutant J99babA. 
A band excised from the Pro-Q-Emerald®-stained gel at the corresponding molecular range 
(see arrow 2 in Fig. 1) was identified by MALDI-TOF and MALDI-TOF/TOF as the salivary 
agglutinin (gp-340, gi|55962155) (Fig. 3). A very strong almost confluent signal involving a 
large group of bands in the molecular range between 30 and 100 kDa was seen after overlay 
with H. pylori wt J99A in parotid secretion and in WS. Similar strong binding in WS and 
parotid saliva was found in the same range after overlay with the sabA-deficient mutant 
M917B. In SMSL secretion, considerably less binding in this range was detected by the wt 
strain J99A but a prominent band at a molecular range of about 40 kDa remained to be bound 
and was also recognized by babA-deficient mutant J99babA in all three salivary secretions. 
With the sabA-deficient mutant M917B no binding in SMSL secretion could be detected in 
this range. An attempt to identify components within this conglomeration of putative receptor 
molecules by MALDI-MS failed because of overlaps between different protein bands. 
Significantly, the babA/sabA-double mutant did not recognize any bands in either secretion. 
BabA- and SabA-dependent recognition of salivary glycoproteins on 2-D transfers 
The bacterial overlay was performed on transfers of 2-D gels from WS, parotid and SMSL 
secretions to allow the identification of salivary receptors for H. pylori that could not be 
separated on 1-D overlays (Fig. 4). The original locations of protein spots on transfers of 2-D 
gels from WS, parotid and SMSL secretions were visualized by Sypro Ruby® blot stain prior 
to bacterial overlay (Fig. 4A). The spot patterns in all three secretions appeared in a 
reproducible fashion when compared to Coomassie-stained spot patterns mapped in a 
previous proteome analysis of human saliva [21] The locations of significant spots or spot 
groups are marked in Fig. 4A. After washing out the Sypro Ruby® blot stain, transfers were 
overlaid with H. pylori J99A wt (Fig. 4A). On 2-D transfers of WS, the wt strain bound to 
salivary mucin MUC7 (gi|22748665), the secretory component (poly-Ig-receptor, gi|514366), 
proline-rich glycoprotein (gi|41349488), zinc-α2-glycoprotein (gi|4699583), carbonic 
anhydrase VI (gi|14530767), and parotid secretory protein (gi|16755850). Binding of the H. 
pylori J99A wt strain to these same components was also observed on transfers of glandular 
secretions but was dependent on their respective expression in parotid and SMSL secretions. 
 The adhesins responsible for binding to these identified receptor molecules were 
examined by the use of adhesin-deficient mutants in overlay experiments (Fig. 4B).  
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Fig. 4: Adhesion of FITC-labeled H. pylori J99A wild-type and adhesin-deficient mutants J99babA, 
M917B, and M61B to transfers of whole saliva (WS), parotid (PAR), and submandibular-sublingual 
(SMSL) secretions separated by 2-D gel electrophoresis. A, Nitrocellulose transfers were stained with 
SyproRuby® blot stain prior to bacterial overlay to visualize the locations of protein spots. After 
washing out the SyproRuby® stain, the same transfers were overlaid with FITC-labeled H. pylori 
J99A wild-type. Following removal of non-adherent organisms, bound bacteria were detected by a 
fluorescence scanner. Spots previously identified by MALDI-MS and MALDI-MS/MS as MUC7, 
secretory component of the poly-Ig-receptor (SC), zinc-α2-glycoprotein (ZGP), parotid secretory 
protein (PSP), carbonic anhydrase VI (CA), and proline-rich glycoprotein (PRG) (21) are indicated 
by arrows. B, Transfers from all three salivary secretions were overlaid by the adhesin-deficient H. 
pylori mutants. The overlays with H. pylori wild-type J99A are identical to Fig. 4A and were included 
for easier comparison of bound salivary receptors. The presence or absence of adhesins BabA and 
SabA are indicated below the strain designations. A sample of the respective salivary secretion, 
separated only in the second dimension, was included on all gels as a control. 
 
The babA-deficient mutant strain J99babA bound to zinc-α2-glycoprotein, carbonic anhydrase 
VI, and parotid secretory protein in all three salivary secretions. Binding to MUC7 was only 
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observed in WS and SMSL secretion, whereas binding to the secretory component (poly-Ig-
receptor) was observed only in WS and parotid secretions. No binding of the babA-deficient 
mutant strain to the proline-rich glycoprotein could be detected. The sabA-deficient mutant 
strain M917B retained binding only to the proline-rich glycoprotein but failed to bind MUC7, 
the secretory component (poly-Ig-receptor), zinc-α2-glycoprotein, carbonic anhydrase VI, and 
parotid secretory protein. In SMSL secretion, the sabA-deficient mutant strongly bound to a 
high molecular weight component in the 1-D lane but no corresponding spot could be 
detected in the 2-D separation. This strong interaction was consistently observed only on the 
1-D lane and may be due to binding of the BabA adhesin to the high molecular weight mucin 
MUC5B that can be easily visualized on the origin of the gel in 1-D PAGE (see Figs. 1 and 2) 
but due to its high molecular weight so far does not appear after 2-D PAGE [21]. 
Significantly, no binding to any component in any of the three salivary secretions could be 
detected by overlay with the babA/sabA-deficient mutant M61B. 
Discussion 
Because the oral cavity is the most feasible entry point for gastric H. pylori, a legitimate 
interest exists, to explore whether H. pylori simply passes through the oral cavity, or whether 
this bacterium may interact with components of saliva, possibly resulting in a modulation of 
its infectivity. The aim of this investigation was to use a novel combination of proteomics 
techniques with the bacterial overlay to comprehensively search for salivary receptors for H. 
pylori adhesins on a previously established salivary proteome map and to assign these 
receptors to the binding activities of the responsible adhesins by probing with adhesin-
deficient isogenic mutants. It was now possible to assign previously reported binding of H. 
pylori to salivary mucin MUC7 exclusively to the activity of the SabA-adhesin, binding to the 
salivary agglutinin gp-340 exclusively to the activity of the BabA-adhesin, and binding to the 
high-molecular weight salivary mucin MUC5B mainly to the activity of the BabA adhesin 
and to a lesser degree to that of the SabA-adhesin. In addition, binding of H. pylori to the 
proline-rich glycoprotein was newly detected by the 2-D bacterial overlay and could be 
assigned to the activity of the BabA adhesin, whereas the SabA adhesin was found 
responsible for binding to additional newly detected receptor molecules including salivary 
carbonic anhydrase VI, secretory component (poly-Ig-receptor), parotid secretory protein, and 
zinc-α2-glycoprotein. 
 Adhesive interaction of H. pylori with MUC5B has been previously reported and was 
postulated to be based mainly on binding of a H. pylori neutrophil-activating protein (NAP) to 
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sulfated glycans on this mucin [11, 12]. In the present study, it could be demonstrated that 
binding of H. pylori to MUC5B is mediated mainly by the BabA adhesin implying that 
ABO/Lewis b blood group antigens that were found on this mucin [26] may serve as the 
prevailing receptor structures. This is supported by a previous characterization of the binding 
properties of H. pylori adhesins utilizing glycoconjugate arrays in which adhesion to salivary 
mucin MUC5B was mainly associated with the BabA-adhesin and to a much lesser extent 
with the SabA-adhesin [20] and agrees with reports that MUC5B carries both fucosylated 
blood group antigens and α2,3-linked sialic acids [27]. Only in few bacterial overlay 
experiments employing sabA-containing H. pylori mutants as probes on 1-D transfers from 
both, WS and SMSL secretion, weak binding to MUC5B could be observed (data not shown), 
further indicating that the interaction of SabA with sialic acid termini on MUC5B may play 
only a subordinate role. A requirement of additional adhesins for binding to MUC5B could 
not be supported by the present results and by previous use of glycoconjugate arrays because 
the babA/sabA double mutant did not bind to this mucin [20]. Analogous findings have been 
reported for the interaction of the BabA-adhesin with gastric mucin MUC5AC [28]. In future 
studies, it would be promising to explore also the secretions of the minor salivary glands to 
clarify the role of sulfatation of glycans for higher binding avidity to MUC5B because highest 
sulfatation was reported in a subpopulation of high molecular weight mucins, secreted from 
the palatine salivary glands [12]. 
 In contrast to MUC5B, previously described binding of H. pylori to the lower 
molecular weight mucin MUC7 [13] was now found to be exclusively mediated by the SabA-
adhesin, implying that α2,3-linked sialic acid termini may serve as the crucial receptor motifs. 
Sialic acid termini are known to be present on this mucin both in context with the sialyl-T 
antigen and the sialyl-Lewis x antigen [29] and the latter had been previously suggested to be 
involved in binding of H. pylori to MUC7 [13]. From the present results, combined with 
knowledge about the specificity of the SabA adhesin for terminal α2,3-linked sialic acids 
[20], it can now be postulated that not only sialyl-Lewis x but also the sialyl-T antigen may 
serve as receptor motifs on MUC7. 
 Salivary agglutinin (gp-340) is another component that had previously been reported 
to interact with H. pylori [13, 14]. This was confirmed in the present study and, by use of the 
adhesin-deficient mutants of H. pylori, binding to this molecule could now for the first time 
be clearly assigned to the activity of the BabA-adhesin. Although presence of sialic acid on 
gp-340 had been reported [30], an involvement of sialic acid epitopes on gp-340, that would 
mediate binding by the SabA-adhesin, could not be supported by the present results. It could 
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be hypothesized that somehow receptor activity of terminal sialic acid might be restrained by 
its linkage to subterminal oligosaccharides or that sialic acid epitopes might not be accessible 
to the adhesin for sterical reasons. In this respect it is noteworthy, that a recent study showed 
different densities of α2,3-linked sialic acids on gp-340 among different individuals [31]. 
Thus, a donor dependency in binding of the SabA-adhesin to gp-340 is possible and would 
deserve further study. 
 By the newly developed use of 2-D transfers for bacterial overlay, it was possible to 
identify several novel receptors for H. pylori in saliva. By comparison to previously 
established proteome maps of WS, parotid, and SMSL secretions [21], salivary carbonic 
anhydrase VI, the parotid secretory protein, zinc-α2-glycoprotein, and the proline-rich 
glycoprotein were found to support binding of H. pylori. In addition, a group of several 
horizontal isoform spots in WS and parotid secretion at a molecular range of about 90 kD 
were also identified as receptors for H. pylori. Database search initially resulted in best 
alignment of the peptides with the poly-Ig receptor [21]. However because the poly-Ig 
receptor is a cell membrane-bound molecule, it is most likely that the protein that was found 
in salivary secretions rather represents the secretory component that becomes cleaved as the 
major part of the poly-Ig receptor upon release of secretory immunoglobulins, e.g. S-IgA, 
from the luminal side of glandular epithelial cells [32]. 
 Binding of H. pylori to the proline-rich glycoprotein could be assigned to the activity 
of the BabA-adhesin. Although a presence of Lewis b antigens on the proline-rich 
glycoprotein was not shown in a structural analysis of its oligosaccharides, it is well known 
that this glycoprotein contains a high amount of α1,2-linked fucose termini [33]. The Lewis y 
antigen (Fucα1,2Galβ1,4GlcNAc[Fucα1,3]) which is the most abundant oligosaccharide 
structure on the proline-rich glycoprotein [33] was not recognized as a receptor for the BabA-
adhesin when performing bacterial overlay on immobilized neoglycoproteins [20]. It might 
be, however, that purely by the high receptor density or by favorable sterical presentation 
provided on a natural glycoprotein, sufficient receptor activity could be gained to mediate 
bacterial binding. Binding of the H. pylori SabA-adhesin to carbonic anhydrase VI, formerly 
also known as gustin, is most likely based on the presence of di-, tri- and tetra-sialylated 
termini on the two N-linked oligosaccharide chains that had been described on this molecule 
whereas fucose was found only in an interior linkage [34, 35]. Similarly, SabA-mediated 
binding of H. pylori to the secretory component (poly-Ig-receptor) can be explained by its 
high sialic acid content including the availability of α2,3-linked terminal sialic acids [36]. An 
additional involvement of BabA-mediated binding to fucose-containing oligosaccharide 
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motifs as suggested in the past [16] could not be confirmed in this present assay system, 
although the presence of Lewis b epitopes has been described on the secretory component 
[16, 36]. Zinc-α2-glycoprotein, that is also recognized by the H. pylori SabA-adhesin, was 
reported to contain 7% sialic acid and only few fucose (0.2%) but a more detailed structure of 
the oligosaccharides or the linkages of sialic acid on this protein is obviously not available 
[37, 38]. Unfortunately, no information about oligosaccharides on the parotid secretory 
protein, another novel receptor for the H. pylori SabA-adhesin, is available so far. Thus, a 
putative presence of sialic acid termini on this protein can only be proposed based on the 
findings of this study. 
 It can only be hypothesized what the biological consequences of binding of H. pylori 
to these glycoprotein receptors in human saliva might be. On one hand, adhesin-mediated 
binding to these receptors may allow H. pylori to attach to oral or dental surfaces coated with 
a film consisting mostly of salivary proteins, the so-called pellicle, or to colonize among the 
complex biofilm microbiota on teeth [39]. There is however conflicting opinion about the 
presence of H. pylori in the oral cavity and its possible role for oral-oral transmission or re-
infection of the stomach [8]. On the other hand, because of the constant influx of saliva into 
the upper alimentary tract and the mixing with gastric juice [6], it could be that H. pylori once 
decorated with certain salivary glycoproteins changes its pathogenic properties in the stomach 
by e.g. better protection from the body's immune response or by a better resistance to gastric 
acid or proteolytic challenge. It has been reported that H. pylori can survive only for a few 
minutes in the hostile environment of gastric juice [40]. In this context it is of interest that an 
acid-protective barrier function of salivary mucins has been reported [41]. Furthermore, it is 
noteworthy, that 10-14 mg of salivary carbonic anhydrase VI that is bound by the H. pylori 
SabA-adhesin are swallowed during one day [42, 43] and that H. pylori by itself expresses 
carbonic anhydrases that were suggested to contribute to the adaptation of H. pylori to the 
harsh environment of the stomach [44]. 
 The described combination of bacterial overlay with 2-D electrophoresis and 
proteomics techniques may be further employed for identification of receptor proteins 
recognized by any given bacterial adhesin for a variety of complex biological fluids, mucous 
secretions, or membrane preparations of eukaryotic cells. 
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Abstract 
Previously performed bacterial overlay assays with fluorescence-labeled Helicobacter pylori 
(H. pylori) had been shown to be suitable for screening adhesin specificities of the bacterium 
on dot-blots. In addition, the adhesive recognition of salivary proteins by H. pylori could be 
shown on transfers of two (2-D)-dimensional gels. The purpose of this study was to apply 
these established overlay techniques to well-characterized commensal bacteria of the oral 
cavity with the aim to show the applicability of this method to other bacteria. Dot-blot arrays 
of natural glycoproteins and synthetic neoglycoproteins were produced. 2-D gels of human 
whole saliva were made and transferred onto nitrocellulose membranes. Dot-blot overlays 
were carried out with fluorescence-labeled Streptococcus gordonii DL1 and Actinomyces  
naeslundii WVU45 wild-type strains and their mutants (D102, WVU45M). With this method 
all known binding specificities of sialic acid/ N-acetylgalactosamine- (S. gordonii) and 
galactose/N-acetylgalactosamine- (A. naeslundii) reactive lectins could be confirmed. 2-D 
overlays were performed with fluorescence-labeled Streptococcus gordonii DL1. These 
revealed the expected interactions of this strain with salivary proteins as well as yet unknown 
interactions. Together, these results show the applicability of fluorescence-labeling in 
bacterial overlay experiments for different species of bacteria. In particular, the 2-D overlay 
proved to be a powerful method for screening diverse bacterial receptors in a complex 
biological fluid. 
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Introduction 
Adhesion of bacteria to cell surfaces, and bacterial colonization of the host, respectively, are 
in many cases based on specific lectin-carbohydrate interactions [1]. In consequence, studying 
receptor specificity of lectin-like bacterial adhesins is useful to understand more about 
pathology and tissue tropism of certain bacteria.  
 In previous studies the bacterial overlay technique was used successfully for exploring 
lectin-dependent binding specificities of bacteria, independently of whether radiolabeled [2, 
3] or biotinylated bacteria [4, 5] were used. An improvement of the bacterial overlay 
technique used fluorescence-labeled bacteria on dot-blot arrays. The dot-blots contained 
various structurally related carbohydrates ranging from high molecular weight glycoproteins 
to monosaccharide-neoglycoproteins. This approach was helpful to characterize adhesin 
specificities of Helicobacter pylori (H. pylori) [6]. The use of fluorescently-labeled H. pylori 
facilitated also the development of a high-resolution overlay on transfers of two-dimensional 
gels of salivary proteins [7] and, thus, the identification of salivary receptors for H. pylori. 
 Gram-positive bacteria, such as actinomyces or viridans streptococci are known to 
initiate bacterial colonization on teeth surfaces. This is in many cases mediated by lectin-
carbohydrate interactions of the bacteria with components of the acquired enamel pellicle [8, 
9]. Actinomyces express type 1 and type 2 fimbriae, depending on the respective strain [10]. 
Type 1 fimbriae (e.g. of Actinomyces viscosus 5519) have adhesins recognizing certain amino 
acid sequences on proline-rich proteins (PRP) [11], while  type 2 fimbriae (e.g. of A. 
naeslundii WVU45) have lectin-like adhesins recognizing saccharide motifs that contain 
either galactose (Gal) or N-acetylgalactosamine (GalNAc). These in turn, are responsible for 
coaggregation with certain streptococci [8, 12]. Viridans streptococci are known to adhere to 
saliva-coated hydroxyapatite, a model of the tooth surface, by interaction with sialic-acid 
containing receptors [13]. Binding of Streptococcus gordonii DL1 to such receptors depends 
on the Hs antigen, a glycosylated surface component, encoded by hsa [14]. In addition, it is 
known that S. gordonii strains coaggregate with bacteria expressing GalNAc-containing 
receptors on their surface [15]. 
 The immediate aim of this study was to show that the improved overlay technique is 
applicable to commensal bacteria of the oral cavity, and other bacterial species. S. gordonii 
DL1,  A. naeslundii WVU45 and clearly defined spontaneous mutants were used as probes. 
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Materials and Methods 
Dot-blot array 
Nitrocellulose membranes (Protran BA 85, pore size 0.45 µm, Schleicher & Schuell GmbH, 
Dassel, Germany) were spotted with 1 µl 0.9% NaCl (Braun, Melsungen, Germany) solution 
containing 1 µg (neo-)glycoprotein and 0.1% NaN3 (Sigma, Steinheim, Germany). 
Glycoproteins and neoglycoproteins used in this study are listed in Table 1. A-C are 
glycoproteins of natural origin, D-I are synthetic neoglycoproteins. 
 
Table 1: Glycoproteins and neoglycoproteins used in this study 
A
rr
ay
 N
o.
 
(Neo-)Glycoprotein 
mol sugar 
residues/ 
mol 
protein 
Sugar chains 
A1 Fetuin1   
A2 Asialofetuin1   
A3 Glycophorin A1   
A4 Asialoglycophorin A1   
A5 Laminin1   
A6 α-acid Glycoprotein1   
B1 Thyroglobulin1   
B2 Mucin (bovine submaxillary gland)1   
B3 Asialomucin1   
B4 Salivary mucin MUC5B2   
B5 Proline-rich protein-1 (PRP-1)3   
B6 Salivary α-Amylase1   
C1 Secretory immunglobulin A (S-IgA)4   
C2 Lactoferrin1   
C3 Fibronectin1   
C4 Lysozyme1   
C5 Bovine serum albumin (BSA)1   
C6 Human serum albumin (HSA)1   
D1 Galβ1-3GlcNAcβ1-3Galβ1-4(Glc)-APD-HSA5 22 Lacto-N-tetraose 
D2 Galβ1-3[Fucα1-4]GlcNAcβ1-3Galβ1-4(Glc)-APD-HSA5 23 Lewis a 
D3 Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1-4(Glc)-APD-HSA5 25 H type 1 
D4 Fucα1-2Galβ1-3[Fucα1-4]GlcNAcβ1-3Galβ1-4(Glc)-APD-HSA5 22 Lewis b 
D5 GalNAcα1-3[Fucα1-2]Galβ1-O-APE-HSA5 19 Blood group A 
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(Neo-)Glycoprotein 
mol sugar 
residues/ 
mol 
protein 
Sugar chains 
D6 Neu5Acα2-3Galβ1-3[Fucα1-4]GlcNAcβ1-3Galβ1-4(Glc)-APD-
HSA5 
12 sialyl-Lewis a 
E1 Galβ1-4GlcNAcβ1-3Galβ1-4(Glc)-APD-HSA5 10 Lacto-N-neotetraose 
E2 Galβ1-4[Fucα1-3]GlcNAcβ1-3Galβ1-4(Glc)-APD-HSA5 20 Lewis x 
E3 Fucα1-2Galβ1-4GlcNAcβ-O-APE-HSA5 19 H type 2 
E4 Fucα1-2Galβ1-4[Fucα1-3]GlcNAcβ-O-APE-HSA5 12 Lewis y 
E5 Galα1-3[Fucα1-2]Galβ1-O-APE-HSA5 19 Blood group B 
E6 Neu5Acα2-3Galβ1-4[Fucα1-3]GlcNAcβ1-3Galβ1-4(Glc)-APD-
HSA5 
13 sialyl-Lewis x 
F1 GalNAcβ1-3Galα1-4Galβ1-4(Glc)-APD-HSA5 8 Globo-N-tetraose 
F2 Galα1-3GalNAcα-O-10 Å spacer-HSA6 20  
F3 GalNAcβ1-4Galβ-O-10 Å spacer-BSA6 20  
F4 Galβ1-3GlcNAcβ-O-10 Å spacer-BSA6 20  
F5 Galβ1-3GalNAcα1-O-APE-HSA5 17 T antigen 
F6 GalNAcβ1-3Galα-O-10 Å spacer-BSA6 20  
G1 Galβ1-4GlcNAc-3 atom spacer-BSA7 11 N-Acetyllactosamine 
G2 Fucα1-2Galβ1-4(Glc)-APD-HSA5 16 2’-Fucosyllactose 
G3 Neu5Acα2-6Galβ1-4(Glc)-APD-HSA5 15 6’-Sialyllactose 
G4 Neu5Acα2-3Galβ1-4(Glc)-APD-HSA5 6 3’-Sialyllactose 
G5 Neu5Acα2-3Galβ1-4GlcNAc-3 atom spacer-BSA7                         11 3’-Sialyl-N-
acetyllactosamine 
G6 Neu5Acα2-3Galβ1-4[Fucα1-3]Glc-3 atom spacer-BSA7 7 3’-Sialyl-3fucosyllactose 
H1 Galα1-O-PAP-HSA8 10-20 α-Galactose 
H2 Galβ1-O-PAP-HSA8 10-20 β-Galactose 
H3 GlcNAcα1-O-PAP-HSA8 10-20 α-N-Acetylglucosamin 
H4 GlcNAcβ1-O-PAP-HSA8 10-20 β-N-Acetylglucosamin 
H5 GalNAcα1-O-PAP-HSA8                                                                 10-20 α-N-Acetylgalactosamine 
H6 GalNAcβ1-O-PAP-HSA8                                                                 10-20 β-N-Acetylgalactosamine 
I1 Galβ1-4Glcβ-O-10 Å spacer-BSA6 20 Lactose 
I2 Fucα1-O-PAP-HSA8 10-20 α-Fucose 
I3 Glcα1-O-PAP-HSA8 10-20 α-Glucose 
I4 Manα1-O-PAP-HSA8 10-20 α-Mannose 
I5 Manβ1-O-PAP-HSA8 10-20 β-Mannose 
I6 Xylβ1-O-PAP-HSA8 10-20 β-Xylose 
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1 Sigma 
 2 kindly provided by M.J. Levine, Department of Oral Biology, SUNY, Buffalo, NY, USA 
 3 kindly provided by Donald I. Hay, Forsyth Institute, Boston, MA, USA 
 4 MP Biomedicals, Aurora, Ohio, USA 
 5 IsoSep AB, Tullingen, Sweden  
 6 Glycorex AB, Lund, Sweden  
 7 Dextra, Reading, UK  
 8 Diagnostic International, Schriesheim, Germany  
Saliva 
Sample collection was performed under cooling. Unstimulated whole saliva (WS) was freshly 
collected from one healthy male subject by expectoration. Samples were filtrated twice using 
a membrane filter (Minisart, Sartorius, Hannover, Germany) of 5 µm and 0.2 µm pore size. 
Saliva was subsequently concentrated with Amicon® Ultra (Millipore, Bedford, MA, USA) 
centrifugal filter devices (molecular weight cut-off, 5,000) at 3,000 x g for twice 30 min. 
Protein concentration of the sample was determined by the bicinchoninic acid (BCA) protein 
assay (Pierce) with BSA as a standard. 
Two-dimensional gel electrophoresis and transfer 
2-D PAGE of WS was performed with ready-made Immobiline Dry Strips (IPG strip, pH 3-
10 NL, 18 cm; GE Healthcare Bio-Sciences, Freiburg, Germany) for the isoelectric focusing 
step as well as with precast Ettan DALT gels for the second dimension (12,5%T, 3%C, 255 x 
196 x 1mm, GE Healthcare Bio-Sciences) as previously described [16]. Amount of proteins 
loaded was 300 µg. 100 µg of proteins of the same sample as applied to the IPG strip,  was 
included as a 1-D separated control. Control saliva was denatured under reducing conditions, 
applied to small piece of filter paper and separated simultaneously with the proteins on the 
IPG strip in the second dimension. Transfer onto the nitrocellulose membrane (0.45 µm pore 
size, Schleicher & Schuell, Dassel, Germany) was carried out by electroblotting in a semi-dry 
transfer unit (Multiphor II with NovaBlot unit, GE Healthcare Bio-Sciences) with a transfer 
buffer containing 25 mM Tris (USB, Cleveland, OH, USA), 192 mM glycine (Merck, 
Darmstadt, Germany) dissolved in 20% v/v methanol (Merck). Settings were 0.8 mA/cm2 for 
2 h. 
Visualization of 2-D-separated proteins 
For displaying the complete 2-D pattern of transferred salivary proteins, the blot was first 
washed with 7% acetic acid (Merck) and 10% methanol (Merck) and was then stained with 
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Sypro Ruby® blot stain (Invitrogen, Karlsruhe, Germany). Staining was carried out according 
to the manufacturer’s instruction at 4°C and protein spots were visualized by a Typhoon 
Imaging System (Sypro Ruby mode, GE Healthcare Bio-Sciences). 
Bacterial overlay 
The bacterial overlay procedure was performed at 4°C. Dot-blot membrane was washed for 5 
min and the 2-D transfer blot for 10 min in Tris-buffered saline (TBS). Membranes were 
blocked in TBS containing 5% BSA (fraction V, Biomol, Hamburg, Germany), 1 mM CaCl2 
and 1 mM MgCl2 for 2 h. Bacteria included in this study, were S. gordonii DL1 (Challis) and 
its spontaneous mutant D102 [14] as well as A. naeslundii WVU45 (ATCC 12104) and its 
mutant WVU45M [8]. Bacteria were grown overnight in complex medium as previously 
described [14]. They were then adjusted to a concentration of 1 x 108 bacteria/ml in 
phosphate-buffered saline (PBS) (equivalent to an optical density of 4). Optical density was 
recorded by measuring the absorption of the bacterial suspension in PBS with a photometer 
(Ultrospec 1000, Pharmacia Biotech, Cambridge, England). Bacteria were washed with PBS 
twice, and were subsequently labeled with 100 µg/ml fluorescein-5-isothiocyanate (FITC, 
Molecular Probes, Oregon, USA) for 30 min. After the labeling procedure bacteria were 
washed with PBS three times. S. gordonii strains were recovered by centrifugation at 3,000 x 
g and A. naeslundii strains at 1,500 x g for 5 min respectively. Bacteria were resuspended in 
10 ml blocking buffer and were then added to the membranes. Final concentration of bacteria 
was 2.5 x 107 organisms per ml in a total volume of 40 ml for dot-blot membranes or 250 ml 
for 2-D transfers blots (~ 0.6 ml of bacterial suspension per cm2 of nitrocellulose membrane). 
Incubation with the bacteria was carried out for 30 min in darkness, and membranes were 
subsequently washed three times for 5 min with TBS containing 0,05% Tween-20, 1 mM 
CaCl2 and 1 mM MgCl2. Bound bacteria were detected using a Typhoon imaging system 
(FITC mode, GE-Healthcare Bio-Sciences).   
Results  
Recognition of natural and synthetic glycoproteins by S. gordonii 
 The extended version of the established glycoconjugate array [6] contained sialic acid,  Gal 
and GalNAc sugar structures in different linkages, and some more natural glycoproteins (Fig 
1). As expected, the FITC-labeled DL1 wild-type strain of S. gordonii could be demonstrated 
to bind components of this array (Fig. 1). The sialic acid-dependent interactions of S. gordonii 
DL1 with fetuin (A1), glycophorin A (A3), laminin (A5), sialyl-Lewis x (E6), 3’-sialyllactose 
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(G4), 3’-sialyl-N-acetyllactosamine (G5) and to a lesser degree 3’-sialyl-3-fucosyllactose 
(G6) described previously [6] could be reproduced  with the extended version of the array. In 
contrast, the S. gordonii mutant strain D102 that does not express a sialic acid binding 
adhesin, failed to bind these components. In addition, the incorporation of GalNAc-containing 
neoglycoconjugates showed the expected binding activity to GalNAc-containing receptors: S. 
gordonii DL1 bound to globo-N-tetraose (GalNAcβ1-3Galα1-4Galβ1-4Glc; F1), GalNAcβ1-
3Galα-disaccharide (F6) and GalNAcβ-monosaccharide (H6). Weaker binding was noted for 
GalNAcα-monosaccharide (H5). Interestingly, GalNAcβ1-4Galβ-disaccharide (F3) was not 
recognized by this strain. The mutant D102 showed the same binding activities and bound 
also to GalNAc-containing receptors. Among natural occurring glycoproteins PRP-1 (B5) and 
fibronectin (C3) were bound by both, DL1 and D102, but with different intensities. α1-Acid 
glycoprotein (A6), mucin from bovine submaxillary gland (B2), α-amylase (B6) and S-IgA 
(C1) were bound only by S. gordonii DL1, but not by D102. 
 
 
Fig. 1: Binding of  S. gordonii wild-type strain DL1 and its mutant D102 to immobilized glycoproteins 
and neoglycoproteins. Nitrocellulose membranes, spotted with (neo-)glycoproteins (1 µg per spot), 
were incubated with FITC-labeled bacteria and fluorescent signals were recorded by a fluorescence 
scanner. Spots can be attributed to array numbers listed in Table 1.  
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Recognition of natural and synthetic glycoproteins by  A. naeslundii 
The well-known Gal/GalNAc-dependent binding characteristics of A. naeslundii could be 
shown clearly by the bacterial overlay assay using the FITC-labeled WVU45 wild-type strain 
in comparison to the nonfimbriated mutant strain WVU45M (Fig. 2). A. naeslundii WVU45 
bound to almost all Galβ- and GalNAcβ-containing neoglycoconjugates (D1, E1, F1, F3-F6, 
G1, H2, H6, I1) with the exception of Lewis a- and Lewis x-antigen, that show a fucose-side 
chain at the Galβ-terminus. In contrast, no binding of A. naeslundii to Galα- and GalNAcα-
containing sugars could be observed. Furthermore, asialofetuin (A2), glycophorin A (A3), 
asialoglycophorin A (A4), thyroglobulin (B1), α-amylase (B6), S-IgA (C1) and lactoferrin 
(C2) were bound by WVU45. The spontaneous mutant strain WVU45M showed only 
negligible binding activities to some components on the array. 
 
 
Fig. 2: Binding of A. naeslundii wild-type strain WVU45 and its mutant WVU45M  to immobilized 
glycoproteins and neoglycoproteins. Nitrocellulose membranes, spotted with (neo-)glycoproteins (1 
µg per spot), were incubated with FITC-labeled bacteria and fluorescent signals were recorded by a 
fluorescence scanner. Spots can be attributed to array numbers listed in Table 1. 
Salivary receptors for S. gordonii revealed by 2-D PAGE 
In order to test for the adherence of S. gordonii DL1 to salivary proteins, 2-D gels of WS were 
transferred onto nitrocellulose membranes and fluorescently labeled S. gordonii DL1 wild-
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type strain was applied to the nitrocellulose membrane surface (Fig. 3B). The identification of 
salivary receptors of S. gordonii DL1 was achieved in the following steps: First, all WS 
proteins on 2-D transfers were detected using the Sypro Ruby® blot stain (Fig. 3A). 
Subsequently, colocalization of bacterial bound spots was determined. Identity of most 
protein spots was known from a previously performed proteome analysis of human WS [16]. 
S. gordonii DL1 bound to salivary mucin MUC7, the secretory component of the poly-Ig-
receptor, zinc-α2-glycoprotein, Ig-α2-heavy chain, carbonic anhydrase VI, and proline-rich 
glycoprotein. Furthermore, it recognized acidic and basic PRPs.  
 
Fig. 3: Binding of S. gordonii wild type strain DL1 to proteins of human whole saliva (WS). Proteins 
were separated by 2D-PAGE, transferred onto a nitrocellulose membrane, A. stained with Sypro Ruby 
® blot stain and B. overlaid with FITC-labeled bacteria. Fluorescent signals were recorded by a 
fluorescence scanner. Proteins bound by DL1 were identified by comparison with a previously 
established 2-D map of WS [16]. SC: secretory component of the poly-Ig-receptor; Zn-α2-GP: zinc-
α2-glycoprotein; CAVI: carbonic anhydrase VI; PRG: proline-rich glycoprotein; PRP: proline-rich 
protein; 
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Discussion 
Adhesion is a key event in bacterial colonization of a host [17]. Therefore, adhesion studies 
are an important method to obtain more information about the biology and pathology of 
bacteria. One possibility to study adhesin specificities of microbes is to perform bacterial 
overlays on immobilized proteins [2-5]. Previous methods for the investigation of bacterial 
adhesion used radiolabeled bacteria or biotinylated bacteria. Both approaches suffer from a 
number of disadvantages: radiolabeling cannot be performed in every laboratory, and 
biotinylation is time consuming. The use of FITC-labeled bacteria in overlay assays is easier 
and faster than the above methods. This technique has been used successfully to characterize 
binding specificities of H. pylori [6]. Because FITC is an amine-reactive fluorescein-derivate 
that labels proteins by covalent binding [18], the question arose, of whether or not this method 
works also with other bacteria that express other types of adhesins, or if FITC interferes in 
some way with the adhesion process. Examining this question was the immediate aim of this 
study. 
 S. gordonii DL1 is known to bind preferentially to receptors with α2,3-linked sialic 
acid termini [14]. Sialic acid-containing glycoproteins and neoglycoproteins were previously 
used in a glycoconjugate array for bacterial overlay with FITC-labeled DL1 [6], in which this 
adhesion property could be confirmed. This study reproduced the finding that S. gordonii 
DL1 binds α2,3-linked sialic acid on natural glycoproteins and on neoglycoproteins. We 
confirmed also that sub-terminal sugars might play a role in the recognition because sialyl-
Lewis a and MUC5B were no substrates for binding.  
Some glycoproteins and neoglycoproteins were newly investigated in this dot-blot-
array for the first time, and were also recognized by S. gordonii. For the mucin from bovine 
submaxillary gland and α1-acid glycoprotein a sialic acid-dependent interaction is very likely 
because S. gordonii DL1 bound these proteins whereas the mutant strain D102 did not. The 
mucin preparation contained 9-17% sialic acid (declaration of the manufacturer), which is 
probably recognized by the Hsa adhesin of S. gordonii. α1-Acid glycoprotein is also known to 
be extensively sialylated and contains, amongst others, α2,3-linked sialic acids [19]. Thus, 
again, a Hsa-dependent adhesion could be suggested. S-IgA was strongly bound by S. 
gordonii wild-type strain DL1 whereas D102 did not bind. This result is consistent with 
previous observations that adhesion of S. gordonii to S-IgA is due to α2,3-linked sialic acids 
on the O-linked oligosaccharides of IgA1 [20]. 
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Furthermore, an interaction of α-amylase with S. gordonii DL1 could be shown 
whereas the hsa-lacking D102 showed no interaction. This result was reproduced several 
times, and a sialic acid-dependent interaction might be possible. This is supported by the 
structure of α-amylase. α-Amylase contains 1 mol sialic acid per mol [21]. However, it was 
hypothesized that the sialic acid terminus is α2,6-linked. This sugar structure is known not to 
be recognized by S. gordonii DL1 [6]. In addition, S. gordonii DL1 did not bind salivary α-
amylase on 2-D transfers of WS. This was also observed in a previous study for 1-D blots of 
salivary glandular secretions [4]. Assuming, that the interaction of S. gordonii with α-amylase 
is abolished by denaturing, as it takes place during the electrophoresis process, a protein-
protein-interaction rather than a lectin-like interaction might be possible. This was also 
supposed for adhesion of S. gordonii to α-amylase coated hydroxyapatite [22]. In this regard, 
amylase-binding proteins AbpA and AbpB could be identified [23, 24]. Therefore, the 
question of why only S. gordonii wild-type strain but not the hsa-lacking mutant strain bound 
to spotted α-amylase has to be investigated in more detail. 
PRP-1 is the sole protein on the array that is not glycosylated, with the exception of 
HSA and BSA. It belongs to the group of acidic PRPs and was investigated several times for 
adhesion of oral streptococci [4, 25-27]. On this array PRP-1 was bound by both, wild-type 
strain DL1 and mutant strain D102, indicating a sialic acid-independent interaction. This 
result confirms previous statements of a PRP-binding adhesin of S. gordonii that binds to 
peptide motifs of acidic PRPs [25].  
Binding to fibronectin was noticed for S. gordonii wild-type strain DL1 and weaker 
for mutant strain D102. This result might be explained by two effects. On the one hand 
fibronectin contains sialic acid residues [28], that might be bound only by the wild-type strain. 
Residual binding as seen on the array of D102, in contrast, might be sialic acid-independent. 
Probably this adhesion is mediated by one of the fibronectin-binding proteins, FbpA or CshA, 
that were previously reported for S. gordonii [29]. 
 Beside the sialic-acid dependent binding property of S. gordonii DL1, it is known that 
this strain coaggregates with other streptococci due to GalNAcβ1-3Gal-receptors presented by 
streptococcal cell wall polysaccharides, e.g. of S. oralis [15]. Results of the dot-blot overlay 
confirmed the preferred binding of S. gordonii DL1 to immobilized neoglycoconjugates with 
GalNAcβ1-3Gal termini as reported previously by using biotinylated bacteria [5]. The use of 
monosaccharide-neoglycoconjugates suggested, in addition, that the avidity of S. gordonii 
DL1 to GalNAcβ may be higher than to GalNAcα. It is also noteworthy that the linkage of 
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terminal GalNAc to Gal alone is not sufficient for binding of DL1, because this strain did not 
bind to GalNAcβ1-4Galβ. Thus, not only the order of saccharides but also their type of 
linkage is crucial for bacterial adhesion. 
 A. naeslundii WVU45 have type 2 fimbriae responsible for binding of Gal- and 
GalNAc containing receptors [8, 12] on certain streptococci and epithelial surfaces. In the 
present study, this property could be verified on immobilized neoglycoproteins not only 
concerning the type of saccharides but also the preference for a β-linkage of Gal and GalNAc, 
respectively. In addition, we found that A. naeslundii WVU45 bound to asialofetuin but not  
to fetuin. This property has been explained by the presence of terminal sialic acid on fetuin 
that blocks the recognition of subterminal galactose [20]. In the case of glycophorin A and 
asialoglycophorin A, it could be observed that A. naeslundii WVU45 bound independently of 
sialylation. On the asialoglycophorin A, WVU45 binds probably to terminal galactose of the 
O-glycan chains. On glycophorin A, it could bind to the few non-masked terminal Galβ1-
4GlcNAc-epitopes of the asparagines-linked N-glycans [30]. Adhesion to immobilized S-IgA 
by A. naeslundii WVU45 was also confirmed. This interaction had been observed previously 
and was attributed to O-linked oligosaccharides at the hinge region of the IgA1 heavy chain 
[20].  
 FITC-labeled H. pylori has been used successfully on transfers of 2-D gels [7]. In this 
study we have used S. gordonii as a probe in order to test for the applicability of this 
technique to other bacteria, because S. gordonii initiates the development of oral biofilms by 
adhesion to various salivary proteins of the acquired pellicle [9]. This overlay experiment was 
carried out with S. gordonii DL1 on transfers of separated WS proteins. Among the detected 
salivary receptors some previously published interactions of S. gordonii DL1 with salivary 
proteins were confirmed, namely the recognition of salivary mucin MUC7 [4], acidic PRPs 
[4], IgA α2 heavy chain [20] and proline-rich glycoprotein [4]. No information was available 
on the adhesion of S. gordonii to, or the interaction of S. gordonii with the secretory 
component of the poly-Ig-receptor, basic PRPs, zinc-α2-glycoprotein, and carbonic anhydrase 
VI. As already mentioned, α2,3-linked sialic acid on O-linked oligosaccharides of the IgA1 
heavy chain was thought to be responsible for the recognition of S-IgA by S. gordonii [20]. At 
present, only speculation is possible about the binding of S. gordonii DL1 to the secretory 
component, another part of S-IgA presenting only N-glycans [31]. Either the respective group 
of spots on the transfer is not the secretory component, or DL1 binds, additionally, other parts 
of S-IgA than only the sialic acid containing O-glycans of IgA1. Considering structural 
studies on the secretory component N-glycans, it seems likely that S. gordonii might also 
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interact with this part of S-IgA because over 70% of the glycans are sialylated. Sialic acid 
occurs on both forms, α2,3 and α2,6-linked [31]. Concerning the detected binding of S. 
gordonii DL1 to basic PRPs it can be hypothesized that this interaction is based on the 
recognition of the same or a similar peptide motif than in the interaction of S. gordonii with 
acidic PRPs. Previous studies indicated that the minimal segment of acidic PRP that promoted 
adhesion of S. gordonii was the carboxy-terminal dipeptide Pro-Gln [25]. This dipeptide was 
also found as carboxy-terminus in three of the basic PRPs [32]. Thus, it has to be investigated 
in more detail, if this is the responsible receptor epitope of basic PRPs for S. gordonii. 
Binding of DL1 to zinc-α2-glycoprotein and carbonic anhydrase VI is most likely due to sialic 
acid present on these molecules [33, 34]. Further experiments using the hsa-deficient mutant 
D102 could solve this question. 
 It must be stated, that in this chapter only the Hsa-adhesin of S. gordonii was 
discussed in more detail because this is the best-characterized adhesin of S. gordonii that 
mediates a lectin-like interaction. However, there are several other adhesins of oral 
streptococci reported in the literature. Some of these have been mentioned above: the 
amylase-binding proteins A and B (AbpA and AbpB) [23, 24], the fibronectin binding 
adhesins CshA and FbpA [29] as well as the PRP-binding adhesin [25]. In addition, the 
antigen I/II proteins have been described as multi-functional adhesins, that bind human 
salivary glycoproteins as well as other microbial cells [35]. The S. gordonii suface proteins 
SspA and SspB belong to this group of proteins and are known to play a role in adherence to 
salivary proteins and in coaggregation with A. naeslundii [36]. First experiments with 
isogenic sspA and sspB mutants of S. gordonii [36] on glycoconjugate arrays were carried out. 
Because these mutants showed no loss of binding activity on the various sugar structures it 
was concluded, that non of these adhesins mediate a lectin-like interaction (data not shown). 
Concluding Remarks 
Fluorescence-labeling of microbes for bacterial overlay on immobilized proteins is an easy 
and powerful method to study adhesin specificities of bacteria because the type of saccharides 
and necessary linkages known from previous studies, were also recognized by FITC-labeled 
bacteria in this study. Glycoarrays with various glycoproteins and neoglycoproteins were in 
this regard very helpful. Finally, it could be shown that the 2-D overlay is suitable for 
different strains of bacteria and for testing of lectin-dependent and peptide-dependent 
bacterial interactions. 
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Since the discovery of Helicobacter pylori (H. pylori) in 1983 [1] enormous progress has been 
made in determining the pathogenesis of this microbe in gastric disease. While the way of 
transmission is still under dispute, it is generally accepted that H. pylori must reach the 
stomach via the oral cavity [2, 3]. However, there are only few studies about interactions of 
H. pylori with salivary components and no study about the influence of saliva on H. pylori 
exists so far (chapter 1). The immediate aim of this thesis was to search for possible 
interactions of H. pylori with glycosylated salivary proteins, by developing an appropriate 
methodological approach to identify such interactions and to characterize the molecular basis 
of such interactions. 
Proteome analysis of human saliva 
In order to utilize two-dimensional gel electrophoresis (2-DE) and subsequent transfer of 
separated proteins onto nitrocellulose membrane (blotting) for a high resolution bacterial 
overlay, a proteome analysis of human whole saliva (WS), parotid, and submandibular-
sublingual (SMSL) secretions was performed. This was carried out by means of 2-D gel 
electrophoresis (2-DE) and matrix-assisted laser desorption/ionization mass spectrometry 
(MALDI-MS).  
In the first part of this thesis, 2-DE of human saliva was optimized in order to obtain 
protein maps as complete as possible with a good quality of the spot pattern (chapter 3). 
Testing and comparing different pH ranges in the first dimension, the optimal pH range for 
isoelectric focusing (IEF) of salivary proteins could be evaluated. It turned out that pH 3-10 
was most suitable to display salivary proteins in a 2-D gel. pH 4-7 and 6-11, in contrast, 
showed only a limited range of protein spots. The way of sample application in the IEF step 
affected the number of spots and the quality of the spot pattern. The best result was achieved 
when the IPG strip was rehydrated directly with the saliva sample under application of 
voltage. WS was initially lyophilized and dialyzed and a first spot analysis of the resulting 2-
D gel was carried out by MALDI-MS. In this gel, a total of 253 spots could be identified, 
whereof 138 spots were identified as keratin. It can be assumed that the keratin contamination  
(mainly keratin 4 and 13) originates from cellular debris. In addition, a number of other 
cellular proteins were identified that may originate from the oral epithelium. Thus, the use of 
saliva that is directly lyophilized turned out to be inapplicable for proteome analysis. 
Filtration of WS prior to gel electrophoresis improved the results by reducing the number of 
spots, including most spots that were identified as keratin. In addition, a new spot group that 
stained pink with Coomassie blue could be detected. It was hypothesized that these spots are 
Chapter 8  Summary and Conclusions 
 
 
 - 149 - 
acidic proline-rich proteins (PRPs) - a major class of salivary proteins that were absent from 
most of the previously performed 2-DE studies on WS. 
 This hypothesis could be verified by the following proteome analysis of filtrated WS 
(chapter 4). In filtrated WS, 131 spots could be identified. Only two of these spots were 
keratin. The pink-stained spot group turned out to be acidic Db-type PRPs. In addition, basic 
PRPs and the glycosylated PRP could be identified. Beside the proteome analysis of filtrated 
WS, a proteome analysis of parotid secretion and, for the first time, of SMSL secretion was 
performed. In parotid secretion 43 spots and in SMSL secretion 53 spots were identified. 
Because the 2-D maps of WS and glandular secretions should be used as tools for adhesion 
studies on H. pylori, the extent of intra-individual and inter-individual variations of 2-D spot 
pattern was investigated. For intra-individual comparison, salivary 2-D gels from one 
individual collected at 3 different days were compared. These gels of WS showed a good 
reproducibility in their overall spot pattern but with some quantitative variations whereas 
glandular secretions showed no apparent differences in the spot pattern between the three 
collection days. For inter-individual comparison, salivary 2-D gels from four different 
individuals were compared. In this case it can be summarized that there was a consistency of 
most major spots. Again, whole saliva showed mainly quantitative differences. Glandular 
secretions appeared similar with only few distinct differences.  
Glycoconjugate array 
For adhesion studies on H. pylori, isogenic mutants were used, lacking either the BabA- 
and/or SabA-adhesins [4]. These mutants and their wild-type strain J99A could be very well 
characterized by overlay with fluorescence-labeled bacteria on immobilized 
(neo)glycoproteins (chapter 5). Interaction between the adhesin BabA and the H-1-, Lewis b- 
and related fucose-containing antigens could be confirmed [5]. The previously described 
interaction of H. pylori with terminal α2-3-linked sialic acids could be shown too [6]. The use 
of a sabA mutant and sialidase treatment of glycoconjugate arrays showed for the first time 
that the adherence of H. pylori to laminin is mediated by the sialic acid-binding adhesin, 
SabA. In addition, it could be shown that the adhesion to salivary mucin MUC5B is mainly 
associated with the BabA adhesin, and to a lesser extent with the SabA adhesin. It turned out 
that the adhesion of H. pylori to fibronectin and lactoferrin persisted in the babA/sabA double 
mutant. This binding could be abolished by denaturation but not by deglycosylation. 
Therefore, it was suggested that this interaction may depend on the recognition of unknown 
receptor moieties by one or more additional unknown bacterial surface components.  
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In order to show that the newly developed fluorescence-labeling of bacteria in the 
overlay experiment does not interfere with adhesion properties, a bacterial overlay on 
glycoconjugate arrays was carried out with two other well-defined species of oral bacteria 
(actinomyces and streptococci) (chapter 7). On these arrays all known binding specificities of 
sialic acid/N-acetylgalactosamine- (S. gordonii) [7, 8] and galactose/N-acetylgalactosamine- 
(A. naeslundii) [9] reactive lectins could be confirmed, providing evidence that fluorescence-
labeling of bacteria may be a universally applicable method. 
Adhesion studies on human saliva 
Characterized H. pylori mutants were applied to blots of 1-D and 2-D gels of human saliva by 
bacterial overlay (chapter 6). Three receptor molecules of H. pylori detected by 1-D overlay 
could successfully be identified by MALDI-MS, confirming the binding of H. pylori to 
MUC5B, MUC7 and gp-340 [10]. Adhesion to MUC5B was associated with both the SabA 
and the BabA adhesins. Adhesion to MUC7 could now be associated with the SabA adhesin 
and adhesion to gp-340 was shown to be mediated by the BabA adhesin. The 2-D overlay 
revealed novel salivary receptors for H. pylori. Identification of these receptors was achieved 
by comparison of the overlay membrane with the established proteome maps of human saliva 
(chapter 4).  Binding of H. pylori to the proline-rich glycoprotein was detected for the first 
time and assigned to the activity of the BabA adhesin. The SabA adhesin was found 
responsible for binding to other newly detected receptor molecules, including carbonic 
anhydrase VI, secretory component (poly-Ig-receptor), parotid secretory protein and zinc-α2-
glycoprotein. 
 In order to show the applicability of the 2-D overlay technique for other species of 
bacteria, it was also carried out with S. gordonii DL1 (chapter 7). This revealed some 
expected interactions of S. gordonii DL1 with salivary receptors (e.g. MUC7, proline-rich 
glycoprotein, acidic PRPs and IgA α2-heavy chain) as well as so far unknown interactions 
including the secretory component of the poly-Ig-receptor, basic PRPs, zinc-α2-glycoprotein 
and carbonic anhydrase VI. 
Conclusion 
In conclusion, this thesis combined for the first time successfully a proteomics approach with 
the bacterial overlay technique. This method showed not only the binding of H. pylori to 
salivary proteins but facilitated the identification of respective receptor molecules 
considerably. In addition, this technique was found to be suitable for other bacteria. Thus, a 
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widely applicable tool for studying adhesion of bacteria was developed. To what extent the 
obtained results maybe of importance for bacterial pathogenesis has to be investigated in the 
future. 
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List of Abbreviations 
1-D     one-dimensional 
2-D     two-dimensional 
2-DE    two-dimensional gel electrophoresis 
AlpAB   adherence-associated lipoprotein A/B 
APD    acetylphenyendiamine 
APE    acetylphenylethyl 
BabA    blood group antigen binding adhesin 
BCA    bicinchoninic acid  
BSA    bovine serum albumin 
CagA    cytotoxin-associated gene A 
CHAPS   3-[(2-amino-2-oxoethyl)amino]ethanesulfonic acid 
DTT    dithiothreitol 
ECM    extracellular matrix proteins 
FITC    fluorescein-5-isothiocyanate 
Gal    galactose 
GalNAc   N-acetylgalactosamine 
GlcNAc   N-acetylglucosamine 
H. pylori   Helicobacter pylori 
HSA    human serum albumin 
IEF    isoelectric focusing 
IPG    immobilized pH gradient 
LC    liquid chromatography 
LTA    Lotus tetragonolobus agglutinin 
MALDI-TOF   matrix-assisted laser desorption/ionization-time-of-flight 
MALT    (mucosa-associated lymphoid tissue)-lymphoma 
Mr    relative molecular mass (dimensionless) 
MS    mass spectrometry 
MudPIT   multidimensional protein identification technology 
NeuNAc   N-acetylneuraminic acid 
NL    non-linear 
OMP    outer membrane protein 
PAGE    polyacrylamide gel electrophoresis 
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PAP    p-aminophenyl 
PBS    phosphate buffered saline 
PCR    polymerase-chain-reaction 
PFF    peptide fragmentation fingerprint 
pI    isoelectric point 
PMF    peptide mass fingerprint 
PMN cells   polymorph nuclear leukocytes     
PRG    proline-rich glycoprotein 
PRP    proline-rich protein 
SabA    sialic acid-binding adhesin 
SDS    sodium dodecyl sulfate 
S-IgA    secretory immunglobulin A 
SMSL    submandibular-sublingual 
SNAP    similarity-neighborhood approach 
TBS    Tris-buffered saline 
TCA    trichloroacetic acid 
Tris    tris(hydroxymethyl)aminomethane 
U    unit 
UEA-I    Ulex europaeus agglutinin 
WS    human whole saliva 
wt    wild-type 
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Supplementary Material to Chapter 4 
Supplementary Figure. Amino acid sequences of proteins newly mapped in 2-DE of human 
saliva. Amino acid sequences determined by MALDI-PFF are highlighted in dark gray and 
amino acid sequences determined by MALDI-PMF are highlighted in light gray.  
 
gi|1310882  Cyclophilin B 
        10         20         30         40         50  
GPKVTVKVYF DLRIGDEDVG RVIFGLFGKT VPKTVDNFVA LATGEKGFGY  
        60         70         80         90        100  
KNSKFHRVIK DFMIQGGDFT RGDGTGGKSI YGERFPDENF KLKHYGPGWV  
       110        120        130        140        150  
SMANAGKDTN GSQFFITTVK TAWLDGKHVV FGKVLEGMEV VRKVESTKTD  
       160        170  
SRDKPLKDVI IADCGKIEVE KPFAIAKE 
 
gi|16116524  CST1 
        10         20         30         40         50  
MAQYLSTLLL LLATLAVALA WSPKEEDRII PGGIYNADLN DEWVQRALHF  
        60         70         80         90        100  
AISEYNKATK DDYYRRPLRV LRARQQTVGG VNYFFDVEVG RTICTKSQPN  
       110        120        130        140  
LDTCAFHEQP ELQKKQLCSF EIYEVPWENR RSLVKSRCQE S 
 
gi|7239109  HSPC059 
        10         20         30         40         50  
MPHLLVTFRD VAIDFSQEEW ECLDPAQRDL YRDVMLENYS NLISLDLESS  
        60         70         80         90        100  
CVTKKLSPEK EIYEMESLQW ENMGKRINHH LQYNGLGDNM ECKGNLEGQE  
       110        120        130        140        150  
ASQEGLYMCV KITCEEKATE SHSTSSTFHR IIPTKEKLYK CKECRQGFSY  
       160        170        180        190        200  
LSCLIQHEEN HNIEKCSEVK KHRNTFSKKP SYIQHQRIQT GEKPYECMEC  
       210        220        230        240        250  
GKAFGRTSDL IQHQKIHTNE KPYQCNACGK AFIRGSQLTE HQRVHTGEKP  
       260        270        280        290        300  
YDCKKCGKAF SYCSQYTLHQ RIHSGEKPYE CKDCGKAFIL GSQLTYHQRI  
       310        320        330        340        350  
HSGEKPYECK ECGKAFILGS HLTYHQRVHT GEKPYICKEC GKAFLCASQL  
       360        370        380        390        400  
NEHQRIHTGE KPYECKECGK TFFRGSQLTY HLRVHSGERP YKCKECGKAF  
       410        420        430        440        450  
ISNSNLIQHQ RIHTGEKPYK CKECGKAFIC GKQLSEHQRI HTGEKPFECK  
       460        470        480        490        500  
ECGKAFIRVA YLTQHEKIHG EKHYECKECG KTFVRATQLT YHQRIHTGEK  
       510        520        530        540        550  
PYKCKECDKA FIYGSQLSEH QRIHRGEKPY ECKQCGKAFI RGSHLTEHLR  
       560        570        580        590        600  
THTGEKPYEC KECGRAFSRG SEHTLHQRIH TGEKPYTCVQ CGKDFRCPSQ  
 
LTQHTRLHN 
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gi|40549418  Lactoperoxidase; salivary peroxidase 
        10         20         30         40         50  
MRVLLHLPAL LASLILLQAA ASTTRAQTTR TSAISDTVSQ AKVQVNKAFL  
        60         70         80         90        100  
DSRTRLKTAM SSETPTSRQL SEYLKHAKGR TRTAIRNGQV WEESLKRLRQ  
       110        120        130        140        150  
KASLTNVTDP SLDLTSLSLE VGCGAPAPVV RCDPCSPYRT ITGDCNNRRK  
       160        170        180        190        200  
PALGAANRAL ARWLPAEYED GLSLPFGWTP GKTRNGFPLP LAREVSNKIV  
       210        220        230        240        250  
GYLNEEGVLD QNRSLLFMQW GQIVDHDLDF APDTELGSSE YSKAQCDEYC  
       260        270        280        290        300  
IQGDNCFPIM FPPNDPKAGT QGKCMPFFRA GFVCPTPPYK SLAREQINAL  
       310        320        330        340        350  
TSFLDASFVY SSEPSLASRL RNLSSPLGLM AVNQEVSDHG LPYLPYDSKK  
       360        370        380        390        400  
PSPCEFINTT ARVPCFLAGD SRASEHILLA TSHTLFLREH NRLARELKRL  
       410        420        430        440        450  
NPQWDGEKLY QEARKILGAF VQIITFRDYL PILLGDHMQK WIPPYQGYSE  
       460        470        480        490        500  
SVDPRISNVF TFAFRFGHLE VPSSMFRLDE NYQPWGPEPE LPLHTLFFNT  
       510        520        530        540        550  
WRMVKDGGID PLVRGLLAKK SKLMKQNKMM TGELRNKLFQ PTHRIHGFDL  
       560        570        580        590        600  
AAINTQRCRD HGQPGYNSWR AFCDLSQPQT LEELNTVLKS KMLAKKLLGL  
       610        620        630        640        650  
YGTPDNIDIW IGAIAEPLVE RGRVGPLLAC LLGKQFQQIR DGDRFWWENP  
       660        670        680        690        700  
GVFTNEQKDS LQKMSFSRLV CDNTRITKVP RDPFWANSYP YDFVDCSAID  
       710  
KLDLSPWASV KN 
 
gi|16116524  Mucin 7 
        10         20         30         40         50  
MKTLPLFVCI CALSACFSFS EGRERDHELR HRRHHHQSPK SHFELPHYPG  
        60         70         80         90        100  
LLAHQKPFIR KSYKCLHKRC RPKLPPSPNN PPKFPNPHQP PKHPDKNSSV  
       110        120        130        140        150  
VNPTLVATTQ IPSVTFPSAS TKITTLPNVT FLPQNATTIS SRENVNTSSS  
       160        170        180        190        200  
VATLAPVNSP APQDTTAAPP TPSATTPAPP SSSAPPETTA APPTPSATTQ  
       210        220        230        240        250  
APPSSSAPPE TTAAPPTPPA TTPAPPSSSA PPETTAAPPT PSATTPAPLS  
       260        270        280        290        300  
SSAPPETTAV PPTPSATTLD PSSASAPPET TAAPPTPSAT TPAPPSSPAP  
       310        320        330        340        350  
QETTAAPITT PNSSPTTLAP DTSETSAAPT HQTITSVTTQ TTTTKQPTSA  
       360        370  
PGQNKISRFL LYMKNLLNRI IDDMVEQ 
 
gi|88462  Proline-rich phosphoprotein (gene PRH1, Db allele) 
        10         20         30         40         50  
QDLNEDVSQE DVPLVISDGG DSEQFLDEER QGPPLGGQQS QPSAGDGNQD  
        60         70         80         90        100  
DGPQQGPPQQ GGQQQQGPPP PQGKPQGPPQ QGGQQQQGPP PPQGKPQGPP  
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       110        120        130        140        150  
QQGGHPPPPQ GRPQGPPQQG GHPRPPRGRP QGPPQQGGHQ QGPPPPPPGK  
       160        170  
PQGPPPQGGR PQGPPQGQSP Q 
 
gi|41349486  Proline-rich protein BstNI, subfamily 1 
        10         20         30         40         50  
MLLILLSVAL LALSSAQNLN EDVSQEESPS LIAGNPQGPS PQGGNKPQGP  
        60         70         80         90        100  
PPPPGKPQGP PPQGGNKPQG PPPPGKPQGP PPQGDKSRSP RSPPGKPQGP  
       110        120        130        140        150  
PPQGGKPQGP PAQGGSKSQS ARSPPGKPQG PPQQEGNNPQ GPPPPAGGNP  
       160        170  
QQPQAPPAGQ PQGPPRPPQG GRPSRPPQ 
 
gi|20070125  Prolyl 4-hydroxylase 
        10         20         30         40         50  
MLRRALLCLA VAALVRADAP EEEDHVLVLR KSNFAEALAA HKYLLVEFYA  
        60         70         80         90        100  
PWCGHCKALA PEYAKAAGKL KAEGSEIRLA KVDATEESDL AQQYGVRGYP  
       110        120        130        140        150  
TIKFFRNGDT ASPKEYTAGR EADDIVNWLK KRTGPAATTL PDGAAAESLV  
       160        170        180        190        200  
ESSEVAVIGF FKDVESDSAK QFLQAAEAID DIPFGITSNS DVFSKYQLDK  
       210        220        230        240        250  
DGVVLFKKFD EGRNNFEGEV TKENLLDFIK HNQLPLVIEF TEQTAPKIFG  
       260        270        280        290        300  
GEIKTHILLF LPKSVSDYDG KLSNFKTAAE SFKGKILFIF IDSDHTDNQR  
       310        320        330        340        350  
ILEFFGLKKE ECPAVRLITL EEEMTKYKPE SEELTAERIT EFCHRFLEGK  
       360        370        380        390        400  
IKPHLMSQEL PEDWDKQPVK VLVGKNFEDV AFDEKKNVFV EFYAPWCGHC  
       410        420        430        440        450  
KQLAPIWDKL GETYKDHENI VIAKMDSTAN EVEAVKVHSF PTLKFFPASA  
       460        470        480        490        500  
DRTVIDYNGE RTLDGFKKFL ESGGQDGAGD DDDLEDLEEA EEPDMEEDDD  
 
QKAVKDEL 
 
gi|350217 0508206A peptide PA (proline-rich peptide),saliva 
        10         20         30  
GPGFVPPPPP PPYGPGRIPP PPPAPYGPGI FPPPPPQP 
  
Supplementary Table: Spot counts and accession numbers of proteins identified by 2-DE and MS in whole saliva and glandular secretions. 
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Protein Name Accession a Swissprot 
pI MW pI MW 
1 2 -- -- Actin 14250401 P02570 5.6 41.0 5.2 52.6-53.7 
2 1 -- -- Calgranulin A 21614544 P05109 5.7 13.2 6.2 16.3 
3 2 -- -- Calgranulin B 4506773  5.7 13.1 5.5-5.6 18.4-18.5 
4 9 1 -- 14530767 (WS; S) P23280 6.6 35.3 5.9 37.5 
 -- 3 4 
Carbonic anhydrase VI 
58736977 (P, S)  9.1 35.3 5.9-6.2 36.4-38.6 
5 4 --    -- 4699583 (WS) P25311 5.7 31.6 5.2-5.3 41.4-56.3 
 -- 2 3 
Human Zinc-α-2-Glycoprotein
  7246026 (P, S)  5.6 31.6 5.2-5.4 40.5-41.1 
6 1 -- -- Cyclophilin B  1310882 P23284 9.2 19.7 9.1 22.2 
7 1 -- -- Cystatin B 4503117 P04080 7.1 11.1 6.6 19.2 
8 1 1 -- Cystatin C 14278690 P01034 9.2 12.3 7.9 19.0 
9 1 -- -- Cystatin D 539565 P28325 7.6 16.1 6.2 19.2 
10 3 -- -- 
Cystatin SA-III precursor of 
acquired enamel pellicle  
235948  4.7 14.2 4.0-4.4 19.5-22.7 
11 1 2 -- Cystatin SA 4503105 P09228 4.7 16.4 3.6-4.5 18.2-18.8 
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12 1 2 -- Cystatin SN precursor 19882251 (WS, S) P01037 6.9 16.4 6.6 18.8 
 -- -- 1  2144579 (P)  7.0 16.4 6.6 19.1 
13 2 -- -- Cytokeratin 1 17318569 P04264 8.2 66.1 7.3 24.5 
14 2 -- -- Enolase 1 4503571 P06733 7.0 47.2 6.6 43.3 
15 32 6 10 Human salivary amylase 1633119 P04745 6.2-6.3 55.9-57.8 5.9-6.3 52.6-57.6 
16 3 -- -- Ig alpha-1 chain  113583 P01876 5.6 37.8 5.6-5.8 56.3-57.6 
17 2 -- -- Keratin 10 40354192 P13645 5.1 58.8 6.0 48.3 
18 1 -- -- Lactoferrin 494252 P02788 8.5 75.9 8.1 82.8 
19 3 4 -- Parotid secretory protein  16755850  5.5 27.1 4.9-5.3 29.8-32.8 
20 1 -- -- Phosphoglycerate kinase  4505763 P00558 8.3 44.6 8.1 44.0 
21 3 2 4 poly-Ig receptor 514366 P01833 5.3 75.5 5.5-6.1 86.1-93.6 
22 2 4 -- Prolactin-inducible protein 4505821 P12273 8.6 16.6 4.5-4.8 17.1-20.5 
23 30 8 6 
Proline-rich phosphoprotein 
(gene PRH1, Db allele) 
88462 sim P02810 4.8 17.5 3.2-6.2 24.3-35.4 
24 1 -- 3 
Proline-rich protein BstNI, 
subfamily 1, isoform 3 
41349486 sim P04280 10.8-11.3 17.7 5.6-9.0 22.5-27.2 
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25 2 -- 1 
Proline-rich protein BstNI, 
subfamily 3 
41349488 sim P10163 10.8 35.1 9.5 57.6 
26 1 -- -- Prolyl 4-hydroxylase 20070125 P07237 4.8 57.1 5.0 56.3 
27 12 3 3 Serum albumin 4389275 P02768 5.5-5.7 65.2-66.4 5.5-5.7 69.8-72.1 
28 1 -- -- Thioredoxin 230939 P10599 4.8 11.4 4.9 18.4 
29 6 -- -- Transferrin 4557871 P02787 6.8 77.1 6.2-6.5 79.8 
P1 -- -- 1 HSPC059 7239109  8.8 70.8 6.1 26.4 
P2 -- -- 4 Ig alpha-2 heavy chain 184761  5.7 36.4 5.5-5.6 57.6 
P3 -- -- 4 Ig κ light chain VLJ region 21669311  5.5 27.7 7.1-7.6 26.1-26.4 
P4 -- -- 1 
Lactoperoxidase, salivary 
peroxidase 
40549418  8.9 80.3 7.2 79.8 
P5 -- --  
Salivary acidic proline-rich 
phosphoprotein 1/2 precursor 
131008 P02810 4.5 17.0 4.1 26.8 
S1 -- 2 -- CST1 16116524  6.9 16.4 6.1-7.2 18.9-19.0 
S2 -- 4 -- Cystatin S 4503109 P01036 5.0 16.2 4.0-4.4 19.5-22.7 
S3 -- 4 -- Histatin 1 4504529 P15515 9.1 7.0 6.2 16.3 
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S4 -- 1 -- Mucin 7 22748665  9.0 39.2 3.1 120.7 
S5 -- 1 -- 
0508206A peptide PA, proline-
rich peptide 
350217  5.0 3.8 8.9 18.2 
 
a WS, whole saliva; P, parotid saliva; S, submandibular-sublingual saliva. 
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Supplementary Material to Chapter 6 
Supplementary Figure. Amino acid sequences used for identification of MUC5B, MUC7, and 
gp-340 as determined by MALDI-PMF. Amino acid sequences additionally determined by 
MALDI-PFF are indicated in bold letters. 
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